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ABSTRACT 
Phytoestrogens are plant compounds that possess estrogenic and biological properties that 
have been postulated to protect against chronic diseases. Isoflavonoids and lignans are two 
main classes of phytoestrogen that have been investigated for their estrogenic efficacy and 
occurrence in the human diet. Isoflavonoids are found in soy and related products, whereas 
lignans are found in a wider range of plant-based foods, such as cereals, vegetables, fruits, 
legumes, nuts and seeds; and in beverages such as tea, coffee and wine. In Western 
populations with low dietary intake of soy products, compared to the Asian counterparts, 
lignans could be a more important and consistent source of phytoestrogens from the diet. Data 
for the phytoestrogen content in foods are now available, as more recent research has been 
conducted to quantify content in commonly consumed food choices in Western populations. 
The collation of these published values has led to the desire to adequately assess lignan 
intake. 
The aims of the research were to evaluate the validity and reliability of a phytoestrogen food 
frequency questionnaire (FFQ) tool, with a reference method, the weighed food record 
(WFR), and urinary biomarkers, to measure phytoestrogen intake in the Australian context. 
The phytoestrogen FFQ was updated and refined to align with food groups and dietary 
patterns in the current Australian Dietary Guidelines, in particular to optimise measurement of 
lignans from the FFQ, and utilise current databases of lignan content available from direct 
measurement of lignans in foods. Intake level and contributing food sources of each class of 
phytoestrogen, and the associations between social and lifestyle characteristics and 
phytoestrogen intake and urinary biomarker were also explored. 
This was a cross-sectional study that recruited 59 Australian men and women aged 18 to 67 
years at Joondalup campus, Edith Cowan University. Intake of lignans, isoflavonoids and 
enterolignans from foods was assessed using the 277-item phytoestrogen FFQ and 3-day 
WFR, and excretion was assessed with urinary biomarkers. Published values of phytoestrogen 
content in foods were utilised to measure the intakes. Subjects collected three 24-hour urine 
samples and phytoestrogen concentration was analysed using a liquid chromatography-mass 
spectrometry (LC-MS) technique for four lignan subclasses, five isoflavonoids and two 
enterolignans.  
Statistical analyses were conducted using IBM SPSS for Windows (SPSS Inc., Version 22 
Chicago, IL). Median intake comparisons were assessed with the Wilcoxon signed rank test. 
Associations between the intake and excretion measurements of two dietary assessment 
methods were assessed using Spearman’s Rho correlations. Level of agreement between 
methods was assessed with cross-classification analysis and Bland Altman plots. A triangular 
comparison between the three methods was conducted with the Method of Triads (MOT) 
using the software R. The Mann-Whitney U test and Kruskal-Wallis one-way ANOVA were 
used to compare the median intakes and excretion across categories of social and lifestyle 
factors. 
The FFQ had acceptable convergent validity for intake of total lignans and enterolignans 
when compared to a WFR, in terms of median intakes (lignans: 3914 versus 4302 µg/day, 
p=0.09; enterolignans: 54 versus 65 µg/day, p=0.81, respectively); and associations between 
the two methods (lignans ρ=0.42, p<0.001 and enterolignans ρ=0.62, p<0.001). Median 
intakes of total isoflavonoids from the FFQ and WFR were also comparable (3851 versus 
2287 µg/day, p=0.67) with a significant association between the two tools (ρ=0.36, p<0.001). 
A 7% to 17% of subjects were misclassified into opposite quartiles for different phytoestrogen 
classes. The FFQ also had acceptable reliability when compared to a repeat FFQ, for all 
classes of phytoestrogens, with strong correlations between intakes (ρ=0.78 to ρ=0.85, 
p<0.001 for all) and minor misclassifications into opposite quartiles, between 2% to 5%. The 
FFQ had poor validity in relation to biomarkers of phytoestrogen excretion. The median 
intake and excretion of combined lignans and enterolignans were not significantly different 
(4051 versus 3104 µg/day, p=0.22, respectively), but there was no significant correlation 
between intake and excretion (ρ=0.16, NS). For total isoflavonoids, excretion was 10-fold 
lower than intake from the FFQ (268 versus 3851µg/day, respectively p<0.001) and there was 
no significant correlation between the two tools (ρ=0.10, NS). Misclassification into the 
opposite quartile was also relatively high for both phytoestrogen classes (21% to 23%). Visual 
inspection of the Bland Altman graphs showed trends towards greater inconsistency at higher 
median intakes and urinary excretion. Higher validity coefficients (VCs) were observed for 
the FFQ in measuring total lignans (VC=0.57) or the FFQ and WFR for measuring combined 
lignans plus enterolignans (VC=0.79, 0.78, respectively). 
Top contributing food sources of lignans were from the nuts and seeds group (30%), 
nonalcoholic beverages (19%), and breads and cereals (19%); for enterolignans, from dairy 
products (86%) followed by nonalcoholic beverages (11%). Soy and related food products 
were the major contributors (78%) to total isoflavones, followed by breads and cereal 
products (17%).  
Female subjects who were Caucasian, were at, or had achieved university education level and 
took regular commercial dietary supplements, were more likely to have a higher lignan and 
enterolignan intake and excretion level than subjects with different characteristics.  
 
Based on these findings, we conclude that the modified phytoestrogen FFQ is highly reliable. 
It would be a useful assessment tool for example to rank usual intake of phytoestrogen classes 
for individuals within a group, or quantify mean intakes between different population groups. 
It is not acceptably valid or accurate for estimation of individual phytoestrogen status, for 
example for use in experimental studies or to investigate associations with chronic diseases. 
The lack of associations between measurement of the FFQ and biomarkers could partly be 
due to limitations of the FFQ tool, such as recall bias or inaccuracies in the estimation of 
frequency of intake or portion sizes. They also suggest that urinary biomarkers alone are not 
sufficient for estimation of phytoestrogen status and that additional biomarkers obtained from 
faecal and plasma samples should be considered for a more complete picture of phytoestrogen 
status. 
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CHAPTER ONE: INTRODUCTION 
1.1 Background and conceptual framework 
The consumption of plant-based diets, including a variety of vegetables, fruits, grains, 
legumes, and nuts and seeds, has been inversely associated with the progression of chronic 
diseases (World Cancer Research Fund/American Institute for Cancer Research 
(WCRF/AICR), 2007; National Health and Medical Research Council (NHMRC), 2013a; 
Mann, 2000). Optimising plant-based diets may increase the potential health benefits, which 
are attributed to vitamins, minerals, and more recently, a diverse array of bioactive 
constituents in plant foods (NHMRC, 2013a). Of these constituents, phytoestrogens have 
been thought to protect against chronic diseases, particularly certain types of cancer, due to 
their estrogenic properties and other biological activities (Adlercreutz, 2007; NHMRC, 2013a; 
WCRF/AICR, 2007). 
The Australian Dietary Guidelines (the Guidelines) and the Australian Guide to Health Eating 
(AGHE) were developed to provide guidance on the types and amounts of foods from the five 
food groups to inform dietary patterns that promote health and wellbeing (NHMRC, 2013a, 
2013b). The Guidelines encourage Australians to consume a variety of items from the five 
food groups, with emphasis on the consumption of plant-based foods, such as vegetables and 
legumes; fruits; grains, especially whole grains and high fibre cereals; and nuts and seeds. It is 
important to measure the dietary consumption of phytoestrogens in Australia, as the 
population is likely to follow dietary patterns that include variable amounts of plant-based 
foods in which phytoestrogens contribute to the perceived health benefits. 
The current research focuses on the capability of a modified food frequency questionnaire 
(FFQ) to measure intake of two major classes of phytoestrogen, the lignans and isoflavonoids, 
in a sample of the Australian population. The validation of the food frequency questionnaire is 
the basis of this applied research. The conceptual framework that depicts the relationship 
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between the development and evaluation of the FFQ is shown in Figure 1. Central to the 
framework is the FFQ and the estimation of phytoestrogen status in relation to dietary intake 
and urinary excretion.  The FFQ food list was reviewed and modified with respect to the 
content of lignans and isoflavones from published databases, to include a range of 
commonly-consumed foods based on dietary patterns described in the Australian Dietary 
Guidelines. Individual differences in colonic microflora could influence the bioavailability 
and hence metabolism and urinary excretion of phytoestrogens.  Demographic, social and 
lifestyle characteristics such as gender, BMI, bowel habits, and supplements use are also 
associated determinants of status (Hanna, O'Neill, & Lyons-Wall, 2010). The repeatability of 
the FFQ was evaluated by administering the FFQ to subjects on two occasions one to two 
weeks apart; and the validity was evaluated by comparing intake from the FFQ with intake 
derived from a 3-day weighed food record (WFR) reference method, and with excretion of 
urinary biomarkers. Phytoestrogen status determined by both the dietary assessment tools and 
urinary biomarkers, is the outcome of this research that informs the bioavailability and 
metabolomics profiles of lignans and isoflavonoids. The Method of Triads was applied for a 
triangular comparison between the FFQ, the 3-day WFR and the urinary excretion of 
metabolites for estimating phytoestrogen status. The implication of the research is to 
investigate the potential applicability of phytoestrogen status as a biomarker of health and 
wellbeing.           
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Figure 1. Conceptual framework for the evaluation of a modified FFQ, dietary phytoestrogen 
intake and status, and associated factors and variables. 
The validation of a dietary assessment tool for estimating phytoestrogen status is the basis of this 
applied research. Methods are shown in green, tools are in red and phytoestrogen status is in blue. 
Phytoestrogen status determined by both the dietary assessment tools and urinary biomarker is the 
outcome of this research that informs the bioavailability and metabolomics profiles. If the FFQ is 
shown to a valid and reliable tool, it could be used to further investigate the role of dietary 
phytoestrogens in health and prevention of disease 
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1.2 Aims and hypotheses 
This research was conducted in a sample of the Australian population. The aims were: 
1. To modify and refine a FFQ to estimate phytoestrogen intake based on a previous 
questionnaire for use in an Australian population;  
2. To estimate the validity of the FFQ by comparison with intake obtained from a 3-day 
WFR reference method and biomarkers of urinary phytoestrogen excretion;  
3. To estimate the reliability of the FFQ by comparison with intake obtained from pre FFQ 
and post FFQ;  
4. To estimate dietary phytoestrogen intake using the FFQ and WFR and evaluate the major 
contributing food sources; 
5. To determine the social and lifestyle characteristics and variables associated with 
phytoestrogen intake and biomarkers.  
 
The hypotheses being tested are: 
1. There is no significant difference between average phytoestrogen intakes derived from the 
FFQ versus the 3-day WFR reference method. 
2. There is no significant difference between the average phytoestrogen intake derived from 
the pre FFQ versus the post FFQ, administered one week apart. 
3. There are significant positive associations between phytoestrogen intake derived from the 
pre FFQ and post FFQ, and FFQ and WFR; and between phytoestrogen intake estimated 
from the FFQ or WFR and urinary excretion of phytoestrogen metabolites. 
4. There is acceptable agreement observed in Bland Altman plots between individual values 
for phytoestrogen intake derived from the FFQ and WFR, and pre FFQ and post FFQ; and 
between phytoestrogen intake estimated from the FFQ and urinary biomarkers. 
5. Of the measures of assessment of phytoestrogen status, the FFQ has a higher validity 
coefficient (VC), calculated with the method of triads, than the WFR or biomarkers; the 
VCs are within the accepted theoretical range of 0 to 1. 
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1.3 Significance 
There is a need for dietary tools to adequately assess phytoestrogen intake of different 
populations living in Western locations, including multiethnic groups such as those living in 
Australia today.  Data for the phytoestrogen content in foods are now available, as more 
recent research has been conducted to quantify content in commonly consumed food choices 
in Western populations. The collation of these published values has led to the desire to 
adequately assess lignan and isoflavonoid intake.   The public interest in following dietary 
patterns that promote health and wellbeing has driven the need to know more about the 
current intake level, and food sources and dietary patterns related to these bioactive 
compounds such as phytoestrogens. These compounds may play a role in the mechanism and 
physiological changes that lead to health benefits and wellbeing.   
 
This study evaluates the validity and reliability of a modified FFQ tool to measure 
phytoestrogen intake in the Australian context. The contribution of these compounds and their 
association with chronic diseases has not been completely elucidated, indicating the 
importance of having valid and reliable tools with low burden for assessment of 
phytoestrogen intake and status. Once validated, the FFQ could be used as the tool to measure 
phytoestrogen intake in nutritional epidemiological studies to investigate the relationship 
between dietary phytoestrogen intake and chronic diseases in Australia. As there is currently 
no optimal intake level established for phytoestrogen, the findings of the research could also 
contribute to development of an optimal intake level for these bioactive constituents in dietary 
guidelines.   
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CHAPTER TWO: LITERATURE REVIEW 
2.1 Phytoestrogens 
Phytoestrogens are non-steroidal plant compounds that possess estrogenic properties due to 
structural similarity to mammalian estrogens (Adlercreutz, 2007; Dixon, 2004; Mostrom & 
Evans, 2011; Wiseman, 2012). The structural features of phytoestrogens, including the 
diphenolic ring and the position of the hydroxyl groups, are crucial for binding to the estrogen 
receptor (ER) to elicit estrogenic activity (Miksicek, 1995; Turner, Agatonovic-Kustrin, & 
Glass, 2007) (Figure 2). Phytoestrogens act like selective estrogen receptor modulators 
(SERMS) to inhibit or stimulate estrogen-like actions that include modulation of enzyme 
activities, induction of gene expression and regulation of cell growth (Cassidy, Hanley, & 
Lamuela-Raventos, 2000; Kurzer & Xu, 1997; Mostrom & Evans, 2011). Scientific attention 
has focused on the two main classes of phytoestrogens, isoflavonoids and lignans for their 
estrogenic efficacy and occurrence in the human diet (Cassidy et al., 2000; Landete, 2012; 
Wang, 2002).  Isoflavonoids are found in soy and related products, and the legume and bean 
family. Lignans are found in a wider range of plant-based foods, such as cereals, vegetables, 
fruits, legumes, nuts and seeds; and in beverages such as tea, coffee and wine (Adlercreutz, 
2007; Cassidy et al., 2000; Dixon, 2004; Landete, 2012).  In Western populations with low 
dietary intake of soy products, lignans could be a more important and consistent source of 
phytoestrogens from the diet (Hanna, 2006).  
 
2.2 Subclasses of phytoestrogens– lignans and isoflavonoids 
Secoisolariciresinol (SECO), matairesinol (MAT), pinoresinol (PINO), and lariciresinol 
(LARI) are the four major dietary plant lignans or lignan precursors, of particular interest in 
relation to their bioavailability for human absorption and degree of conversion into two major 
lignan metabolites or enterolignans, enterodiol (END) and enterolactone (ENL) (Heinonen et 
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al., 2001).  Two other lignan precursors from rye, syringaresinol (SYR) and medioresinol 
(MED), have also been identified as major dietary determinants of urinary lignan 
concentrations in the Finnish population (Heinonen et al., 2001; Peñalvo, Haajanen, Botting, 
& Adlercreutz, 2005). The chemical structures of lignans are illustrated in Figure 2b, c.  
Genistin, daidzin and glycitin are the major dietary isoflavonoids. They are hydrolysed and 
converted by colonic bacteria into metabolites, in particular genistein, daidzein and glycitein, 
that can be absorbed and excreted into the urine (King & Bursill, 1998; Watanabe et al., 
1998). 
 
2.3 Absorption and metabolism of lignans and isoflavonoids 
Lignans and isoflavonoids show similar patterns of absorption and metabolism with 
production of their unique metabolites (Heinonen, Hoikkala, Wähälä, & Adlercreutz, 2003; 
Landete, 2012).  Lignans are diphenolic compounds that occur in plants as inactive 
conjugated glycosides or glycones with sugar moieties attached (Dixon, 2004).  The active 
aglycone is formed through the removal of the sugar moiety by intestinal microbial enzymes, 
β-glucosidases (Mostrom & Evans, 2011). The unconjugated lignans undergo 
biotransformation through a further series of metabolic reactions to form two metabolites, 
enterodiol (END) and enterolactone (ENL) (Landete, 2012).  The active lignan aglycones 
and their metabolites possess estrogenic properties and can act either as an estrogen agonist or 
an antagonist (Dixon, 2004; Kurzer & Xu, 1997; Mostrom & Evans, 2011; Thompson & Ward, 
2002).  
Dietary lignans undergo metabolic transformations in the colon. Metabolites are absorbed 
from the gastrointestinal tract into the portal vein and transported to the liver where they are 
conjugated with glucuronate or sulphate. They may be secreted with bile into the 
gastrointestinal tract and undergo hepatic recirculation or distributed in the body and finally 
excreted into urine or faeces; lignans are also secreted into bodily fluids such as breast milk. 
The absorption and metabolism of lignan precursors is summarised in Figure 3 (Cassidy et al., 
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2000; Duncan, Phipps, & Kurzer, 2003; Heinonen et al., 2001; Landete, 2012; Mostrom & 
Evans, 2011; Wang, 2002). In brief, SECO diglucoside (SDG) is deglycosylated by intestinal 
glucosidases to form the aglycone SECO, which can be further metabolised to END through a 
series of demethylation and dehydroxylation reactions, or dehydrogenated to form ENL as the 
end product. Both END and ENL can be detected in urine and reflect dietary intake of SECO. 
In a study of lignan metabolism using an in-vitro incubation model, Heinonen et al. (2001) 
measured the degree of conversion of lignan precursor to enterolignans in a 24 hour 
incubation period and observed that 72% of added SECO, 55% of PINO, 100% of LARI and 
4% of SYR were converted to both ENL and END, and 62% of MAT to ENL only (Bowey, 
Adlercreutz, & Rowland, 2003; Wang, 2002; Wang, Meselhy, Li, Qin, & Hattori, 2000).    
The conjugated isoflavone glycosides, genistin, daidzin and glycitin, and methylated 
precusors formononetin and biochanin A, form the main sources of dietary isoflavonoids 
(Setchell, Brown, Desai, Zimmer-Nechemias, & et al., 2001). Similarly to lignans, the 
isoflavonoid glycosides require the hydrolysis of the sugar moiety by intestinal 
β-glucosidases to release the aglycones, genistein, daidzein and glycitein (Setchell et al., 
2002). The aglycones can be absorbed into the portal vein or undergone further 
transformation to different metabolites. For example, daidzein can be metabolised to 
dihydrodaidzein, O-desmethylangolensin and equol; genistein can be metabolised to 
dihydrogenistein and 6’-hydroxy-O-desmethylangolensin (Heinonen et al., 2003); glycitein 
can be metabolised to dihydroglycitein, dihydro-6,7,4’-trihydroxyisoflavone and 
5’-O-methyl-O-desmethylangolensin (Simons, Renouf, Hendrich, & Murphy, 2005)  
8-hydroxyl-glycitein and 6-hydroxyl-daidzein (Rüfer, Maul, Donauer, Fabian, & Kulling, 
2007) (Figure 4). The methylated precursors, formononetin and biochanin A can be 
metabolised to daidzein and genistein, respectively (Reinli & Block, 1996).  
 
2.4 Biological activities of lignan metabolites 
END and ENL possess biological functions and weak estrogenic properties like other 
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phytoestrogenic compounds (Figure 2c). It has been postulated that high production of these 
metabolites results from a high dietary exposure and provides subsequent protection against 
hormonal-dependent cancers, particularly breast and prostate cancer (Adlercreutz, 2007; 
Wang, 2002).  Structural differences amongst phytoestrogen compounds exhibit different 
selective binding affinity for variants of the estrogen receptor (ER). While certain 
phytoestrogens, like the soy isoflavonoids, genistein and coumestrol, have a higher binding 
affinity for ER beta (β) than ER alpha (α), ENL preferentially binds to ER (α) (Kuiper et al., 
1997; Mueller, Simon, Chae, Metzler, & Korach, 2004).  This implies that selective binding 
affinity may be an attribute that enables phytoestrogenic compounds, particularly END and 
ENL, to have biphasic estrogenic or antiestrogenic characteristics, that is, the phytoestrogens 
exhibit estrogenic activity at low concentration (0.1-10µM) but antiestrogenic at high 
concentration (>10µM) (Wang & Kurzer, 1997). The biphasic effect allows END and ENL to 
potentially regulate biological functions that are related to health. Upon binding to the ER, 
END and ENL might modulate ER protein metabolism and influence hormonal status of 
tissues, modify gene expression and the activity of enzymes. For instance, Adlercreutz et al. 
(1993) showed that ENL at high concentration can inhibit aromatase, which could reduce 
concentration of circulating estrogen; Chen et al. (2009) demonstrated that ENL inhibits 
cyclin D1 expression, which is responsible for proliferation and migration of prostate cancer 
cells. In addition to the discussed activities, END and ENL possess antioxidant activities as 
described by Hu, Yuan, and Kitts (2007), which could protect cells against DNA damage and 
lipid peroxidation.   
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Figure 2. Chemical structures of a) mammalian estrogen, oestradiol; b) plant lignan precursors; and c) lignan metabolites and 
enterolignans. 
 (Images adapted and modified from Landete (2012) Hydroxyl groups and the diphenolic ring are structural features required for binding to the estrogen receptor.
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Figure 3. Metabolism of plant lignans and their metabolites.  
 
(Adapted and modified from Cassidy et al. (2000); Duncan et al. (2003); Heinonen et al. (2001); 
Landete (2012); Mostrom and Evans (2011); Wang (2002))  
Inactive plant lignans, or glycone, are obtained through the diet and are deglycosylated by 
intestinal bacterial enzymes to the active form or aglycone. Aglycone plant lignans can be 
readily absorbed but the majority are further metabolised into lignan metabolites, which are 
absorbed into bloodstream. Lignan metabolites circulate through the body and are secreted 
into body fluids or enter enterohepatic recirculation. They are finally excreted in urine. 
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Figure 4. Metabolism of isoflavonoids. 
(Adapted and modified from Cassidy et al. (2000); Duncan et al. (2003); Mostrom and Evans (2011) 
Isoflavonoids and lignans share similar metabolic pathways. Isoflavonoids in the glycone 
form, are obtained through diet and are deglycosylated by intestinal bacterial enzymes to the 
active form or aglycone. The aglycones can be readily absorbed or further transformed into 
metabolites, which are absorbed into bloodstream. Metabolites circulate through the body and 
are secreted into body fluids or undergo enterohepatic recirculation, and finally excreted in 
urine 
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2.5 Epidemiological studies of lignans and isoflavones and risk of chronic diseases 
Lignans and isoflavones are recognised as natural bioactive compounds with a spectrum of 
biological activities that could potentially influence progression of chronic diseases (Cunha, e 
Silva, Veneziani, Ambrosio, & Bastos, 2012; Vitale, Piazza, Melilli, Drago, & Salomone, 
2013). Interest in lignans and isoflavones has been fueled by epidemiological research 
investigating the association between lignans and chronic diseases; particularly 
hormone-dependent cancers due to structural features of phytoestrogens being able to the bind 
to the estrogen receptor (ER) to elicit estrogenic activity (Turner et al., 2007)  
Epidemiological evidence for the effect of lignans and isoflavones on chronic diseases is 
briefly presented in this section of the literature.   
 
Breast cancer 
A case-control study conducted by McCann et al. (2004) examining lignan intake and breast 
cancer risk in pre- and post-menopausal women concluded that there was a significant 34% 
reduction of breast cancer risk in premenopausal women (OR: 0.66 95% CI 0.44 – 0.98) with 
the highest quartile intake of lignans of at least 673μg/d. Further, higher lignan intakes were 
found associated with improved survival among postmenopausal women with breast cancer 
(HR: 0.29, 95%CI 0.11-0.76) (McCann et al., 2010). However one limitation of these studies 
was that the results were not controlled for dietary confounding variables, for example, diets 
high in lignans and isoflavonoids are also high in other food components that have been 
investigated for potential disease prevention benefits.  In a meta-analysis on epidemiological 
studies of lignans in relation to breast cancer risk, Buck, Zaineddin, Vrieling, Linseisen, and 
Chang-Claude (2010) found high lignan exposure was associated with a reduced risk of breast 
cancer in postmenopausal women (pooled RE:0.86, 0.77-0.94). These studies suggest that the 
protective effect may be more prominent in women with post-menopausal status, with 
reduction of estrogen production by the ovaries.   
Isoflavone intake was inversely associated with risk of breast cancer for Japanese Brazilians 
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(OR: 0.25, 0.09-0.68), p<0.01) and non-Japanese Brazilians (OR: 0.56, 0.35-0.90) but these 
effects were not significantly associated with menopausal status (Iwasaki et al., 2009). In 
contrast, a study conducted by Morimoto, Maskarinec, et al. (2014) observed no significant 
associations between isoflavone intake and overall breast cancer risk in a multiethnic cohort 
(HR: 0.96, 0.85-1.08, p=0.40) although a trend of decreasing risk was observed with 
increasing intake in Latina, African American and Japanese American women. Similarly in 
Canadian women no associations were found between isoflavone intake and breast cancer risk 
among all women (OR: 1.06, 0.87-2.30), pre- (OR: 0.96, 0.69-1.33) or post- menopausal (OR: 
1.09, 0.83-1.41) women (Cotterchio, Boucher, Kreiger, Mills, & Thompson, 2008). In a 
meta-analysis by Chen et al. (2014) isoflavone intake had a protective effect on both pre- (OR: 
0.59, 0.48-0.69) and post- (OR: 0.59, 0.44-0.74) menopausal women in Asian countries but a 
marginal protective effect in Western countries (OR: 0.92, 0.83-1.00). These studies suggest 
that the protective effect of isoflavone intake does not differ by menopausal status. Living 
environment, location or a background diet traditionally high in soy intakes was a more 
important potential influence in the relationship between isoflavone intake and breast cancer 
risk, with the protective effect observed in Asian but not in Western women. Notably, these 
studies did not report intake of lignans, which are found broadly in plant-based foods, and in 
Western cultures could provide a more important source of phytoestrogens than isoflavones, 
which are mainly derived from soy and soy products. 
 
Prostate cancer 
A case-control study conducted by Heald, Ritchie, Bolton-Smith, Morton, and Alexander 
(2007) investigated serum phytoestrogens and risk of prostate cancer in a group of 916 
Scottish men, and found a significant reduction of prostate cancer risk with increased level of 
serum ENL >28.9 nmol/l (OR: 0.40, 0.22-0.71), and with soy food consumption (OR: 0.52, 
0.30-0.91), but not with serum daidzein, genistein and equol. However, conflicting evidence 
was observed in other case-control studies with no significant associations between risk of 
prostate cancer and circulating serum enterolactone (Kilkkinen et al., 2003; Stattin et al., 2002; 
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Ward et al., 2008), isoflavone intake (Hedelin, Klint, Chang, Bellocco, Johansson, Andersson, 
Heinonen, Adlercreutz, Adami, Grönberg, et al., 2006), or urinary isoflavonoids (Jackson, 
McFarlane-anderson, Simon, Bennett, & Walker, 2010); or an increased risk of prostate 
cancer associated with higher concentrations of urinary enterolactone (OR: 1.85, 1.01-3.44) 
and intake of phytoestrogens (OR: 1.41, 1.12-1.76) (Jackson et al., 2010; Ward & Kuhnle, 
2010).  
 
Other cancers and chronic diseases 
The associations between lignans and isoflavones and other cancers and chronic diseases have 
also being investigated. Lignan and isoflavone intakes have been associated with decreased 
risks of adenocarcinoma of the oesophagus and gastroesophageal junction in Swedish women 
(Lin, Yngve, Lagergren, & Lu, 2012), endometrial and ovarian cancer in American and 
Australian women (Horn-Ross, John, Canchola, Stewart, & Lee, 2003; Neill et al., 2014), 
lung cancer (Schabath, Hernandez, Wu, Pillow, & Spitz, 2005) and oesophageal cancer in 
Chinese subjects (Tang et al., 2014).   
A cross-sectional study conducted by Franco et al. (2005) investigated lignan intake and 
cognitive function in postmenopausal women and found that high intakes were associated 
with intact cognitive function in the older postmenopausal women. Another cross-sectional 
study exploring the phytoestrogen intake and cardiovascular disease risks conducted by Van 
der Schouw et al. (2005) concluded that the risk of coronary heart disease was lower with 
increasing lignan and isoflavone intake in Western women, particularly in current or past 
smokers. In contrast Talaei, Koh, van Dam, Yuan, and Pan (2014) found that intake of soy and 
isoflavones were not associated with the risk of cardiovascular disease mortality in Chinese 
Singaporean adults. 
The studies presented in this section demonstrate epidemiological evidence to support an 
inverse association between lignan and/or isoflavones, and risk of chronic diseases, although 
some studies have found conflicting results. There were no systematic reviews or 
meta-analyses found on epidemiological studies on prostate and other cancers or chronic 
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diseases in relation to phytoestrogen intake. The potential health benefits and high prevalence 
of lignans in Western diets cannot be ignored and to our knowledge there are limited 
epidemiological studies in the Australian population. This highlights the need to develop a 
dietary assessment tool specifically to quantify intake of lignans and isoflavones in Australian 
context.  
2.6 Food frequency questionnaire 
The food frequency questionnaire (FFQ) is a dietary assessment tool used to assess habitual 
dietary intake by determining the frequency of consumption of a list of foods that are dietary 
contributors to that particular nutrient or dietary component, over a specified period of weeks, 
months or years (Willett, 1998).  There are usually three components of a FFQ, a food list, a 
frequency, and a portion size response section, where the responders indicate how often and 
how much of each food is consumed.   
The FFQ is a common method used in epidemiological studies with large population size 
because it can be self-administered, thus allowing the investigators to collect a substantial 
amount of dietary data in a relatively inexpensive manner.  In addition, FFQs allow 
investigators to identify food patterns associated with certain nutrient intakes, to rank 
individuals by quantile of food or nutrient intakes and to examine the intake in relation to risk 
of chronic diseases (Bingham, 2007; Willett & Lenart, 1998).  The ability of the FFQ to 
correctly reflect the intake of the population is determined by the discrimination between the 
variation in dietary patterns in different groups (Willett, 1998). Therefore, identifying dietary 
patterns and inclusion of commonly consumed food sources in the study population is 
fundamental to the design of a FFQ to successfully capture the dietary component from the 
appropriate food sources.  
There are seven approaches used to evaluate a FFQ, as stated by Willett and Lenart (1998): (1) 
comparison of means, (2) proportion of total intake accounted for by foods included on the 
questionnaire, (3) reproducibility, (4) validity, (5) comparison with biochemical markers, (6) 
correlation with a physiological response and (7) the ability to predict disease. Of these, the 
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common methods used in validation studies of phytoestrogen FFQs in this literature review 
were the comparison of means or medians, and comparison of biochemical markers (Bhakta 
et al., 2005; French, Thompson, & Hawker, 2007; Hanna et al., 2005; Heald, Bolton-Smith, 
Ritchie, Morton, & Alexander, 2005; Horn-Ross et al., 2006; Huang et al., 2000; Lin, Wolk, et 
al., 2012; Tseng et al., 2008; Yamamoto, Sobue, Sasaki, Kobayashi, & et al., 2001), 
convergent validity in comparison with an independent reference method (Bhakta et al., 2005; 
Chan et al., 2008; Fernandez, Omar, & Husain, 2013; Hanna et al., 2005; Horn-Ross et al., 
2006; Huang et al., 2000; Yamamoto et al., 2001), and reproducibility with the FFQ in 
repeated measures (Frankenfeld et al., 2003; Frankenfeld et al., 2002; French et al., 2007; 
Hanna et al., 2005; Horn-Ross et al., 2006). Four of the above approaches were implemented 
in this study to evaluate a specific FFQ in the Australian context; and the other three 
approaches in relation to measurement of total intake, physiological response and disease risk 
were not utilised, as they were not relevant for the current research.  
 
2.7 Evaluation of food frequency questionnaires 
2.7.1 Validity 
2.7.1.1 Weighed food record – convergent validity 
Food records are records of weighed or estimated amounts of food and beverages at the time 
of consumption for a specified number of days (Bingham, 2007). Multiple food records are 
often conducted to consider the daily variation in intake of individual subjects.  Three to ten 
days of food records, with weekend days included, are usually required to represent individual 
usual intake of energy and macronutrients (Buzzard, 1998; Lee & Nieman, 2010).  
Choosing an appropriate reference method is important for assessing the convergent validity 
of the FFQ, to compare the newly established instrument with other related instruments and 
verify that it measures the same construct (Thorkildsen, 2010). Since there is no perfect 
reference method in validation studies, the associated errors of the FFQ and the reference 
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method should be as independent and uncorrelated as possible (Nelson, 1997; Willett & 
Lenart, 1998). The FFQ and the diet history interview are both retrospective dietary tools and 
therefore share similar sources of errors that may lead to the underestimation of the 
correlation between the two methods (Willett and Lenart 1998). The ‘ideal’ reference method 
for validating a FFQ is a food record because the sources of errors of food records are 
reasonably uncorrelated to those of the FFQ (Willett & Lenart, 1998).  The bias related to 
these errors impacts on the accuracy, completeness and representativeness of the dietary data 
collected, and therefore on the validity assessment of the two dietary tools. Since the bias 
associated with these sources of error cannot be eliminated, a good reference method should 
ideally share different sources of error. Therefore, the proposed reference method for 
validating the phytoestrogen FFQ in the current study was a weighed food record (WFR).  
Food scales and household measuring tools were provided to assist in portion size estimation 
to ensure accuracy and consistency of the dietary data obtained.  
Subjects may subconsciously modify their usual food intake for ease of recording a food 
record, which will lead to inaccurate assessment, potentially undermining a correlation 
between the intake derived from the FFQ and the food record (Lee & Nieman, 2010; Willett 
& Lenart, 1998). Other sources of error are attributed to the food composition data used to 
measure the nutrient intakes (Willett & Lenart, 1998). Both FFQ and food record methods 
could under- or over-estimate the intake due to the natural variability of the dietary 
components in food, for instance, phytoestrogen content in plant foods can vary because of 
genetics, growth and environmental factors, and effects of harvesting and processing (Kuhnle, 
Dell'Aquila, Runswick, & Bingham, 2009; Lyons-Wall, 2007). Due to the natural variability 
of phytoestrogen content in foods and incompleteness of databases, especially for lignan 
intake, it is challenging to measure the exact ‘true’ dietary intake, even with a valid and 
reliable dietary assessment tool. For the current study, lignan and isoflavonoid intakes were 
estimated from the content currently available from published international databases. 
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2.7.1.2 Urinary biomarkers – the criterion validity 
Willett and Lenart (1998) stated that biochemical indices could be an informative and 
objective comparison method when there is uncertainty regarding the estimated intakes and 
validity between the questionnaire and a reference dietary assessment method. The associated 
errors of biomedical indices are likely to be independent to those of the two dietary 
assessment methods, and are mainly attributed to subject variation in absorption and 
metabolism of the nutrients, and external errors related to laboratory measurement and 
bioavailability of the nutrient or constituent from food (Willett & Lenart, 1998).  
Biological markers or biomarkers, in blood and urine are collected as a criterion to compare 
with the estimated intake derived from the dietary tool in validation and epidemiological 
studies (Borneman, 2010; Hunter, 1998). The biomarker must be sensitive to intake of the 
nutrient (Willett & Lenart, 1998). The time interval of biomarker collection is dependent on 
the pharmacokinetics of the target nutrient, the subjects’ variability of the nutrient intake, and 
the research design (Bates, Thurnham, Bingham, Margetts, & Nelson, 1997; Kelemen, 2007; 
Samet & Alberg, 1998). 
 
2.7.1.3 Strengths and limitations of the food frequency questionnaire, food record and 
urinary biomarker tools 
The strengths and limitations of the food frequency questionnaire, food record and biomarker 
tools are summarised in Table 1. The sources of errors of a FFQ, WFR and urinary 
biomarkers are relatively unrelated to each other.  For example, completion of a FFQ relies 
on the subject’s memory to recall the correct food consumption and frequency of intake, 
whereas when completing a food record, the process of recording is open-ended and does not 
depend on the subject’s memory because details about the food and drinks are recorded at the 
time of consumption. In addition, a food record does not restrict subject’s choice on a fixed 
list of foods from a FFQ.   
However, given that details about the subject’s dietary intake are required to complete food 
records, the subject burden is relatively high and literacy and numeracy are required to 
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understand the process to accurately complete food records. Biomarkers can reflect true status 
assessed by the diet assessment method; nevertheless biomarkers are prone to be affected by 
systematic errors related to work in laboratory measurement. 
For the current study the modified FFQ was administered for the previous month to capture 
usual intake over a feasible retrospective time period. The weighed food record was 
administered over a relatively short period of 3 days, to minimise the subject burden, and 
included 2 weekdays and 1 weekend day to optimise the chance of capturing usual intake. 
Data for urinary biomarkers were collected over a 3-day period to coincide with the intake 
from the food record and provide an estimate of usual excretion. Laboratory measurements of 
urinary biomarkers were based on standardised methods from the published literature. 
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Table 1. Limitations (sources of errors) and strengths of food frequency questionnaire (FFQ), weighed food record (WFR), and biomarker 
(Buzzard, 1998; Hunter, 1998; Willett, 1998; Willett & Lenart, 1998)  
FFQ WFR Biomarker 
Limitation Strength Limitation  Strength Limitation Strength 
Reliance on subjects’ 
memory on food 
consumed over the 
period of time 
Relative low 
subject’s burden 
compared to weighed 
record 
High subject’s numeracy and literacy requirement 
and burden to complete the recording - to record 
the weighed food consumptions and details like 
specific types/brands, amount, preparation 
method, ingredients used in recipe and dishes 
Open-ended, do not depend 
on subjects’ memory or 
restrict subject’s choice on a 
fixed list of foods 
External sources of errors: 
subject variation in metabolism 
of the nutrient, bioavailability 
of nutrient from food 
Reflect true intake when it is 
time integrated to reflect 
nutrient intake during the period 
evaluated by the diet assessment 
methods being tested 
Restrictions imposed 
by a fixed list of 
foods 
Potential to reflect 
long-term habitual 
intake 
 
Poor response rate* resulted from low subject 
motivation 
Direct assessment of portion 
size by measuring the weight 
and size of the food and 
drinks consumed 
Systematic errors associated 
with laboratory and analytical, 
techniques, contamination and 
stability of biomarker 
Specific and sensitive to the 
intake of the nutrient 
Interpretation of the 
questions and 
perception of serve 
sizes 
Can be 
self-administered or 
completed with 
assistance of trained 
personnel 
Day-to-day dietary variation, require multiple days 
of intake to account the variability of the subject’s 
intake. 
 
More detailed dietary 
information can be recorded 
and more accurate dietary 
analysis and assessment 
 
Stress or inconvenience brought 
to subjects when collecting 
samples for the biomarkers  
 
Difficulty in 
choosing the 
correct/appropriate 
category of 
frequency of the 
food is consumed 
 Error associated with the measuring and recording 
process which leads to change in eating behaviour 
– the food record may not be representative of 
what subject normally eat (change in eating 
behavior) 
   
*Cole (1997) stated that “In nutritional studies involving the measurement of food intake over several days, the degree of non-response can be 30% or more” (p.67). A study conducted by Kolar et al. (2005) indicated 
that the response rate of a self-administrated 3-day food record is 68% (32% non-response rate) in one hundred 50-76 years men and women. Another study conducted by Dietrich et al. (2003) showed that the response 
rate of a 24-hour food record, which was designed to measure fruit and vegetable intake of primary school children, is 76% (24% non-response rate). 
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2.7.1.4 Method of Triads 
The Method of Triads is a statistical model for a triangular comparison developed by Kaaks 
(1997) to assess the interrelationship between the dietary questionnaire or test method (Q), a 
detailed dietary assessment or reference method (R) and biochemical measurements or 
biomarkers (M) to the ‘true’ (T) intake of nutrients. The assumptions for this method to be 
valid are that the errors associated with the questionnaire, reference method and biomarker 
measurements are uncorrelated or independent, and the measurements Q, R and M are 
linearly related to the ‘true’ intake (T) (Kaaks, 1997; Willett & Lenart, 1998; Yokota, 
Miyazaki, & Ito, 2010). Ocké and Kaaks (1997) described this method as an approach to 
assess the agreement between the questionnaire (Q), reference method (R) and biomarker (M) 
measurements in relation to a nutrient status. Validity coefficients (VC) are calculated for the 
correlation between the measurement intakes of the methods and the hypothetical ‘true’ intake 
status. The VC is readily influenced by the strength of the correlation coefficient (r) because 
the VC is mathematically derived from the associations between the two individual 
assessment methods. The theoretically acceptable range of VC is between 0 and 1, although 
VC exceeding 1 is acceptable if the assumptions were not violated.  A VC exceeding 1 is 
called Heywood case.  
Several validation studies have applied the method of triads to assess three or more 
measurement methods for different nutrients (Andersen et al., 2005; Bhakta et al., 2005; 
Daures et al., 2000; Kabagambe et al., 2001; McNaughton, Marks, Gaffney, Williams, & 
Green, 2004; Ocké & Kaaks, 1997; Shai et al., 2005; Tan, Charlton, Tan, Ma, & Batterham, 
2013). Studies conducted by Kabagambe et al. (2001), Daures et al. (2000), Shai et al. (2005) 
and Andersen et al. (2005) assessed more than three measurement methods. The four other 
studies by Ocké and Kaaks (1997), McNaughton et al. (2004) and Bhakta et al. (2005) Tan et 
al. (2013) assessed two dietary and one biochemical assessment method. Bhakta et al. (2005) 
was the first and only study to apply the method of triads to evaluate phytoestrogen status, 
using a specific FFQ, 24-hour recalls and plasma phytoestrogens. 
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2.7.2 Reliability 
The reliability of the FFQ is the consistency of the measurement of the tool for the same 
subject at different occasions of administration (Cade, Burley, Warm, Thompson, & Margetts, 
2004; Willett & Lenart, 1998). The reliability assessment is often a component of the 
evaluation of FFQ in validation studies (Cade, Thompson, Burley, & Warm, 2002; Willett & 
Lenart, 1998). Correlation coefficients are frequently used in assessing the reliability of the 
FFQ (Cade et al., 2002). Acceptable correlation coefficients commonly range from 0.5 to 0.7 
and the correlation tends to be higher for administration of the FFQ with shorter periods of 
time, one month or less apart, when compared to longer periods, six months to one year apart, 
due to possible recall bias with shorter timeframe, or time or seasonal change in food intake 
with longer time periods (Cade et al., 2004; Cade et al., 2002; McLennan & Podger, 1995).   
Although correlation coefficients can be used to assess the validity and reliability of the FFQ, 
the Bland-Altman plot is a more robust method to assess the level of agreement between the 
intake estimated with two assessment methods or with the same method at different occasions 
(Altman & Bland, 1983; Bland & Altman, 1986). The plot is constructed by plotting the 
differences in intake against the mean intakes derived from the two points of measure. In the 
current study, reliability of the FFQ was tested by administering a repeat FFQ after a short 
period of time, 1 to 2 weeks, to minimise the possibility of seasonal changes in food intake. 
 
2.8 Validation studies on phytoestrogen food frequency questionnaires 
Of previous studies that have evaluated phytoestrogen food frequency questionnaires, ten 
studies measured isoflavones only, one study measured lignans only, and four studies 
measured both isoflavones and lignans (Table 2). This section addresses the research, 
published in 2000 and onwards, in the evaluation of these food frequency questionnaires in 
relation to convergent and/or criterion validity.   
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Convergent validity 
Studies conducted by Bhakta et al. (2005) and Horn-Ross et al. (2006) assessed convergent 
validity of the phytoestrogen FFQ and demonstrated that their FFQs were moderately to 
highly correlated to the reference methods, with correlation coefficients ranging from r=0.50 
to 0.79. For Bhakta et al. (2005); the correlations were significant for both lignans (r=0.70, 
p<0.001) and isoflavones (r=0.57, p<0.001), with higher correlations observed for lignans 
suggesting that the FFQ was valid for phytoestrogen intake, particularly lignans, when 
compared to the reference method.  
 
Criterion validity 
Criterion validity of the phytoestrogen FFQs was assessed in five studies, with Hanna et al. 
(2005), Horn-Ross et al. (2006) and French et al. (2007) using urinary phytoestrogen 
excretion, Bhakta et al. (2005) using plasma phytoestrogen levels, and Lin, Wolk, et al. (2012) 
using serum ENL levels. The associations between intake from the FFQ and excretion for 
lignans were weaker than those for isoflavones for Hanna et al. (2005) (lignans: r=0.138, 
p>0.05; isoflavones: r=0.207, p<0.05), and French et al. (2007) (lignans: r=0.46, p=0.02; 
isoflavones: r=0.64, p<0.001). Further comparison between lignan and isoflavone intakes and 
urinary excretion conducted by Horn-Ross et al. (2006) suggested that the both 24h dietary 
records (DR) and FFQ had a stronger correlation with measurement of urinary isoflavones 
(ρ=0.43-0.50) than lignans (ρ=0.16-0.21). Similar findings were observed by Bhakta et al. 
(2005) who compared intake from a FFQ with 24h dietary records (DRs), and with plasma 
concentrations, and found stronger correlations for isoflavones (r=0.21-0.43) than lignans 
(r=0.08-0.10). The study conducted by Lin, Wolk, et al. (2012) compared lignan intake from 
two different FFQs with serum ENL levels; tLin, Wolk, et al. (2012)Lin, Wolk, et al. 
(2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al. 
(2012)Lin, Wolk, et al. (2012)Lin, Wolk, et al. (2012)hey found that the FFQ-97, with 
open-ended responses allowed more dietary information to be recorded in addition to the 
closed-ended frequency category response, was significantly correlated with serum ENL 
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levels (ρ=0.22, p=0.01) and concluded that FFQ-97 was a better tool for assessing lignan 
intake. 
Notably, two studies have estimated phytoestrogen intake in Australian populations (Hanna et 
al., 2005; Lahmann et al., 2012). In one study, the FFQ was valid for measurement of 
isoflavonoids when tested against urinary biomarker excretion but had poor validity for 
measurement of lignans, possibly due to the inability of the FFQ to capture the range of food 
items consumed in varied diets; or due to use of an indirect method for estimating the lignan 
content in food items, which may not have accurately estimated intake (Hanna et al., 2005). 
The second study used a FFQ that was validated for energy and nutrient intake but not 
specifically for phytoestrogens (Lahmann et al., 2012).  
 
This section informs the key results and study design from earlier research in the evaluation 
of the current FFQ for measuring phytoestrogen intake. While all studies provided 
comparisons of average intakes and correlations between tools at the group level, three studies 
further conducted Bland-Altman analyses to evaluate agreement at the individual level (Chan 
et al., 2008; Fernandez et al., 2013; Frankenfeld et al., 2003).  Five studies conducted 
cross-classification analyses for level of agreement by calculating the percentage of subjects 
categorised into the same and opposite quantiles of isoflavone intake and biomarker 
concentration (Bhakta et al., 2005; Chan et al., 2008; Fernandez et al., 2013; French et al., 
2007; Heald et al., 2005). Bhakta et al. (2005) additionally used the Method of Triads to 
evaluate the FFQ for phytoestrogen intake in a triangular comparison of the measurements 
from an FFQ, 24hDRs, and plasma phytoestrogens. These statistical analyses were employed 
to evaluate the modified FFQ in the current research. Open-ended questions were also 
incorporated into the modified FFQ in addition to the closed frequency questions, to elicit any 
further information on subjects’ food intake. 
 
Estimation of lignans 
Earlier studies only measured two lignans, SECO and MAT, as more recently quantified 
26  
lignan precursors, LARI and PINO, were not available at the time. Lin, Wolk, et al. (2012) 
estimated intakes of LARI, PINO, MED and SYR in addition to SECO and MAT. For the 
current research, four primary lignan precursors, SECO, MAT, LARI and PINO were 
measured, as they are present in a wide range of food sources commonly consumed in the 
Australian population.  From the validation studies conducted to evaluate isoflavone intake, 
two to eight isoflavone-rich food items listed in the FFQ were reported to be sufficient to 
capture variability in intake (Frankenfeld et al., 2003; Frankenfeld et al., 2002; Tseng et al., 
2008; Verkasalo et al., 2001). As lignans are present in a wider range of food sources than 
isoflavones, the FFQ for the current research was modified to focus on enhancing lignan 
measurement by including a range of food sources for which lignan content were available. 
Subjects from the majority of validation studies were females, but male subjects and subjects 
of both gender were recruited by Heald et al. (2005) and Frankenfeld et al. (2002). Lignans 
are found ubiquitously in Western and non-Western dietary patterns and lignans are 
considered to be nutritionally important to the Australian community with diverse 
demographic backgrounds.  Therefore both male and female subjects from various cultural 
backgrounds were recruited for the current research to reflect the diversity in dietary intake.  
 
Verkasalo et al. (2001) recognised the importance of the timing of biomarker collection with 
respect to the administration of the dietary assessment tool, hence understanding the 
pharmacokinetics of phytoestrogens is essential for the study design. Huang et al. (2000) and 
Tseng et al. (2008) collected the first morning/overnight sample separately from the rest of the 
24-hour sample and found that phytoestrogen concentrations in the first morning or overnight 
urine were highly correlated to concentrations in the 24-hour sample.  In the current study, 
three consecutive 24 hour urine samples including one weekend and two weekdays, were 
collected in an attempt to capture usual intake of lignans and isoflavonoids for comparison 
with usual intake from the modified FFQ.  
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2.9 Phytoestrogen databases 
Much of the pioneering work on direct analysis of lignans in foods has been done by Mazur 
and colleagues (Adlercreutz & Mazur, 1997; Mazur, 1998b; Mazur & Adlercreutz, 2000; 
Mazur & Adlercreutz, 1998; Mazur, Duke, Wähälä, Rasku, & Adlercreutz, 1998; Mazur et al., 
1996; Mazur, Uehara, Wähälä, & Adlercreutz, 2000; Mazur et al., 1999; Mazur, Wähälä, 
Rasku, et al., 1998; Mazur, Wähälä, Wang, & Adlercreutz, 1998; Nilsson et al., 1997a, 1997b; 
Nurmi et al., 2003). In these studies, SECO and MAT were the only two lignans analysed. In 
the past decade, other researchers have discovered additional lignan precursors that are major 
determinants of dietary lignan intake and metabolism, including LARI, PINO, SYR and MED 
(Bonzanini, Bruni, Palla, Serlataite, & Caligiani, 2009; Durazzo, Zaccaria, Polito, Maiani, & 
Carcea, 2013; Milder, Arts, Putte, Venema, & Hollman, 2005; Moreno-Franco et al., 2011; 
Peñalvo, Adlercreutz, Uehara, Ristimaki, & Watanabe, 2008; Smeds et al., 2007; Smeds, 
Jauhiainen, Tuomola, & Peltonen-Sainio, 2009; Thompson, Boucher, Cotterchio, Kreiger, & 
Liu, 2007; Thompson, Boucher, Liu, Cotterchio, & Kreiger, 2006). SYR and MED have been 
analysed in cereals, such as rye, wheat, and in seeds like sesame seeds but have not yet been 
comprehensively quantified in other foods (Peñalvo et al., 2005; Smeds et al., 2007). 
  
The prominent isoflavones in foods are daidzein, genistein and glycitein, however, the latter 
contributes only approximately 10% to the total isoflavones in soy (Rüfer et al., 2007; Simons 
et al., 2005). The U.S. Department of Agriculture has compiled a comprehensive database for 
isoflavone content in 557 foods from various articles containing analytical data for the two 
major isoflavones, daidzein and genistein, and their methylated precursors formononetin and 
biochanin A, and also glycitein (Bhagwat, Haytowitz, & Holden, 2008). 
 
Lignans are present in a wide range of plant-based foods, including breads and cereals, 
vegetables, nuts, seeds and legumes, fruits, and beverages like tea, coffee and wine (Mazur, 
1998b; Mazur & Adlercreutz, 1998; Mazur, Duke, et al., 1998; Mazur, Wähälä, Rasku, et al., 
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1998; Milder, Arts, et al., 2005; Moreno-Franco et al., 2011; Nurmi et al., 2003; Peñalvo et al., 
2008; Thompson et al., 2006).  Oil seeds and nuts contain high amounts of lignans, with 
linseed (or flaxseed) being the richest source with approximately 3.4 mg/g (Horn-Ross et al., 
2000; Meagher & Beecher, 2000; Pillow et al., 1999; Smeds et al., 2007; Thompson et al., 
2006).  Small but significant concentrations of lignan metabolites, especially ENL, have 
been detected in dairy products like cheese, milk and yoghurt (Antignac, Cariou, Le Bizec, & 
Andre, 2004; Kuhnle et al., 2008b).  There are negligible quantities of lignan metabolites in 
meat and seafood (Kuhnle et al., 2008b).  
 
Isoflavones are concentrated in soybeans, with approximately 2-4 mg isoflavones/g, and 
foods derived from soy, such as soymilk beverages, and foods fortified with and/or containing 
soy as an ingredient (Adlercreutz & Mazur, 1997; Bhagwat et al., 2008; Mazur, 1998b). 
Moderate amounts are present in other legumes such as beans and peas (0.03-0.08mg 
isoflavones/g), and small amounts in bread (0.02-0.03mg/g) and other food sources (<0.01mg 
isoflavones/g) namely fruits and vegetables, nuts and seeds, beverages, meat and dairy 
(Bhagwat et al., 2008; Kuhnle, Dell'Aquila, Aspinall, Runswick, Joosen, et al., 2009; Kuhnle 
et al., 2008a, 2008b; Kuhnle, Dell'Aquila, Aspinall, Runswick, Mulligan, et al., 2009; Mazur, 
Duke, et al., 1998; Mazur, Wähälä, Rasku, et al., 1998).   
 
As no culturally-specific database is available for Australian foods, data on the lignan and 
isoflavone content of foods was sourced from published international values. Examining 
different lignan databases provided information on the range of lignan content from different 
food sources. This assisted in selecting appropriate food items to be included in the food list 
to ensure the design of the FFQ to be relevant to the target population. Foods rich in lignans, 
for example, linseed and related food items, soy and linseed bread were included. A range of 
commonly consumed items in Australia with moderate lignan content, including vegetables, 
fruits, nuts, seeds and legumes, grains and cereals, and beverages like tea, coffee and wine, 
and soy and related food products were also included. 
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2.10 Cross-sectional studies on phytoestrogen intake and food sources 
Intake of phytoestrogens and contributing food sources 
Previous studies have quantified intake of dietary phytoestrogens in different populations 
from various countries and regions with 24 cross-sectional studies conducted from 2005 to 
2014. Five studies have estimated intakes of lignans, isoflavones and enterolignans; five 
estimated lignans and isoflavones; two estimated lignans and enterolignans; six studies have 
estimated only lignans and six studies estimated only isoflavones. The intakes and 
contributing food sources varied across different studies due to a number of factors such as 
dietary diversity and demographic differences in the population, and different phytoestrogen 
databases and dietary tools for assessment of intake (Table 3). 
 
Dietary lignan intake varies with different dietary patterns. For instance, Milder, Feskens, et al. 
(2005) found that beverages like tea, coffee and wine, Brassica vegetables like cabbage, nuts 
and seeds, wheat bread and fruits were major lignan-contributing foods in the Dutch 
population, whereas in the Finnish population, the main contributors were rye products, 
berries, coffee, tea and whole grains (Nurmi, Mursu, Peñalvo, Poulsen, & Voutilainen, 2010).  
Similarly in Latvia, rye and seed bread, nuts and seeds and coffee and tea beverages were 
major contributing foods for lignans (Meija et al., 2013). Despite differences in dietary 
patterns, the average lignan intakes were comparable in the three studies, between 1.22 mg/d 
and 1.26 mg/d. 
 
Differences in phytoestrogen intakes and food sources were reflected in regional dietary 
preference in The EPIC cohort study (Zamora-Ros, Knaze, et al., 2012; Zamora-Ros, Not, et 
al., 2012). Major food sources of lignans were fruits, vegetables and alcoholic beverages such 
as wine in Mediterranean (MED) countries, Greece, Spain, Italy and South of France; and 
non-alcoholic beverages like tea and coffee, vegetables, cereals in Non-Mediterranean 
(non-MED) countries, North-East and North-West of France, Germany, the Netherlands, 
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Denmark, Sweden and Norway, and U.K.. Major food sources of isoflavones were soy 
products, legumes and vegetables in MED countries and soy products, and non-alcoholic 
beverages such as soy beverages in non-MED countries. Dairy products contributed more 
than 90% of enterolignan intake in both MED and non-MED countries. Population groups of 
different ethnic backgrounds and dietary habits had different intake levels and contributing 
food sources of phytoestrogens. In the EPIC study, the Health conscious group in U.K. had 
the highest intake of lignans (2.15 mg/d) and isoflavones (12.1 mg/d) as the group was 
characterised by higher consumption of fruit, vegetables, legumes, nuts and seeds, cereal and 
soy products than other cohorts in the EPIC study (Zamora-Ros, Knaze, et al., 2012); 
corresponding intakes from Greece were 1.04 mg/d for lignans and 0.24 mg/d for isoflavones. 
Vegetables dishes, milk beverages and bread products were main food sources of 
phytoestrogens in the soya-consuming groups and bread products, breakfast cereals, and tea 
and coffee in the non soya-consuming groups from the EPIC-Norfolk cohort study (Mulligan 
et al., 2013).  
 
Chinese and Japanese American women had relatively high intake of isoflavones (9.71 mg/d 
and 12.59 mg/d) compared to Caucasian and African American women (0.32 mg/d and 0.28 
mg/d) although intakes of lignans were comparable (0.20 to 0.40 mg/d) (Huang et al., 2012). 
Main food sources for lignans were coffee, black tea, Chinese herbs in soup or tea and green 
tea amongst the multiethnic women. The main food sources for isoflavones were soymilk 
beverages in Caucasian, African American and Chinese Americans but soybean and related 
products for Japanese Americans. In contrast, Chinese living in China consumed vegetables 
namely soybean sprouts, Chinese lettuce, tofu and taro as their main sources of isoflavones, 
and carrot, Chinese lettuce, taro and white gourd as main sources for SECO (Hu et al., 2014).  
 
The intake of lignans (0.14 mg/d, 0.18 mg/d) and isoflavones (0.32 mg/d, 0.37 mg/d) of South 
Asian residents and native British residents, respectively, living in U.K. were similar but with 
different contributing food sources (Bhakta et al., 2006). The South Asians had more 
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vegetables and vegetable dishes (38%) for isoflavones than the native British, who had only 
2% contribution from vegetables. Breads provided the main source of lignans in both groups.   
 
2.11 Pharmacokinetics of lignans and isoflavones 
Based on pharmacokinetic studies, enterolignans, END and ENL appeared in blood 7-10 
hours after a lignan supplement from flaxseed, and daidzein and genistein appeared 2 hours 
after an isoflavone supplement from soy meal, with the majority excreted in urine within 24 
hours of the supplement (King & Bursill, 1998; Kuijsten, Arts, Vree, & Hollman, 2005; 
Watanabe et al., 1998). The delay of appearance reflected the time required for the bacterial 
conversion to metabolites in the colon prior to absorption. Plasma END reached its peak at 15 
hours and ENL at 20 hours in Dutch subjects; daidzein and genistein reached at 6 hours in 
Japanese subjects and at 7-8 hours in Australian subjects.  In some subjects, a second peak of 
enterolignans, predominantly ENL, and genistein were observed in plasma. This peak could 
be explained by the reabsorption via the gastrointestinal tract into bloodstream and 
redistribution of enterolignans and isoflavones through the enterohepatic circulation. Both 
enterolignans and isoflavones were continually excreted for the first two days before they 
declined on the third day. In pharmacokinetic studies conducted in human subjects, 
approximately 40% of enterolignans, 62% of daidzein and 22% of genistein in Australian 
subjects (King & Bursill, 1998), and 36% daidzein and 18% genistein in Japanese subjects 
(Watanabe et al., 1998) were accumulatively excreted through urine over the two to three days 
after intake of the flaxseed or soy supplement.  
A positive dose-dependent relationship has been established between supplement 
consumption and urinary excretion in humans for both isoflavonoids (Morimoto, Beckford, 
Franke, & Maskarinec, 2014) and lignans (Hutchins, Martini, Olson, Thomas, & Slavin, 
2000); and similarly in animal models (King, Broadbent, & Head, 1996; Rickard et al., 1996).  
Dietary lignan precursors, SECO, MAT and LARI have been detected in human urine as a 
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result of incomplete metabolism to enterolignans by intestinal microbes (Adlercreutz et al., 
1995; Bannwart, Adlercreutz, Wähälä, Brunow, & Hase, 1989). Isoflavonoid metabolites, 
glycitein, formononetin, biochanin A and equol have also been reported in urine (Hanna et al., 
2005). 
These studies, demonstrate a positive dose-dependent relationship between intake and 
excretion, and justify the choice of urinary excretion of isoflavonoid and lignan metabolites as 
appropriate biomarkers of dietary intake for the current study. They further indicate that a 
variable proportion, between 18% to 62% for different metabolites, is excreted in urine within 
1 to 3 days after ingestion of precursors in the diet. 
2.12 Phytoestrogen status and demographic, social and lifestyle characteristics 
Epidemiological studies have shown that higher intakes of phytoestrogens and phytoestrogen 
rich foods were associated with lower risks of breast and prostate cancers (Heald et al., 2007; 
Iwasaki et al., 2009; McCann et al., 2004; McCann et al., 2010). Demographic, social and 
lifestyle characteristics associated with the intake of phytoestrogen rich diets could contribute 
to these health outcomes. Factors related to the demographic, social and lifestyle status, for 
instance, age, gender, occupation, education, participation in physical activity and smoking, 
influence food choices and could therefore impact the observed relationships between 
phytoestrogen intake and risk of chronic diseases. This section is briefly presented with 
results from correlation, regression and quantile analysis of population-based cross-sectional, 
prospective cohort and case-control studies. 
Milder et al. (2007) in a cross-sectional analysis of a Dutch population identified several 
factors, namely age, weight, current smoking status and frequency of defecation (all p<0.001), 
that explained 12.7% of the differences in plasma ENL, and age and use of antibiotics 
explained 2.1% of the difference in plasma END. Kilkkinen et al. (2001) found that 
constipation contributed to a 2.7% variance in serum ENL of Finnish men (R2=0.0268), 
whereas BMI, smoking, age and constipation together contributed to a 14% variance in serum 
ENL in Finnish women. Rybak, Sternberg, and Pfeiffer (2013) observed that smoking 
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compared to non-smoking was associated with a 25% reduction in urinary 
O-desmethylangolensin (DMA) and ENL; a 25% increase in BMI was associated with a 21% 
decrease in urinary ENL; and increasing physical activity was associated with a greater than 
6% increase in urinary ENL. The relationship between urinary phytoestrogens and 
socio-demographic and lifestyle variables was metabolite-specific, which further complicated 
the situation. 
Johnsen et al. (2004) in a case-control study, found that smoking, more frequent bowel 
movements, and higher BMI were inversely correlated with concentrations of plasma ENL 
(p<0.001), while in a prospective cohort study, significant determinants of urinary lignan and 
isoflavone excretion for Chinese women were BMI, menopausal status, participation in 
exercise, and vitamin supplement use (p<0.05)(Wu et al., 2012). Morisset et al. (2009) in a 
cross-sectional analysis found that older Canadian women who consumed higher lignan 
intake and had higher plasma ENL tended to have lower BMI and total body fat mass 
(p<0.05). Older Australian women, who consumed soy and linseed, had higher levels of 
physical activity level, socio-economic position and education, were more likely to use 
supplements (all p<0.001) (Hanna et al., 2010). Using regression analysis, these determinants 
were inversely associated with urinary phytoestrogen metabolites, which suggested that older 
women with higher body weight and body fat composition may have lower dietary 
phytoestrogen intake, or different metabolism and distribution in body tissues, compared to 
women with the opposite characteristics. 
Lampe (2003) and Lampe, Atkinson, and Hullar (2006) in a review of experimental studies in 
human subjects, suggested that gender-specific physiological differences in phytoestrogen 
absorption and metabolism i.e. gut transit time, and composition of intestinal microbiota may 
have influenced the bioavailability of phytoestrogen and consequently the level of biomarkers, 
i.e. women tend to have more phytoestrogen metabolite-producing bacterial communities than 
men (Clavel et al., 2005).  The formation of lignan and isoflavone metabolites is facilitated 
by intestinal microbiota, and use of antibiotics that disrupt the composition and balance of 
intestinal microbiota have impacted on the bioavailability and metabolism of phytoestrogens. 
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For example, Kilkkinen et al. (2002) found that subjects who had used antibiotics up to 12-16 
months prior to serum sampling had significantly lower serum ENL concentrations. 
Sutherland et al. (2012) found that the antimicrobial agent tetracycline inhibited the 
daidzein-metabolising bacteria; thus less daidzein metabolites were produced. 
In summary demographic, social and lifestyle variables, such as BMI, bowel movement, 
smoking status, physical activity level, age and gender, supplement and antibiotics use are 
important determinants in dietary phytoestrogen intake and consequently biomarker levels. 
Information on these sociodemographic variables was obtained for the current study to 
explore possibly associations with phytoestrogen status, and recent intake of antibiotics was 
an exclusion criterion. In Australia, the population consists of different cultural and ethnic 
groups (Australian Bureau of Statistics, 2014). This would enrich the cultural diversity as 
different ethnic groups have distinctive dietary preferences. Therefore cultural background 
and ethnicity was also explored in relation to phytoestrogen intake and metabolites in the 
current research.   
2.13 Concluding remarks 
The literature review of the current thesis firstly covered the background knowledge of 
phytoestrogen absorption and metabolism, and epidemiological health outcomes of 
phytoestrogen consumption. Secondly it discussed the use of dietary tools and evaluation of 
the dietary tool with a reference method and biomarkers. Thirdly, it reviewed recent research 
conducted on validation and evaluation of FFQ to measure phytoestrogen, and pioneering and 
recent work on analysing phytoestrogen content in foods and establishment of phytoestrogen 
databases. Then it critically appraised studies that quantified intake of phytoestrogens and 
identified contributing food sources in different populations from various countries and 
background, with the use of different methodologies, dietary tools and phytoestrogen 
databases. Lastly, it described the pharmacokinetics of phytoestrogen metabolism and the 
influence of demographic, social and lifestyle factors associated with phytoestrogen status.  
Much of the early research had focused on isoflavones, being one of the two main classes of 
35  
phytoestrogen. More recent research work has focused on lignans because they are more 
prevalent in dietary patterns followed by Western populations. Lignans and isoflavones being 
structurally alike, their pathway of absorption and metabolism is similar. The metabolism of 
phytoestrogens indicates that dietary precursors are actively converted to metabolites and 
excreted in urine in a dose-dependent manner. Measurement of metabolites in urine therefore 
provides a feasible method to assess phytoestrogen status and evaluate the validity of the 
dietary assessment tool. A range of sociodemographic and lifestyle factors can influence this 
association and therefore need to be considered. 
Epidemiological research has demonstrated that phytoestrogens are positively associated with 
reduced risk of hormone dependent cancers, although not all studies are supportive and more 
evidence is required to draw conclusions regarding the relationship between phytoestrogens 
and risk of chronic diseases.  
Results from validation studies showed that the FFQs were not consistently valid or reliable 
in measuring phytoestrogen intake, especially for lignans, possibly due to lack of specificity 
of the FFQ for measuring the range of lignan sources in a varied diet; or limitations of 
available databases for estimation of lignans. Most studies have been restricted to female 
subjects, therefore, in the current research, subjects of both genders from diverse backgrounds 
were recruited.  
Previous cross-sectional studies have focused on phytoestrogen intake of populations from 
Scandinavian, European, American and Asian countries, with isoflavones being the focus in 
Asian countries and lignans and enterolignans being the focus in Western countries. 
Contributing food sources to phytoestrogens varied amongst countries, as populations had 
different food choices and cultural preferences. Limited data are available on phytoestrogen 
intake in the Australian multicultural context. 
 
This review of the literature mapped the ground of knowledge on phytoestrogens, critically 
reviewed what has been done in this field of research, and informed the knowledge gap that 
should be addressed. For the current study an original phytoestrogen FFQ needs to be updated 
36  
and refined to align with food groups and dietary patterns in the current Australian Dietary 
Guidelines, in particular to optimise measurement of lignans from the FFQ, and utilising 
current databases of lignan content available from direct measurement of lignans in foods.   
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Table 2. Results of the evaluation of food frequency questionnaires in measuring phytoestrogen intake 
Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Validation studies that evaluate for both lignan and isoflavone phytoestrogen 
Hanna 
(Australia) 
2005 
 
  
IFs (daidzein, 
genistein, 
glycitein);  
LGs (SECO, 
MAT) 
PEs (IFs+LGs), 
112 items 
 
141F 
(40-59y) 
The questionnaire was 
previously validated with 
7dWFRs, adopted and 
modified for PEs 
measurement 
 
√ FFQ and 3x24h urine over 1week 
Total IFs (r=0.207, P≤0.05), Total LGs 
(r=0.138, P>0.05), Total PEs intake and 
urine IFs in (r=0.245, P≤0.01), Total 
PEs intake and urine LGs (r=0.199, 
P≤0.05), Total PEs intake and urine 
PEs(r=0.283, P≤0.01) 
Median excretion: IFs 0.418 (0.005-41), 
LGs 0.771 (0.004-11) 
 
√ FFQ1 and FFQ2 
after 6-10months 
IFs Intake (r=0.60, 
CI95% 0.23-0.81)  
LGs intake (r=0.36, 
CI95% 0.07-0.68) 
Intake not reported 
FFQ intake: IFs median 0.00mg/d, LGs 
1.61mg/d  
Conclusion: FFQ appeared more reliable for 
IFs than LGs. FFQ was not valid with urine 
LGs 
Strength: Australian population 
Limitation: female subjects; LGs intake 
measured based on LGs content from an 
indirect method 
Bhakta 
(U.K.) 
2005 
 
  
IFs (genistein, 
daidzein),  
LGs (SECO, 
MAT), 277 
items 
 
58F 
(25-75y) 
√ FFQ and 12x24hDRs 
for 1year 
IFs (r=0.57, P<0.001) 
LGs (r=0.70, P<0.001) 
IFs Mean: 405 µg/d, 
median:194µg/d 
LGs mean:141µg/d, 
median:110µg/d 
√ FFQ and 4x2ml plasma every 3month 
for 1 year 
FFQ and plasma Genistein (r=0.21, 
P=0.12), plasma Daidzein (r=0.32, 
P=0.02), and plasma ENL (r=0.10, 
P=0.43) 
24hDRs and plasma Genistein (r=0.43, 
P<0.001), plasma Daidzein (r=0.40, 
P<0.002), and plasma ENL (r=0.08, 
P=0.50) 
Mean excretion: genistein 18.3nmol/L, 
daidzein 7.8nmol/L, ENL 13.7nmol/L 
× FFQ intake: IFs mean 471µg/d, median 
327µg/d, LGs mean 208µg/d, median 
149µg/d 
Conclusion: FFQ appeared valid for LGs. 
FFQ had highest VC for LGs 
Strength: method of triads. 
Genistein,24hDrs(0.95),FFQ(0.46),Plasma(0
.45).Daidzein,24hDRs(0.83),FFQ 
(0.67),Plasma(0.45).LGs,24hDRs(0.73);FFQ
(0.91),Plasma(0.11), cross classification 
Limitation: female subjects; no reliability 
was assessed. 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker  
Reliability, Intake 
by FFQ2 
Results and comments 
Horn-Ross 
(U.S.) 
2006 
 
  
IFs (daidzein, 
genistein, 
formononetin, 
biochanin A),  
LGs (SECO, 
MAT) 
Coumestant 
(coumestrol), 
Block95 FFQ 
plus 32 items 
for PEs 
175F 
(≤85y) 
√ FFQ and 4x24DRs for 
10 months (no p-values) 
FFQ1, IFs (ρ=0.70), LGs 
(ρ=0.74) 
FFQ2, IFs (ρ=0.72), LGs 
(ρ=0.76) 
IFs median1.6mg/d, LGs 
161µg/d 
√ FFQ and 2x24h urine (no p-values 
reported) 
FFQ and urine IFs (ρ=0.50), urine LGs 
(ρ=0.16) 
24hDRs and urine IFs (ρ=0.43), urine 
LGs (ρ=0.21) 
Excretion not reported 
√ FFQ1 and FFQ2 
10 month apart (no 
p-values reported) 
IFs (ICC=0.77) 
LGs (ICC=0.80) 
SECO (ICC=0.81) 
MAT (ICC=0.67) 
IFs median 
1.5mg/d, LGs 
137µg/d 
FFQ intake: Median IFs 1.5mg/d, LGs 
138µg/d 
Conclusion: FFQ appeared more valid for 
IFs than LGs when comparing with 24hDRs 
and urine PEs, but it appeared more reliable 
for LGs than IFs 
Strength: large sample size 
Limitation: female subjects, no p-values 
reported for the significance of results 
 
French, 
Thompson 
and Hawker 
(Canada) 
2007 
:  
 
 
 
 
IFs (daidzein, 
genistein), LGs 
(SECO, MAT), 
53 items 
 
26F 
(25-42y) 
 
× 
 
√ FFQ and 1x24h urine 
FFQ1 and urine IFs (r = 0.54, P = 
0.004), and urine LGs (r = 0.40, P = 
0.045), FFQ2 and urine IFs (r = 0.64, P 
<0.001), and urine LGs (r = 0.46, P = 
0.019) 
IFs mean 17.4umol/d, median 
4.1umol/d, LGs mean 20.6umol/d, 
median 6.4umol/d 
 
√ FFQ1 and FFQ2 
one month apart 
IFs intake (r = 0.69, 
P < 0.001), LGs 
intake (r = 0.69, 
P<0.001) 
IFs mean 10.8mg/d, 
median 0mg/d, LGs 
mean 8.8mg/d, 
median 0.7mg/d 
 
FFQ intake: IFs mean 13.7mg/d, median 
15mg/d, LGs mean 13.8mg/d, median 
3.8mg/d  
Conclusion: FFQ appeared valid for LGs 
and IFs when compared to urine PEs and 
equally reliable for LGs and IFs 
Strength: cross-classification 
Limitation: female subjects, no convergent 
validity and reliability, small sample size 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Validation study that evaluate for lignans 
Lin (Sweden) 
2012 
  
LGs (SECO, 
MAT, LARI, 
PINO, MED 
and SYR), 67 
items for 
FFQ-87, 93 
items for 
FFQ-97 
140F 
(55-75y) 
× √ FFQs and 1x serum 3 months apart 
FFQ-87 and serum ENL (ρ=0.09, 
P=0.47), FFQ-97 and serum ENL 
(ρ=0.22, P=0.01) 
ENL Mean 23.2nmol/l, median 
20.8nmol/l,  
× FFQ intake: FFQ87 mean 1616µg/d, 
median 1552µg/d, FFQ97 mean 1516µg/d, 
median 1497µg/d (P=0.002) 
Conclusion: FFQ-97 was a better tool to 
measure LG status than FFQ-87.  
Strength: lignan specific, include more LG 
subclasses 
Limitation: not validation study because no 
reference method. Only comparing two 
FFQs with serum LGs to determine which 
FFQ is a better tool for LGs 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Validation studies that evaluate for isoflavones 
Huang (U.S.) 
2000 
IFs (daidzein, 
genistein), 
Block 95 FFQ 
plus additional 
58 items for PEs 
69F.  
51 
Japanese 
(48.4) and 
18 
Caucasian 
(45.8) 
√ FFQ and 4x48hDRs 
over 4weeks 
Daidzein (r=0.58, 
P<0.0001), Genistein 
(r=0.52, P<0.0004) 
(Mean, median) Japanese, 
daidzein 7336µg/d, 
4402µg/d, genistein  
11118µg/d,6887µg/d. 
Caucasian, daidzein 
1036µg/d, genistein 
2049µg/d 
√ FFQ and 4x24h urine over 4 weeks 
Daidzein (r=0.49, p<0.0002, 
unadjusted), Genistein (r=0.30, 
p=0.0346, unadjusted) 
Average of 48hDRs and 4x24h urine) 
Daidzein (r=0.45, p<0.0027, 
unadjusted), Genistein (r=0.41, 
p=0.0057, unadjusted) 
First morning and 24h urine 
Daidzein (r=0.58), Genistein (r=0.50) 
Excretion not reported 
× FFQ intake: (mean, median) Japanese, 
daidzein 7580µg/d, 5680µg/d, genistein 
11402µg/d, 8778µg/d, Caucasian, daidzein 
736µg/d, 108µg/d, genistein, 1435µg/d, 
210µg/d 
Conclusion: IFs Intake moderately 
correlated with that of 48DRs and excretion 
Strength: Intake by ethnicity. 
Limitation: female subjects; no reliability 
was assessed. Small sample size 
Verkasalo 
(U.K.) 2001 
IFs (daidzein, 
genistein), Total 
IFs (sum of 
daidzein, 
genistein, 
glycitein), FFQ 
from UK arm of 
EPID study plus 
3 questions of 
soya intake 
80F (20 in 
each 4 
groups of 
soy intake 
level) 
(20-39y) 
× √ (FFQ and 1x plasma) (p<0.001) 
Daidzein (r=0.74), genistein (r=0.69), 
Total IFs intake and plasma daidzein 
(r=0.56), and plasma genistein (r=0.53) 
7dFDs and 1x plasma 
Daidzein (r=0.79), Genistein (r=0.80), 
Total IFs intake and plasma daidzein 
(r=0.79) and plasma genistein (r=0.80) 
No overall excretion reported 
 
 
× No overall FFQ intake reported 
Conclusion: IFs intake can be estimated 
with either a FFQ or 7dFDs. Plasma can be 
biomarker of soy intake 
Strength: Small number of soy items 
sufficient to estimate intake and have good 
correlation with biomarker 
Limitation: no convergent validity and 
reliability assessed. 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Yamamoto 
(Japan) 2001 
IFs (daidzein, 
genistein), 8 
items 
247 
subjects, 
125F  
(55y) and 
122M 
(56y) 
√FFQ and 4x7dDRs over 
1 year 
Daidzein (r=0.60, 
CI:0.5-0.69), Genistein 
(r=0.59, CI:0.5-0.68) 
Mean daidzein 14.5mg/d, 
genistein 23.4mg/d  
 
√ FFQ and 1x serum, and 2x 24h urine 
serum daidzein (r=0.26, CI:0.13-0.39), 
genistein (r=0.22, CI: 0.08, 0.35), urine 
daidzein (r=0.40, CI:0.21-0.60), 
genistein (r=0.30, CI:0.08-0.51) 
7dDRs and 1x serum, and 2x 24h urine 
serum daidzein (r=0.37, CI:0.25-0.49), 
genistein (r=0.36, CI:0.18, 0.55), urine 
daidzein (r=0.48, CI:0.31-0.64), 
genistein (r=0.36, CI:0.18-0.55) 
1x serum and 2x 24h urine 
serum and urine daidzein (r=0.22, 
CI:0.01-0.42), genistein (r=0.32, 
CI:0.12-0.52) 
Mean serum daidzein 119.9nmol/l, 
genistein 475.3nmol/l, Mean urine 
daidzein 17µmol/d, genistein 
14.2µmol/d 
 
 
 
 
 
 
√ FFQ1 and FFQ2 
one year apart 
r=0.75, CI: 0.68- 
0.82 
r=0.72, CI: 0.61- 
0.83 
FFQ intake: mean daidzein 18.3mg/d, 
genistein 31.4mg/d  
Conclusion: FFQ appeared to be a valid and 
reproducible in estimating IFs intake 
Strength: female and male subjects, large 
sample size, account for seasonal difference 
(repeated DRs for each season and repeated 
FFQ one year apart) 
Limitation: single urine and serum samples 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Frankenfeld 
(U.S.) 2002 
IFs (daidzein, 
genistein), 40 
items for Soy 
FFQ, 122 items 
(2 for IFs) for 
WHI FFQ 
77F and 
M 
(20-40y) 
× √ FFQs and 1x plasma 
Soy FFQ daidzein (r=0.45, CI:0. 
25,0.61), genistein (r=0.53, CI:0. 35, 
0.67) 
WHI FFQ daidzein intake (r=0.45, 
CI:0. 25,0.61), genistein intake (r=0.46, 
CI:0. 26, 0.62) 
Daidzein plasma concentration mean 
8.8mmol/dl, median 4.7mmol/dl, 
genistein mean 16.9mmol/dl, median 
12.8mmol/dl 
√ Soy FFQ and 
WHI FFQ, 
completed at the 
same time  
-compare 2 different 
FFQs) (p<0.001) 
Daidzein (r=0.82), 
Genistein (r=0.83) 
WHI FFQ daidzein 
mean 5.6mg/wk 
median 2.1mg/wk, 
genistein mean 
6.5mg/wk median 
3mg/wk 
FFQ intake: daidzein mean 9.7mg/wk, 
median 7.6mg/wk, genistein mean 
11.9mg/wk, median 11.1mg/wk  
Conclusion: Soy FFQ appeared to be a valid 
estimate of soy intake 
Strength: female and male subjects 
Limitation: convenience sample, only 
compare the intake from two different FFQs 
(no reliability of one FFQ was assessed) 
  
Frankenfeld 
(U.S.) 2003 
IFs (daidzein, 
genistein), 20 
items for soy 
FFQ, 122 items 
(2 for IFs) for 
comprehensive 
FFQ 
96F 
postmeno
pausal, 
(50-79y) 
× √ FFQs and 2x plasma one at each visit 
(p<0.001) 
Soy FFQ daidzein (r=37), genistein 
(r=0.43) 
Comprehensive FFQ daidzein (r=0.35), 
genistein intake (r=0.38) 
Daidzein plasma concentration (mean, 
median) 6.9mmol/dl,5mmol/dl, 
genistein12.2mmol/dl, 10.9mmol/dl 
√ FFQs one week 
apart 
Diadzein and 
genistein (r=0.67, 
p<0.001) 
Comprehensive 
FFQ daidzein mean 
2.2mg/wk, genistein 
mean 2.5mg/wk 
FFQ intake: daidzein mean 6.2mg/wk, 
median 3.7mg/wk, genistein mean 
8.1mg/wk, median 7.5mg/wk  
Conclusion: Soy FFQ and comprehensive 
FFQ appeared to be reliable and valid 
Strength: Bland Altman analysis (no plots) 
between the two FFQs 
Limitation: female subjects. No convergent 
validity assessed 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Frankenfeld 
(China) 2004 
IFs (daidzein, 
genistein), 107 
items (6 soy 
items) 
1823F 
(30-64y) 
× √ FFQ and 2x serum 
Significant trend of increasing serum 
daidzein and genistein level across 
increasing quartiles of isoflavone intake 
(p<0.01) 
No overall excretion reported 
× No overall FFQ intake reported 
Conclusion: FFQ provided ranking of IFs 
consumption and exposure 
Strength: rank intake for large sample size 
Limitation: Population not representative 
(female textile workers). No convergent 
validity, reliability and correlation were 
assessed. 
Heald 
(Scotland) 
2006 
IFs (daidzein, 
genistein), 155 
items 
203M 
(50-74y) 
Previously validated 
against with 4dWDRs for 
nutrients intake, but for 
PEs 
√ SCG-FFQ and 1x serum 4-9 weeks 
apart 
daidzein (r=0.24, CI:0.11,0.36, 
p=0.001)  
genistein (r=0.26, CI:0.12,0.38, 
p<0.001)  
Total IFs (r=0.27, CI:0.13,0.39, 
p<0.001) 
Median daidzein 18nmol/l, genistein 
33.79nmol/l, IFs 51.49nmol/l  
 
 
 
 
 
 
× FFQ intake: median IFs 1mg/d 
Conclusion: FFQ appeared to be valid for 
ranking intakes 
Strength: level of agreement (cross 
classification) analysis (categorised into 
same and opposite tertile of intake and serum 
concentration) 
Limitation: male subjects, no convergent 
validity and reliability were assessed 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Tseng (U.S.) 
2008 
IFs (daidzein, 
genistein), 26 
items for soy 
FFQ, 126 items 
for DAF 
27F 
(30-50y) 
× √ Soy FFQ, DAF and 4x24h urine (no 
p-values reported) 
Soy FFQ daidzein (r=0.49), genistein 
(r=0.54) 
Diet assessment form (DAF) daidzein 
(r=0.54), genistein (r=0.33) 
24h urines and overnight urine daidzein 
(r=0.84), genistein (r=0.93), glycitein 
(r=0.76), ODMA (r=0.94), equol 
(r=0.61) 
24h excretion daidzein mean 
323ng/mgC, median 110ng/mgC, 
genistein mean 136ng/mgC, median 
67ng/mgC 
× FFQ intake: SFQ daidzein mean 2.9mg/d, 
median 0.015mg/d, genistein mean 3.9mg/d, 
median 0.013mg/d, DAF daidzein mean 
2.1mg/d, median 0.032mg/d, genistein mean 
2.2mg/d median 0.129mg/d 
Conclusion: Soy FFQ and DAF valid in 
ranking intake; overnight urine correlate well 
with 24h urine 
Strength: Comparison of excretion between 
first-morning and 24h urine (similar to 
Huang et al. 2000).  
Limitation: female subjects, small sample 
size, no p-values reported 
Fernandez 
(Malaysia) 
2013 
If (genistein), 
19 items 
64 
pregnant F 
√ FFQ and 7dFDs 
Genistein (r=72, p<0.001)  
FD mean=9.9mg/d 
√ FFQ and serum 
No coefficient and p-values presented 
Dose-response relation (p<0.01) 
between intake and serum level across 
quintile of intake: mean of serum level 
increases as quintile of intake increases 
Mean serum 55.9nmol/l 
√ FFQ1 and FFQ2 
three to four weeks 
apart 
No coefficient and 
p-values presented 
FFQ2 intake mean 
13.3mg/d 
 
FFQ intake: mean 13.7mg/d 
Conclusion: 33 items FFQ is valid in 
measuring genistein.  
Strength: Bland Altman plot and percentage 
agreement (cross-classification) 
Limitation: female subjects, small sample 
size, measure only genistein 
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Author 
(country) 
FFQ: PEs 
measured, # of 
food items 
Study 
sample 
Convergent validity, 
Intake by reference 
method 
Criterion validity, Excretion by 
biomarker 
Reliability, Intake 
by FFQ2 
Results and comments 
Chan (Hong 
Kong) 2008 
IF (combined 
total IFs), 47 
items 
145 
Chinese 
mid-life 
women 
√ FFQ and 23 day x 24h 
DRs throughout 1-year) 
IFs (ρ=0.53, p<0.001) 
Median intake 6.3mg/d 
(p<0.0057) 
 
 
× √ (FFQ1 and FFQ2 
thirteen month 
apart) 
ICC=0.68 
FFQ2 median 
7.7mg/d (P=0.83) 
FFQ intake: IFs mean 6.6mg/d 
Conclusion: soy FFQ is valid and reliable in 
measuring IFs. 
Strength: Bland Altman plot and percentage 
agreement (cross-classification) 
Limitation: female subjects 
Key: FFQ = food frequency questionnaire, 24h-, 48h-,7d-DRs = 24-hour, 48-hour, 7-day dietary recalls/records, 7dWFRs = 7-day weighed food records, 4dWDRs=4-day weighed diet record, 7dFDs=7-day food diaries, DAF =Diet assessment form, LGs 
= lignans, IFs = isoflavones, PEs = phytoestrogens, ENL = enterolactone, VCs= validity coefficients, r = Spearman correlation coefficient, ρ = Pearson correlation coefficient, ICC = intraclass correlation coefficient, F=female, M=male 
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Table 3. Cross-sectional studies of lignan and isoflavone intake and food sources 
Author 
Country 
Population Dietary tool Intake µg/d, (mean and/or median) Phytoestrogens measured; Database; Food sources (%) 
Studies that measure lignan, isoflavone and enterolignan phytoestrogens 
Hedelin (2006) 
Sweden 
1,130 male 
control,  
1,499 case of 
prostate cancer, 
35-65y  
261-items 
validated FFQ for 
phytoestrogens 
Mean (range), Median 
Control 
Total LGs 4,855 (292-106,958), 3,045 
Total enterolignans 16.06 (0-167), 13.05 
Total IFs 343 (1-18,975), 15 
Case  
Total LGs 4,929 (310-73,754), 3,044 
Total enterolignans 16.06 (0-102), 13.05 
Total IFs 491 (0-37,760), 16 
LGs: SECO, MAT, PINO, LARI, SYR, MED; Enterolignan; END, 
ENL; IFs: daidzein, genistein, formononetin, biochanin A, equol; 
Finnish, Swedish; 
N/A 
Hedelin (2008) 
Sweden 
45,448 female 
control,  
1,014 case of 
breast cancer, 
30-49y, 
80-items 
self-administered 
validated FFQ 
Mean±SD (range), Median 
Control 
Total plant LGs 1,763±886 (15-14,473), 1,632 
Total enterolignans 11±9 (0-110), 9 
Total IFs 73±166 (0-5,023), 7 
Case  
Total plant LGs 1,784±887 (31-7,435), 1,639 
Total enterolignans 10±8 (0-67), 8 
Total IFs 78±181 (0.2-1,979), 7 
 
 
 
 
 
LGs: SECO, MAT, PINO, LARI, SYR, MED; Enterolignan: END, 
ENL; IFs: daidzein, genistein, formononetin, biochanin A, equol; 
Finnish, Swedish; 
N/A 
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Author, 
Country 
Population Dietary tool Intake µg/d, (mean and/or median) Phytoestrogens measured; Database; Food sources (%) 
Lahmann 
(2012) Australia 
2,078 female 
control cohort 
from case-control 
gynaecological 
cancer study, 
18-79y 
135-items FFQ, 
modified and 
validated in 
Australia for 
energy and 
nutrients intake 
Mean±SD, Median (IQR) 
Total LGs 693±296, 639 (323), 
Total enterolignans 22±12, 21(15) 
Total IFs 3,293±5,71, 1,286 (1,693) 
LGs: SECO, MAT, PINO, LARI; Enterolignan: END, ENL; IFs: 
Equol, daidzein, genistein, glycitein, formononetin, biochanin A;  
U.K. (for SECO, MAT, and total enterolignans and IFs), Canadian 
(LARI, PINO); 
Low intake (≤1286µg/d): non-soya bread (23%), vegetables (22.5%), 
fruits (16%) 
High intake (≥1286µg/d): Soybean and linseed bread (22%), Soybean 
milk (19%), non-soya bread (12%) 
Zamora-Ros 
(2012) 
European 
countries 
36,037 adults 
from European 
Prospective 
Investigation into 
Cancer and 
Nutrition (EPIC) 
study, 35-74y 
24 hour dietary 
records 
Mean±SE 
Total LGs 1,037±30 (Greece) to 2,145±90 
(U.K.) 
Total enterolignans 10±0 (Greece) to 18.5±0 
(Sweden) 
Total IFs 236±140 (Greece) to 12,133±360 
(U.K) 
LGs: SECO, MAT, PINO, LARI; Enterolignan: END, ENL; IFs: daidzein, 
genistein, glycitein, formononetin, biochanin A;  
Dutch, U.K., Canadian; 
Mediterranean countries Total LGs: Fruits (31%), vegetables (26%), 
alcoholic beverages (11%) 
Non-Mediterranean countries Total LGs: Non-alcoholic beverages (25%), 
vegetables (23%), Cereals products (20%) 
Mediterranean countries Total IFs: Soy products (49%), legumes (9%), 
vegetables (7%) 
Non-Mediterranean countries Total IFs: Soy products (32%), sugar and 
confectionary (17%), non-alcoholic beverages (13%) 
Mediterranean countries Total enterolignans: dairy (92%), sugar and 
confectionary (2%), condiments and sauces (2%), meat (1%) 
Non-Mediterranean countries total enterolignans: dairy (90%), condiments 
and sauces (3%), sugar and confectionary (2.9%) 
 
 
48  
Author, 
Country 
Population Dietary tool Intake µg/d, (mean and/or median) Phytoestrogens measured; Database; Food sources (%) 
Mulligan 
(2012) U.K. 
20,437 adults 
from of EPIC 
Norfolk cohort, 
40-79y 
7 day food diaries Mean±SD, Median (IQR)  
Total LGs, non soya-consuming (NSC) men 
311±178, 273 (209-364), 
Total LGs, soya-consuming (SC) men 
361±230, 309 (237-422)  
Total LGs, NSC women 251±141, 229 
(180-293) 
Total LGs, SC women 318±212, 276 
(215-351) 
Total enterolignan NSC men 19±9, 18 (13-24) 
Total enterolignan SC men 18±9, 17 (12-24)  
Total enterolignan NSC women 16±8, 16 
(11-21) 
Total enterolignan SC women 16±8, 15 
(10-20) 
Total IFs, NSC men 1,033±871, 858 
(633-1,155) 
Total IFs, SC men 4,664±4,973, 2,413 
(998-6,845) 
Total IFs, NSC women 734±597, 615 
(457-819) 
Total IFs, SC women 5,055±6,054, 2,830 
(779-6,938) 
 
 
LGs: SECO, MAT, Shonanin; Enterolignan: END, ENL; IFs: daidzein, 
genistein, glycitein, formononetin, biochanin A; 
U.K.;  
NSC group (men and women); bread and bread rolls (43%), breakfast 
cereals (12%), tea and coffee (6%) 
SC group (men and women): vegetables dishes (41%), milk, 
soy/goat/sheep (25%), bread and bread rolls (11%) 
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Country 
Population Dietary tool Intake µg/d, (mean and/or median) Phytoestrogens measured; Database; Food sources (%) 
Studies that measure lignans and isoflavones 
Bhakta (2006) 
U.K. 
221 South Asians 
residents in U.K. 
and 49 Native 
British residents, 
25-75y 
12 x 24-hour 
recalls for 1 year 
Mean±SD, Median (IQR) 
Total IFs South Asians 322±877, 184 
(121-278) 
Total LGs South Asians 137±82, 111 (77-182) 
Total IFs Native British 366±176, 334 
(227-449) 
Total LGs Native British 183±132, 149 
(87-229) 
IFs: daidzein, genistein; LGs: SECO, MAT; 
U.K. (for IFs), Finnish (LGs)  
IFs - South Asians, breads (51%), vegetables/vegetable dishes (38%), 
milk/milk products (8%), flours, grains & cereals (2%) 
Native British, breads (93%), milk/milk products (3%), 
vegetables/vegetable dishes (2%), flours, grains. cereals (1%) 
LGs - South Asians, breads (70%), vegetables/vegetable dishes (12%), 
miscellaneous (7%), fruit and fruit juices (5%), flours, grains, cereals 
(3%) 
Native British, breads (60%), fruit and fruit juices (21%), 
miscellaneous (9%), vegetables/vegetables dishes (6%), alcohol (2%) 
Cotterchio 
(2008) Canada 
3,370 women 178-items FFQ Median (IQR) 
Total LGs, 857 (305, 4,005),  
Total IFs, 230 (93, 842) 
LGs: SECO, MAT, PINO, LARI; IFs: daidzein, genistein, glycitein, 
formononetin; 
Canadian; 
IFs, soybean (37%), soy milk (18%), tofu (13%) 
LGs, Flaxseed (88%), multigrain bread (6%), flax bread (3%) 
Saleh (2011) 
Bangladesh 
111 
postmenopausal 
women 
7-day FFQ Mean±SD, Median (range) 
Total LGs, 7,320±3,280, 7,310 (5,530-9,830) 
Total IFs, 320±160, 320 (190-390) 
 
LGs: SECO, MAT; IFs: daidzein, genistein, formononetin, biochanin 
A; 
Finnish (scoring PEs concentration); 
IFs, soybean oil (96%), Beans and peas (4%), cabbage, cauliflower 
LGs, beans and peas (6%), cabbage, cauliflower, carrot (5%), onion, 
garlic, pepper (3%) 
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Country 
Population Dietary tool Intake µg/d, (mean and/or median) Phytoestrogens measured; Database; Food sources (%) 
Huang (2012) 
U.S. 
Multiethnic 
women from The 
Study of 
Women’s Health 
Across the Nation 
(SWAN) midlife  
137-items FFQ Median (IQR) 
Total LGs, 191 (146) African American 
Total LGs, 250 (170) Caucasian 
Total LGs, 291 (248), English speaking 
Chinese  
Total LGs, 354 (232), Chinese speaking 
Chinese 
Total LGs, 233 (180), English speaking 
Japanese 
Total LGs, 371 (292), Japanese speaking 
Japanese  
Total IFs, 285 (545) African American 
Total IFs, 318 (699) Caucasian 
Total IFs, 5,487 (13,545) English speaking 
Chinese 
Total IFs, 9,714 (15,215) Chinese speaking 
Chinese 
Total IFs, 6,743 (9,334) English speaking 
Japanese 
Total IFs, 24,585 (21,704) Japanese speaking 
Japanese  
 
LGs: SECO, MAT, PINO, LARI; IFs:daidzein, genistein, glycitein, 
formononetin;   Canadian; 
LGs - African American: coffee (12-13%), black tea (7-16%), green 
salad (9-11%), Chinese herbs in soup/tea (5-12%) 
Caucasian: coffee (13-23%), black tea (6-20%), green salad (10-12%), 
broccoli (6-8%) 
English speaking Chinese: Chinese herbs in soup/tea (25%), black tea, 
(13%) green tea (8%), green leafy vegetables (6%). Chinese speaking 
Chinese: Chinese herbs in soup/tea (23%), black tea (16%), green 
leafy vegetables (11%), green tea (9%) 
English speaking Japanese: coffee (15%), green tea (12%), green salad 
(10%), black tea (9%). Japanese’s speaking Japanese: green tea (20%), 
Chinese herbs in soup/tea (13%), black tea (11%), coffee (9%) 
IFs - African American: soymilk (76-86%), tofu (4-11%), donut 
(2-9%), meat substitute (6%)    
Caucasian: soymilk (54-86%), tofu (5-18%), meat substitute (5-8%), 
fresh green soybean (5-21%) 
English speaking Chinese: Soymilk(51%), tofu(21%), fresh green 
soybeans(10%), dry spiced tofu(9%). Chinese speaking Chinese: 
Soymilk(52%), tofu(27%), dry spiced tofu(5%), fermented 
soybean(3%)  
English speaking Japanese: Fresh green soybean(36%), tofu(21%), 
soymilk(15%), roasted soybean(13%). Japanese speaking Japanese: 
fermented soybean(30%), fresh green soybean(26%), tofu(21%), 
soymilk(8%) 
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Country 
Population Dietary tool Intake µg/d, (mean and/or median) Phytoestrogens measured; Database; Food sources (%) 
Hu (2014) 
China 
1,000 subjects 
from 31 
provinces or 
province-level 
administrative 
regions 
Modified 
semi-quantitative 
food frequency 
questionnaire 
Mean±SD, Median 
Total IFs 183.2±122.7μg/kg/day, 
149.9μg/kg/day 
SECO 26.1±20.2μg/kg/day, 22.5μg/kg/day 
With average weight of Chinese population, 
60kg 
Estimated Total IFs, 10,992μg/day, SECO, 
1,566μg/day 
 
Total IFs daidzein, genistein, glycitein, LGs, SECO; 
Chinese (on plant-derived foods) 
Total IFs 
Soy (22%), soybean sprouts (19%), Chinese lettuce (17%), silken 
bean curd (13%), taro (6%) 
SECO 
Carrot (40%), Chinese lettuce (10%), taro (9%), white gourd (6%) 
Studies that measure lignans and enterolignans 
Touillaud 
(2007) France 
58,049 women, 
41-72y 
208-items 
self-administered 
validated diet 
history 
questionnaire 
Median (range) 
Total LGs 1,112 (0-5,702) 
Total enterolignans 768 (0-2,538) 
 
Total LGs: SECO, MAT, PINO, LARI, Total enterolignans: END, 
ENL;  
Finnish, Dutch, French, Canadian (indirect analysis for content of 
lignan metabolites produced); 
Fruit (35%), vegetables (30%), tea (11%) 
Peñalvo (2012) 
Spain 
3,534 children 
and young 
adults, 2-24y 
24 diet recalls 
over the year 
Mean, Median (IQR) 
Total LGs, 1,080, 830 (0.49-1.33) 
ENL alone, 14, 13 (8-20) 
Mean 
SECO, MAT, PINO LARI, 786  
Total LGs: SECO, MAT, PINO, LARI, SYR, MED, Enterolignan: 
ENL; 
Spanish; 
White bread (17%), olive oil (16%), virgin olive oil (11%) 
Studies that measure lignans 
Milder (2005) 
The 
Netherlands 
4,660 adults, 
19-97y 
 
2 day dietary 
record 
Mean±SD (range) 
Total LGs 1,241±2,052 (43-77,584) 
Total LGs SECO, MAT, PINO, LARI; 
Dutch; 
Beverages (37%), vegetables (24%), nuts and seeds (14%) 
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Galvan-Portillo 
(2007) Mexico 
50 women, 
17-37y 
 
54-items FFQ Mean±SD 
104, plant lignan mean 
Total LGs, SECO, MAT, PINO, LARI; 
Dutch, Finnish; 
Pinto bean (76% to SECO), broccoli (20% to LARI, 10% to 
PINO), orange (55% to MAT) 
Nurmi (2010) 
Finland 
100 men 4 day food 
record 
Mean±SD (range) 
Total LGs 1,224±539 (250-989) 
Total LGs SECO, MAT, PINO, LARI; 
Dutch, Finnish; 
Rye products, berries, coffee, tea, wholegrains 
Sohrab (2013) 
Iran 
2,618 adults, 
19-84y 
168-items 
validated 
semi-quantitative 
FFQ 
Median 
Total LGs, 200 
Total LGs SECO, MAT, PINO, LARI; 
European Phenol-Explorer online database; 
Nuts (r=0.28), wholegrain (r=0.26), meat poultry and fish (r=0.10) 
González 
(2013) Iran 
304 
institutionalised  
elderly adults 
Specially 
designed FFQ 
for each 14 
institution 
Mean±SD 
Total LGs, 450±0.3  
Total LGs, SECO, MAT, PINO, LARI; 
European Phenol-Explorer online database; 
Olive oil, white bread, red wine, wholemeal bread 
Meija (2013) 
Latvia 
172 men and 97 
women, 40-75y 
147-item, 
country specific 
food frequency 
questionnaire 
modified for 
lignan  
Mean±SD, Median (IQR) 
Total LGs 
Men 5,151±6,364, 2,783 (1,266-6,815) 
Women 3,339±4,429, 1,823 (1,022-3,349) 
Total LGs, SECO, MAT, PINO, LARI, SYR, MED; 
Canadian (for SECO, MAT, PINO, LARI), Latvian (all LGs, 
particular SYD and MED, for Latvian local breads); 
Food sources (only SECO, MAT, PINO, LARI) 
Men, cereals (rye and seed bread) (90%), nuts and seeds (flaxseed) 
(7%), beverages (coffee and tea) (1%), vegetables (cabbage) (1%) 
Women, cereals (rye and seed bread) (60%), nuts and seeds (35%), 
vegetables (2%), fruit and berries (2%) 
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Population Dietary tool Intake µg/d, (mean and/or median) Phytoestrogens measured; Database; Food sources (%) 
Studies that measure isoflavones 
Wong (2007) 
Hong Kong 
(H.K.) SAR, 
China 
1,701 men with 
lower urinary 
tract symptoms, 
≥65y 
Modified 
285-item Block 
FFQ with 10 
commonly 
consumed soya 
items in H.K. 
Mean±SD, Median (IQR) 
Total IFs 
15,730±23,130, 11,470 (13,230) 
Total IFs daidzein, genistein, glycitein; 
U.S. (Dwyer et al. 1994, Anderson 1997); 
N/A 
Iwasaki (2009) 
Japan and 
Brazil 
780 Japanese  
in Japan, 162 
Japanese 
Brazilian in 
Brazil, 758 
non-Japanese 
Brazilian in 
Brazil, 
case/control of 
breast cancer 
study, 20-74y 
136-item 
semi-quantitative 
FFQ for Japan, 
118-item version 
for Brazil 
Mean 
Total IFs 
Cases 
Japanese in Japan 43,500 
Japanese Brazilian in Brazil 16,500 
Non-Japanese Brazilian in Brazil 1,100 
Control 
Japanese in Japan 46,100 
Japanese Brazilian in Brazil 24,900 
Non-Japanese Brazilian in Brazil 4,400 
Total IFs, daidzein, genistein 
Japanese (Kimira et al.1998, Arai et al. 2000); 
N/A 
 
Zamora-Ros 
(2010) Spain 
40,483 subjects, 
15,446 men and 
25,237 women, 
35-64y 
Computerised 
diet history 
questionnaire 
developed/ 
validated for 
EPIC Spain 
cohort 
Mean±SD, Median 
Total IFs 
Men 110±440, 0 
Women 40±160, 0 
All 80±330, 0 
Total IFs, daidzein, genistein, glycitein; 
USDA isoflavone database; 
Soybean sprouts (72%), beans (17%), chickpeas (8%), legumes 
(2%) soy sauce (0.1%) 
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Lee (2013) 
Korea 
8,502 subjects 
from 2008 
Korea National 
Health and 
Nutrition 
Examination 
Survey 
(KNHANES) 
2008, ≥2y 
24-hour dietary 
recall 
Mean±SE 
Total IFs, subjects meet *dietary 
recommendation 25,800±2,800 
Total IFs subjects do not meet *dietary 
recommendation 5,400±500 
Total IFs daidzein, genistein, glycitein; 
Korean (Food composition table supplied by Korea National 
Academy of Agricultural Science); 
Mandarin (67%), soybean curd (15%), soybeans (11%), orange 
(3%), soybean sprout (2%); 
*Dietary recommendation: 1 to 3 servings of fruit and 5 to 7 
servings of vegetables  
Tang (2013) 
China 
(North-West) 
359 cases of 
oesophageal 
cancer, 380 
controls, 
(mean±SD age 
61±11) 
Validated 
137-item 
semi-quantitative 
FFQ 
Mean±SD 
Total IFs 
Cases 16,500±29,900 
Controls 27,100±36,500 
 
Total IFs, daidzein, genistein, glycitein; 
USDA isoflavone database; 
N/A 
Bai (2014) 
U.S. 
17,900 subjects 
from NHANES 
III 
24-hour dietary 
recall 
Mean±SE 
Total IFs, 2,350±270  
Total IFs, daidzein, genistein, glycitein; 
USDA isoflavone database; 
N/A 
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CHAPTER THREE: METHODS 
3.1. Research design 
This is a cross-sectional study that evaluated the validity and reliability of a modified 
phytoestrogen-specific dietary tool. The study was conducted to firstly, compare 
phytoestrogen intake derived from the modified dietary tool with intake derived from a 
reference dietary tool and with urinary excretion of phytoestrogen biomarkers; secondly, 
assess the dietary intake and food sources of phytoestrogens in a group of 59 Australians 
with the modified dietary tool, and thirdly explore the relationship between phytoestrogen 
intake and excretion, and selected social and lifestyle characteristics. An overview of the 
study design, including tools development, data collection and analysis is illustrated in 
Figure 5. 
 
3.2. Tools and method development for data collection 
This section describes the development of the tools and methods used for data collection. 
Databases for the lignan and isoflavone content from dietary sources were collated and 
utilised to measure intake of phytoestrogens from foods and beverages consumed by the 
research subjects.  Phytoestrogen intake status was assessed with a previously-developed 
specific FFQ, which was reviewed, expanded and updated to measure phytoestrogen 
intake in the current Australian context. A 3-day weighed food record (WFR) was used as 
the reference method to collect details of foods and beverages consumed over three 
consecutive days. Phytoestrogen excretion status was assessed with urinary biomarkers of 
phytoestrogen metabolites. A questionnaire was designed to collect selected demographic 
and lifestyle characteristics which were shown to be associated with phytoestrogen status 
in previous research.
56  Figure 5. Overview of the study design
57  
3.2.1. Dietary lignan and isoflavonoid database 
There are no published data for the lignan content of Australian foods and therefore data 
were sourced from international published studies from The Netherlands, Finland, the 
U.S, and Canada (Blitz, Murphy, & Au, 2007; Mazur, 1998a; Mazur et al., 1999; Mazur, 
Wähälä, Rasku, et al., 1998; Meagher & Beecher, 2000; Milder, Arts, et al., 2005; 
Thompson et al., 2006).  The database was compiled by a previous Master of Nutrition 
and Dietetics student at the University of Wollongong (2009) under the supervision of 
Associate Professor Philippa Lyons-Wall, and used with permission for the current study.  
This database was reviewed and updated by the candidate with more recently published 
lignan values and was used in the current study to quantify intake of the four primary 
dietary lignan precursors, SECO, MAT, LARI and PINO (Bonzanini et al., 2009; Clarke 
et al., 2013; Durazzo, Azzini, et al., 2009; Durazzo, Azzini, et al., 2013; Durazzo, 
Raguzzini, et al., 2009; Durazzo, Turfani, Azzini, Maiani, & Carcea, 2013; Durazzo, 
Zaccaria, et al., 2013; Kuhnle, Dell'Aquila, Aspinall, Runswick, Joosen, et al., 2009; 
Kuhnle et al., 2008a; Kuhnle, Dell'Aquila, Aspinall, Runswick, Mulligan, et al., 2009; 
Moreno-Franco et al., 2011; Nurmi et al., 2003; Peñalvo et al., 2008; Peñalvo et al., 2005; 
Smeds et al., 2007; Smeds et al., 2009).  
Intake of two enterolignans, END and ENL was calculated using the one available 
database from the UK for animal-based foods (Kuhnle et al., 2008b). No plant-based 
foods contained END and ENL and no animal-based foods contained plant lignans. 
 
Databases which provided the lignan content for all four dietary lignan precursors were 
preferentially selected for assigning lignan content to items for the current study. To 
account for the effect of the natural variability of phytoestrogens in foods, values for the 
same food item across multiple databases were averaged.  The averaged values were 
used to assign lignan content to the food items in the phytoestrogen specific food 
frequency questionnaire and in the 3-day weighed food record. The final collated lignan 
database contained a total of over 1000 food and beverages items and included individual 
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foods, processed foods and mixed dishes from the major food groups: vegetables, fruits, 
fruit and vegetable juices; nuts and seeds, breads and cereals; dairy products and 
milk-like beverages; meats; also herbs and spices, tea and coffee, and alcoholic beverages. 
The collated database is available on request.   
Intakes of five isoflavones, daidzein, genistein, glycitein, formononetin and biochanin A 
were quantified using the comprehensive United States Department of Agriculture 
isoflavone database (Release 2.0) (Bhagwat et al., 2008). The phytoestrogen values of the 
aglycone forms, based on wet weight, were used to quantify the dietary intake.   
 
3.2.2. Phytoestrogen specific food frequency questionnaire 
An existing 112 item phytoestrogen FFQ was developed by two Nutrition and Dietetics 
students at the University of Sydney under the supervision of Associate Professor 
Philippa Lyons-Wall.  This FFQ was adopted by Hanna et al. (2005) in her doctoral 
research to measure phytoestrogens intake and is used with permission for the current 
study.  The modification of this FFQ by the candidate for the current research was based 
on updating the content of lignans and isoflavones of items from published databases and 
increasing the number of items to include dietary patterns and typical serve sizes 
described in the Australian Dietary Guidelines (NHMRC, 2013a). Food sources rich in 
lignans and isoflavones i.e. flaxseed and soy and related food products, and commonly- 
consumed food sources of lignans, such as broccoli, pumpkin, oranges and berries, were 
included in the questionnaire.  Food groups and common foods consumed in Australia 
were identified from the 1995 National Nutrition Survey conducted in a broad sample of 
13,800 adults (McLennan & Podger, 1995) and from a secondary data analysis in 2010 of 
the baseline diet of 106 Australian men and women enrolled in a clinical trial, previously 
conducted by the candidate under the supervision of Associate Professor Philippa 
Lyons-Wall. The FFQ was designed to recall usual diet over the past month (4 weeks) and 
contained five columns.  The ‘Food Item’ column contained the list of 277 foods and 
beverages in the FFQ. The ‘Brand’ and ‘Type’ column provided additional space for the 
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subjects to state further details about the food item, for example, the brand, the type or the 
colour. The ‘Standard serve size’ column stated the reference serve size of the food items 
taken from The Australian Dietary Guidelines (NHMRC, 2013a).  Subjects used the 
standard serve size as a comparison to respond how much they usually consumed for that 
particular food item, which they entered in the ‘Portion size’ column. The ‘Frequency’ 
column allowed subjects to report how often they consumed each food item with 
reference to their portion size over the previous month. The questionnaire comprised 14 
frequency categories: never/<1 per month, 1 per month, 2 per month, 3 per month, 1 per 
week, 2 per week, 3 per week, 4 per week, 5 per week, 6 per week, 1 per day, 2 per day, 3 
per day and ≥4 per day (Appendix A).  
 
3.2.2.1 Pilot study of food frequency questionnaire  
A pilot study of the FFQ was conducted to pretest the feasibility of the research tool 
(Persaud, 2010).  A group of 10 people, known to the candidate and mainly from a 
nutrition and sport sciences background, were invited to complete the food frequency 
questionnaire and provided feedback based on a list of pilot questions, including the time 
it took to complete, the format and feasibility of the questionnaire, and improvement for 
the questionnaire from the respondent’s perspective (Appendix B). On average, 
approximately 35 minutes was spent to complete the questionnaire. Most respondents 
believed that the format of the questionnaire was easy to understand and three suggested 
changes were made to improve the response for portion size in comparison to standard 
serve size or to answer portion size in exact amounts consumed or household measures. 
Half of the respondents thought that having visual aids for standard serve size and 
common household measures would be helpful in completing this questionnaire. 
Respondents also nominated commonly consumed food items to be considered on the 
questionnaire. Amendments were made to the FFQ according to this feedback. A food 
model booklet (Stamatis, 2000) was made available as a visual aid on request. The 
candidate embedded extra rows on the questionnaire for recruited subjects to record other 
foods and beverages that they consumed regularly but were not listed.  
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3.2.3. Demographic and lifestyle questionnaire 
A questionnaire was designed to collect demographic and lifestyle information 
(Appendix C). The questions were based on those from the Australian Health Survey 
(ABS, 2013b), and previous published research (Hanna et al., 2010; Johnsen et al., 2004; 
Milder et al., 2007). Several social characteristics were found to be associated with lignan 
intake and/or biomarkers in the literature review. These variables included age, gender, 
height, weight and BMI, occupation, level of education, physical activity level, smoking 
status, bowel habits (frequency and movement) and commercial dietary supplemental use. 
The associations between ancestry/ethnicity and cultural background (language spoken at 
home, country of birth) and lignan status were also explored in the current study to 
address the multicultural nature of the sample group. 
 
3.2.4. Three-day weighed food record 
A 3-day weighed food record was chosen as the reference method for validating the 
phytoestrogen specific FFQ because the weighed food record has unrelated sources of 
errors from those of a food frequency questionnaire (Willett & Lenart, 1998).  Subjects 
were provided with the weighed food record booklet to record and describe their food and 
beverages intake over 3 days.  Subjects were required to record the amount, type and 
brands of the food and beverages consumed, the meal type, preparation method, and place 
of preparation and the time of consumption (Appendix D). Where subjects consumed a 
dish they prepared from a range of ingredients, they were required to record the recipe in 
the recipe section of booklet and to specify the amount consumed in the food booklet.  
Details of the ingredients and the amounts used in the recipes were important to identify 
ingredients that were rich in phytoestrogen content.  A set of digital kitchen scales, 
which measured to the nearest 1g (Propert 5 kg capacity, slimline stainless steel, Propert 
Houseware, NSW) and modular measuring cups and spoons (Décor Cook, The Décor 
Corporation, VIC) were provided to each subject to standardise weighing and estimating 
the amount of their food and beverages intake.  
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3.2.5 Urine sample collection 
A dose-dependent relationship between phytoestrogen consumption and urinary excretion 
has been reported in human intervention studies for both lignans (Hutchins, Martini, 
Olson, Thomas, & Slavin, 2000) and isoflavonoids (Morimoto, Beckford, Franke, & 
Maskarinec, 2014). This relationship demonstrates that the use of urinary biomarkers of 
phytoestrogen metabolites is an informative and objective method to test the criterion 
validity of the phytoestrogen questionnaire.  
Subjects were asked to collect 24-h urine samples for three consecutive days. Each 
subject was provided with three 3 L bottles (SteriHealth, VIC) with ascorbic acid (1g per 
bottle) added as preservative (Sigma Aldrich, L-Ascorbic acid, NSW), funnels 
(SteriHealth, VIC) and specimen collectors (Victoria Healthcare Products, VIC). Subjects 
were given a urine collection protocol developed for this study and the procedure for 
urine collection was explained to subjects at their first visit to the study venue (Appendix 
E). On the day of collection, subjects discarded the first morning void and collected all 
urine for the remainder of the day, completing the collection with the first morning void 
on the next day. The candidate provided the subjects with advice on how to store the 
collected samples and agreed on an appropriate storage method during the urine 
collection period. An insulated cooler bag and three freezer blocks was provided to assist 
each subject with samples storage prior to delivery to the study venue. To verify the 
completeness of urine samples, subjects were asked to record on the bottle label whether 
each sample was either complete or incomplete, with the time of missed samples noted in 
a space provided (Murakami et al., 2008). Collections were repeated on the next two 
consecutive days. 
Subjects delivered the three 24-hour urine collection to the study venue on completion. 
The samples were refrigerated and processed at the chemistry laboratory at Edith Cowan 
University within 48 hours of receipt. The total volume and total weight of each 24-hour 
urine sample was measured with graduated cylinders and a top pan balance (Appendix F). 
A set of five aliquots was prepared from each sample, and to each aliquot 10µL of 30% 
62  
sodium azide solution (0.3g/ml) was added as a bacteriostat (Appendix G). Each aliquot 
was labeled and stored at -80°C until analysis.  
Protocols for urine sample preparation and working with chemicals, and the Risk 
Assessment and Management Plan (RAMP) was developed with the Analytical Chemist 
to ensure the consistency of laboratory work, to assess the risk of the protocols and to 
outline any emergency response. The RAMP was assessed and approved by the School of 
Natural Sciences Safety Officer.    
 
3.3. Subject recruitment 
3.3.1 Selection criteria 
 
3.3.1.1 Inclusion criteria 
Subjects of both genders, aged between 18-70 years, from different cultural and social 
backgrounds were eligible to participate. These inclusion criteria were designed to 
capture the dietary diversity of phytoestrogen intake.  
 
3.3.1.2 Exclusion criteria 
Subjects were excluded from participating in the study if they were using or have used 
regular doses of antibiotics for at least one month over the past 6 to 12 months, have 
made substantial changes to their usual diet during the past month, have current 
gastrointestinal problems such as ulcerative colitis and Crohn’s disease, or have 
undergone gastrointestinal surgery involving removal of the large intestine, or have had 
chronic or acute renal or liver disease in the previous 6-12 months (Appendix H).  
3.3.2 Determination of an adequate sample size 
The a priori estimated sample size to detect the significance was determined with a 
statistician using G*power (Version 3.1.3 for Mac OS X, Institut für Experimentelle 
Psychologie, Düsseldorf, Germany) for assessing the association between phytoestrogen 
intake and status measured by dietary methods and urinary biomarkers. The sample size 
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calculation indicated that 80 individuals were required to achieve a suggested moderate 
effect size (R2 of 68%), based on correlations between the FFQ and reference methods 
from previous validation studies, and correlations between dietary methods and 
biomarkers (R2 of 30%), with 80% power and a 5% significance level. This sample was 
within the range of the sample size recruited from previous validation studies (Bhakta et 
al., 2005; Hanna et al., 2005). The anticipated dropout rate was 10% resulting in a 
required sample size of 88 subjects.  
 
3.3.3 Advertisement 
A flyer was designed to advertise the study throughout the Edith Cowan University 
Joondalup campus across various facilities, including the library, student village and 
student guild, and online via the Graduate Research School Google group, Health and 
Wellness flyer, and Research news on Edith Cowan University portal (Appendix I). 
 
3.3.4 Ethics 
The study was granted ethical approval by the Human Research Ethics Committee, Edith 
Cowan University (Project number: 10415). All subjects provided informed written 
consent prior to starting the study and were given the contact details of the principal 
investigators and Ethics Officer in case of any concerns. Confidentiality of the data was 
strictly enforced. All questionnaires, food records and urine samples collected were stored 
securely. All data collected were entered into the candidate’s computer and stored 
securely. Individual subjects were identified by study codes that matched his or her 
questionnaire, food record and urine samples. This study involved human subjects and 
was conducted following the principles in the National Statement on Ethical Conduct in 
Human Research, Edith Cowan University Policy for the Conduct of Ethical Human 
Research, and The Declaration of Helsinki. 
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3.3.5 Subjects  
The subjects consisted of staff and students recruited at Edith Cowan University. 
Recruitment techniques included word of mouth and snowballing. Subjects who were in 
the study were asked to suggest the study to other interested individuals. Figure 6 
illustrates the process of subject recruitment from the start of the recruitment, screening, 
commencement and undertaking of the study, to the completion of the study. 
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Figure 6. The process of subject recruitment from commencement, screening and 
selection, and participation, to the completion of the study 
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3.4. Data collection and analysis 
Dietary intake was collected using the phytoestrogen FFQ and the 3-day WFR.  
Biomarkers of phytoestrogen metabolites were measured in the 24-hour urine samples, 
collected over three days to reflect subjects’ habitual urinary excretion. Assuming that 
biomarker excretion was delayed after consumption of phytoestrogens in the diet, due to 
possible metabolic conversions in the colon prior to absorption, urinary excretion would 
more likely reflect intake on the previous day (King & Bursill, 1998; Kuijsten et al., 2005; 
Watanabe et al., 1998). Therefore urine collections were timed to start one day after 
commencement of the WFR.  
 
The collection of the FFQ, 3-day WFR and urine samples is illustrated in Figure 7. In the 
first session, subjects completed the pre-study FFQ that reflected habitual diet over the 
past month, and the demographic and lifestyle questionnaire. They received instructions 
and the equipment for conducting a 3-day WFR and 3-day 24-hour urine collection 
(Figure 8). For the current research, the minimum 3 days, including a weekend day, was 
required for the food record as it is sufficient to obtain usual dietary intake, and practical 
and feasible within the short data collection timeline (Buzzard, 1998; Lee & Nieman, 
2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67  
 
Figure 7. Data collection protocol 
The study extended over a 7 day period with a 3 day WFR collected on days 1 to 3 and 24 
hour urine samples on day 2 to 4. The FFQ was completed on two occasions at the 
beginning and end of the study period, coinciding with subject visits to the study venue.  
Figure 8. Equipment provided to subjects to conduct the 3-day WFR and three 
24-hour urine collections 
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Subjects returned the completed 3-day WFR and 3-day urine collection at the second visit 
to the study venue. The candidate reviewed all food records with the subjects to verify 
completeness and clarify ambiguous information. Subjects then completed the same FFQ 
(post-study FFQ).  
 
3.4.1 Quality assurance and subject compliance 
To ensure the quality of data collection, subjects were required to attend the first session 
at the study venue. The candidate explained each step of the data collection procedure and 
demonstrated the use of equipment. Subjects were encouraged to ask any questions that 
they had during the session to make sure they understood the process. The candidate 
discussed with the subjects their anticipated commence and finish date so a second 
session could be scheduled for collection of equipment, weighed food record and urine 
samples. Subjects were encouraged to contact the candidate anytime if they wished to 
have any questions answered or would like advice when they had events that affected 
their food recording and urine collection. A study calendar was provided to subjects as an 
outline of the steps they needed to complete during the study. Spaces were available on 
the calendar for subjects to record relevant information, for example, any events that 
affected the dietary recording and urine collection, e.g. sickness, menstruation for female 
subjects, travelling (Appendix J). Subjects who missed their urine sample or WFR 
recording were advised to immediately contact and discuss with the candidate to resolve 
the issue.  
 
3.4.2 Assessment of energy and nutrient intake 
The subjects’ food intake from the WFRs was analysed for intake of energy, 
macronutrients and micronutrients using the AUSNUT (2007) database (FoodWorks® 
Professional Edition version 7, Xryis Software, QLD). Details of the type or brand and 
the preparation method were taken into account when choosing appropriate food items. 
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For food items not available in the AUSNUT database, a new food was constructed based 
on nutrient values of an existing similar food from other databases in FoodWorks®, or a 
new food was entered or edited with nutrient values from external sources, for example, 
the food label of the product or the USDA National Nutrient Database (U.S. Department 
of Agriculture, 2014). For subjects who provided detailed recipes in their WFRs, each 
ingredient and the quantity used for cooking the dish was entered into FoodWorks® to 
construct a new item. 
 
3.4.3 Assessment of phytoestrogen intake 
 
3.4.3.1 Analysis of phytoestrogen intake derived from food frequency questionnaire 
A template based on the FFQ was constructed using a Microsoft Excel spreadsheet to 
calculate the phytoestrogen intake of usual diet over the past month. Values of 
phytoestrogen content (based on wet weight and edible portion) were selected from the 
dietary lignan and isoflavone databases and assigned to the listed 277 food and beverage 
items. The portion size in grams and the number of times (how often) this item was 
consumed was entered into portion size and frequency columns corresponding to that 
particular food item. The first step was to calculate the weight of the item consumed per 
day = portion of item consumed (g) x (number of times consumed per month/30) + 
portion of item consumed (g) x (number of times consumed per week/7) + portion of item 
consumed (g) x (number of times consumed per day). The second step was to measure 
each lignan, enterolignan and isoflavone intake, for example, SECO (µg) consumed = 
weight of item consumed per day (g) x SECO content (µg/100g). Total lignan intake (µg) 
was calculated as the sum of intake of SECO, MAT, PINO, LARI; total enterolignan 
intake (µg) was calculated as the sum of END and ENL; and total isoflavone intake (µg) 
was calculated as the sum of daidzein, genistein, glycitein, formononetin and biochanin A 
intakes.  
Subjects recorded foods and beverages that were regularly consumed, but not listed, at the 
end of the questionnaire. These items were flagged and grouped together on a separate 
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spreadsheet and the foods were assigned with phytoestrogen content and added in to the 
totals. 
 
3.4.3.2 Analysis of phytoestrogen intake derived from weighed food records 
The data from the 3-day WFR analysed by FoodWorks®, were managed with Microsoft 
Access and exported to a Microsoft Excel spreadsheet to calculate phytoestrogen intake.  
Intake data were sorted by alphabetical order of food names to streamline the assigning 
process by giving the same phytoestrogen content values to all the same items at once. 
Phytoestrogen intake (µg) was calculated as: phytoestrogen content (µg/100g) x weight of 
item consumed (g). For recipes, the calculation of phytoestrogen content took into 
account the weight of the recipe consumed and content of phytoestrogen per serve. 
 
For items where no phytoestrogen values were available from the database, the values 
were based on those from an appropriate item available within the same food group 
Phytoestrogen content of mixed foods (foods and dishes composed of two or more 
different components) was estimated based on the proportion of each ingredient specified 
by the subjects or common recipes. Where appropriate, the water content of the food item, 
particularly those with high water content e.g. fruits juice, and water-based recipes, soup, 
was identified with NUTTAB 2010 and the proportion of the solid content calculated, 
assuming phytoestrogens are only present in the solid part of the food matrices. Food 
items with no available values and no appropriate substitution were left unassigned and a 
phytoestrogen content of zero was assumed, for example, sugar, salt, confectionary, soft 
drinks, vodka, seafood like crab and octopus, spices like cinnamon and cumin. 
  
3.4.4 Assessment of food sources contributing to lignan and isoflavone intake 
Food items from the FFQ were listed according to food groups specified in the Australian 
Dietary Guidelines with nuts and seeds, and legumes and beans, as two separate groups, 
(NHMRC, 2013a) and two additional groups, non-alcoholic beverages including coffee, 
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tea and juices, and alcoholic beverages.  Using the Australian Dietary Guidelines 
assured the food sources identified reflected the Australian dietary patterns.  Total and 
individual phytoestrogen intake from each food group and from all foods was calculated, 
and the percentage food contribution was calculated by dividing total phytoestrogen 
intake of each food group with the total intake of all foods. 
 
3.4.5 Assessment of urinary excretion of lignans and isoflavonoids  
 
Chemicals 
Methanol, acetonitrile and water were all LC-MS grade and supplied by Fisher Scientific. 
Pinoresinol, lariciresinol, secoisolariciresinol, enterodiol were supplied by PhytoLab 
(Vestenbergsgreuth, Germany). Matairesinol, enterolactone, daidzein, genistein, glycitein 
and equol were supplied by Cayman Chemical (Michigan, U.S.). LKT Laboratories 
(Minnesota, U.S.) supplied biochanin A and formononetin. Taxifolin was supplied by 
Sigma Aldrich (Castle Hill, NSW, Australia) and glucuronidase (activity > 100,000 
U/mL) /sulfatase (> 20,000 U/mL) enzyme extracted from red abalone (Haliotis 
rufescens) was sourced from Kura Biotech (Puerto Varas, Chile). Formic acid and acetic 
acid were supplied by Fluka and Ajax Finechem Pty Ltd. respectively.  
 
Sample preparation 
The urine was thawed to room temperature and then centrifuged (10 min at 13.2 rpm, 
23°C) (Eppendorf Centrifuge 5415R, Eppendorf, Germany). A 200 µL aliquot of the 
supernatant was transferred to a 2 mL Eppendorf tube before adding 240 µL of 
glucuronidase/sulfatase enzymes from Kura Biotec (Puerto Varas, Chile), 10 % (v/v) in 
sodium acetate (140 mM pH 4.8). Taxifolin (20 ng) was added as the internal standard 
(Fluka, Sigma Aldrich, Castle Hill, NSW, Australia).  Enzyme and internal standard 
were mixed thoroughly with the supernatant (Boeco Vortex V1 Plus, Boeco, Germany). 
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The sample was then mixed gently and heated at 37 oC overnight (approximately 16 hrs) 
(Eppendorf thermomixer comfort, Eppendorf, Germany).  
Methanol (20 µL) was added to each sample.  The sample was then passed through a 
preconditioned solid phase extraction cartridge (Alltech 100 mg, C18). The loaded 
cartridge was washed with 90:10:0.1 water:methanol:acetic acid (1.0 mL) followed by 
acetonitrile (1.0 mL) to elute the lignans. The lignan extract was freeze dried and stored at 
-80 oC until analysed (Labconco FreeZone 2.5, Labconco, United States). The freeze 
dried sample was reconstituted in 90:10:0.1 water:methanol:formic acid (400 µL). 
Chloramphenicol (20 ng) was added to each sample and standard as an instrument check 
(Valentin-Blasini, Blount, Schurz Rogers, & Needham, 2000). 
 
Liquid chromatography-mass spectrometry (LC-MS) analysis  
Concentration of urinary phytoestrogen metabolites (ng/ml) was measured by an 
Analytical Chemist with a high resolution Time of Flight Mass Spectrometer (ABSCIEX 
5600, AB SCIEX, Framingham, MA, United States) using electrospray ionisation in 
negative mode.  This instrument was interfaced to a Shimadzu Nexera LC system (LC 
30AD pump, SIL30AC autosampler and a CTO-20A column oven). The LC separation 
was carried out using a Grace Smart RP 18 column (50 mm x 2.1 mm x 3 mm) with a 10 
µL injection loop. The flow rate was 0.5 mL/min. The mobile phase consisted of 0.1% 
v/v formic acid in water (A) and 0.1% v/v formic acid in acetonitrile (B) in a gradient 
starting with 10% B to reach 50% B after 7 min, 100% B after 9 min, held for 5 minutes 
and returning to 10% B for 5 min to equilibrate. The mass spectrometer was run in 
independent data acquisition (IDA) mode with enhancement to the precursor ions for the 
target analytes (secoisolariciresinol, matairesinol, pinoresinol, lariciresinol, enterodiol, 
enterolactone, daidzein, genistein, glycitein, equol, biochanin A and formononetin). The 
nebulizer gas, heater gas and curtain gas were run at 30, 45 and 50 psi respectively. The 
ion source voltage was 4500 V and the probe temperature was 550°C. Collected mass 
range was m/z 50-1000. MSMS data was collected with a collision energy of -35 V with a 
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spread of 15 V (Grace, Mistry, Carter, Leathem, & Teale, 2007). 
 
Creatinine analysis 
Twenty four-hour urinary creatinine concentrations were determined with Jaffé Creatinine 
method (Husdan & Rapoport, 1968) to assess completeness of the urine collection. Two 
ml urine samples without added sodium azide were centrifuged for 90 seconds at 130rpm 
(Eppendorf MiniSpin) and 200µL of sample was pipetted into a sample cup. The urine 
sample was diluted 1/20 on board the analyser for analysis (Abbott Architect c16000, 
Analytical Imprecision 5.4 mmol/L:CVA: 2.0%, 12.2 mmol/L:CVA:1.8 %). Creatinine 
reacts with picric acid in an alkaline medium to produce a coloured creatinine-picrate 
complex.  The rate of formation of this complex, measured over a selected time interval at 
a primary wavelength of 500nm and secondary wavelength of 572 nm, is proportional to 
the concentration of creatinine in the sample (uncertainty of measurement, 0.22 mmol /L at 
5.4 mmol/L ± 0.42 mmol/L at 12.2 mmol/L).  Day-to-day variation in creatinine 
excretion of the three 24 hour urine samples of each subject was examined and compared 
with expected urinary creatinine excretion (creatinine index) to determine possible 
incompleteness of the 24 hour urine sample (Barr et al., 2005; De Keyzer et al., 2012; 
Dugdale, 2011).   
 
3.4.6 Assessment of phytoestrogen status and social and lifestyle characteristics 
Social and lifestyle characteristics data were collected with the demographic and lifestyle 
questionnaire. Height and weight were measured with subjects wearing light clothing and 
no shoes. Height was measured to the nearest 0.01cm and weight to the nearest 0.1kg 
with a digital measuring and weighing station (Seca 763, Seca GmbH & Co. KG., 
Hamburg, Germany) (Stewart, Marfell-Jones, Olds, & de Ridder, 2011). The height and 
weight were used to calculate body mass index (BMI): weight (kg)/square of height (m) 
(Diehl, 2011).  
74  
Subjects stated their occupation. All responses for the occupation were classified into one 
of the eight major groups according to the Australian and New Zealand Standard 
Classification of Occupation (ABS, 2013a). There were six categories of education level: 
University postgraduate, University undergraduate, Certificate or diploma, Year 12 Senior 
secondary school, Year 10 Junior secondary school and Other (e.g. primary education) 
(ABS, 2001). Subjects selected ethnic group that best described their and their biological 
parents ancestry/ethnicity and the language they speak the most at home. They indicated 
their country of birth and all responses were listed and classified into one of nine regions 
according to the Standard Australian Classification of Countries (ABS, 2011).  
Physical activity was categorised at four different levels and subject selected the level that 
best described them: 1) Sedentary, move only for necessary chores/walking/other 
activities 1-2/week; 2) Light, walking/other activities >3/week; 3) Moderate, exercise to 
perspire 1-2 times/week, or moderate labour or physically demanding work; 4) High, 
heavy exercise or sport several times/week, heavy labour or physically demanding work 
(ABS, 2013b; Hanna et al., 2010). Subjects were asked to select the best option to 
describe his or her usual physical activity over the past month.  
 
Smoking status was categorised as: never smoked, current smoker (daily, weekly or other 
frequency) and past smoker. Subjects described their bowel habits using frequency such 
as how many times per week and the movement such as ‘hard to pass’, ‘smooth and soft’ 
or ‘mushy and watery’ according to the Bristol stool chart (Lewis & Heaton, 1997).  
Subjects stated whether they used any commercial dietary supplements (yes or no), and 
provided the details of regular supplements they were taking.  
 
3.4.7 Statistical analysis 
Data entry and cleaning 
Quality assurance procedures were implemented in data entry and analysis. All 
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questionnaires and WFRs were reviewed by the candidate to check for completeness and 
ensure that food weights and ingredients were recorded. Subjects were contacted by the 
candidate to clarify any missing or ambiguous details in the dietary, and demographic and 
lifestyle data. 
The WFR data were checked for consistency. All WFRs and recipes were visually 
checked for accuracy by the candidate. All quantity and frequency numbers entered into 
the FFQ template were crosschecked with the hard copy of the FFQ. The candidate 
examined the nutrient analysis of 3-day WFR for extreme values that were not feasible 
and corrected for any errors. Data of phytoestrogen excretion were checked by the 
Analytical Chemist responsible for the LC-MS analysis. High and low outliers were 
identified by boxplots and histogram and checked they were correctly assessed for 
phytoestrogen intake and excretion. To calculate the average daily urinary excretion of 
phytoestrogens over the three days, the weighted average was calculated based on the 
relative urine volume for each day: average weighted phytoestrogen excretion (µg/day) = 
(volume (L) of day 1 /Total volume (L) of all 3 days) x (phytoestrogen in µg/day 1) + 
(Volume (L) of day 2 /Total volume (L) of all 3 days) x (phytoestrogen in µg/day 2) + 
(Volume (L) of day 3 /Total volume (L) of all 3 days) x (phytoestrogen in µg/day 3). The 
weighted averages for urinary excretion data were used in the statistical analysis. 
The Mann-Whitney U test and Pearson’s Chi-Square test of contingencies were 
conducted to test if the demographic and lifestyle characteristics of subjects who 
completed significantly differed from that of those who withdrew from the study. 
Statistical analysis was conducted using Statistical Package for Social Sciences (SPSS for 
Windows, Version 22, 2014, Chicago, Illinois, USA). 
 
Analysis for estimating dietary phytoestrogen intake 
The normality of the phytoestrogen intakes from the FFQ and 3-day WFR were tested 
with the Shapiro-Wilk test. Transformation of natural log was applied to the data but the 
normality test indicated that not all data became normally distributed. Therefore, all data 
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were treated as non-normal distributions and non-parametric statistical tests were used 
throughout for median comparisons and correlations. For values of ENL, END and total 
enterolignan intake that were zero, a natural log transformation plus a constant was 
applied. Data were expressed as the mean±SD, median (IQR), and the minimum and 
maximum.  
 
 
Analysis for assessing validity and reliability of FFQ 
Non-parametric tests were applied to compare the median of FFQ with 3-day WFR for 
validity, and the median of pre FFQ and post FFQ for reliability. Comparison between 
phytoestrogen intake from the pre-FFQ and post-FFQ, the FFQ and 3-day WFR, and the 
FFQ or WFR and urinary biomarkers were conducted as follows. Associations were 
assessed with the Spearman’s rank correlation coefficient on raw data. 
Cross-classifications (quartile agreements) were calculated by establishing the percentage 
of subjects in the same/exact, adjacent (±1 and/or ±2 quartiles) or extreme/opposite 
quartile; each set of intake and excretion data were divided into four equal groups with 
the three quartile points as the boundaries (Bhakta et al., 2005).  
Bland Altman plots were used to assess the degree of agreement between methods and 
provide a graphical means to assess whether the two techniques or points of measure at 
different occasions were comparable for measuring phytoestrogens. Raw phytoestrogen 
intake data were used to construct Bland Altman plots (Altman & Bland, 1983; Myles & 
Cui, 2007).    
 
Associations between phytoestrogen status and social and lifestyle characteristics  
Social and lifestyle factors were organised in an Excel spreadsheet and imported to SPSS. 
As there were only one or two subjects in some categories, these factors were 
recategorised as follows. Occupation was coded into four categories: level 1 - Family 
duties and Students, level 2 - Clerical and administrative workers, level 3 - Community 
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and personal service workers and Technical and trade workers, level 4 - Professionals and 
Managers. Education was coded into two categories: level 1- Below university level 
(Other and Secondary education, and Certificate or diploma), level 2 – University level 
(University undergraduate and university postgraduate). Ancestry was coded into two 
categories: Caucasian and other ethnic groups which included South East Asian, South 
Asian, North East Asian, Middle Eastern, North Africa and Somalia Peninsular, 
Central/South America and Other and Mixed ancestry. Language spoken at home was 
coded into two categories with English and Other languages, including Cantonese, Arabic, 
Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonia and 
Bahasa Indonesian. Country of birth was coded into four categories: group 1 - Oceania 
and Antarctica, group 2 - Europe, group 3 - North Africa and the Middle East, 
Sub-Saharan Africa and Americans, group 4 - Asia (South-East, North-East Asia, and 
Southern and Central Asia).  Physical activity level (PAL) was coded into four 
(sedentary, light, moderate and high) and smoking status into three (never smoked, past 
and current smoker) categories, respectively. Bowel frequency was coded into two levels 
(1-7/week and >7/week) and two categories, mushy and watery/liquidy and smooth and 
easy to pass, and lumpy and hard to pass, for bowel movement (Lewis & Heaton, 1997).  
 
The median ± IQR intake of total lignan, total enterolignan, total isoflavone and total 
phytoestrogens with respect to different categories of social and lifestyle characteristics 
were presented. The Mann Whitney U test was used to compare the difference in median 
intake with two levels or categories of the characteristic, namely, gender (male or female), 
education (below university or university level), ancestry (Caucasian or other ethnic 
groups) languages spoken at home (English or other languages), bowel frequency 
(1-7/week or >7/week), bowel movement (mushy/liquidy to smooth and easy to pass or 
hard to pass) and supplement use (yes or no). The median intake for the other 
characteristics with three or more levels or categories was assessed with Kruskal-Wallis 
One-way ANOVA.  
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Analysis of contributing food sources of phytoestrogens 
Food items from the FFQ were listed in food groups specified in the Australian Dietary 
Guidelines with Nuts and seeds, and Legumes and beans as two separate groups. Three 
additional groups, Nonalcoholic beverages including coffee, tea and juices, Alcoholic 
beverages and Mixed food was added to reflect consumption of beverages and food 
composed of ingredients from two or more food groups. The FFQ template constructed 
for measuring phytoestrogen intake was used to evaluate the contributing food sources to 
dietary total lignans, total enterolignans and total isoflavones. Individual phytoestrogen 
intakes from each food group were calculated from the pre-FFQs. Total phytoestrogen 
intakes of all subjects were then calculated by summing individual phytoestrogens. The 
percentage contributions of each food group were calculated by dividing total 
phytoestrogen intake from that food group by total phytoestrogen intake in the whole 
group. The pre-study FFQ was selected to conduct this analysis to reduce possible bias 
and influence from completing the other dietary assessment tools. 
 
Analysis for triangular comparison between FFQ, WFR, and urinary biomarker for 
phytoestrogen status 
 
The Method of Triads (MOT) was used for the triangular comparison between the FFQ 
(Q), WFR (R) and urinary biomarkers (M) for assessing phytoestrogen status (Figure 9) 
(Kaaks, 1997). The analysis was conducted using software R (version 3.1.2, R Core Team, 
Vienna, Austria).   
Scripts for performing analysis of correlations between the measurement methods (r QR, 
r QM, r RM), validity coefficients (VCs) between each measurement method and the true 
but unknown intake (VC QT, VC RT, VC MT), and the confidence intervals (CIs) for 
VCs using the bootstrapping method, were written by the Statistician on the R script 
interface. Bootstrapping is a random sampling technique with replacement from the 
research population; the data from the current research population were randomly 
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sampled for 1000 times (Kaaks, 1997; Ocké & Kaaks, 1997).  A template that contained 
the dataset for intake and excretion measurements of Q, R and M from each subject, was 
constructed and linked to the scripts. Demographic and lifestyle continuous variables, 
such as age and BMI, and categorical variables, such as physical activity level, bowel 
movement, and language spoken at home were included in the MOT model.   
 
Figure 9. Graphical interpretation of the method of triads  
(Adapted from (Ocké & Kaaks, 1997; Shai et al., 2005)) 
The method of triads is the triangular comparison between FFQ, reference method and 
biomarker. VCs are the associations between the measurement derived from the method 
and the unknown true intake. VCs are mathematically derived from correlations between 
the measurements from the two methods. 
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CHAPTER FOUR: RESULTS 
4.1 Subjects 
There were 131 individuals who expressed interest in the study during the four-month 
recruitment, of which 48 did not respond to the candidate’s invitation, 10 declined, 2 were 
ineligible, and 71 consented to participate. Of these, 12 subjects withdrew and 59 completed 
the study (Figure 10). The study was powered for a minimum of 80 subjects but due to the 
time constraints of subject recruitment, only 59 completed the study. 
 
 
 
Figure 10. Flow chart of subject recruitment 
 
The study population consisted of 40 females and 19 males aged 18 to 67 years who ranged in 
BMI from 17.9 to 54.0 kg/m2. Almost half of the population (48%) were of normal weight 
(20.0-25.0 kg/m2) and 44% were in the overweight/obese range (>25.01 kg/m2). The 
demographic and lifestyle characteristics of recruited subjects according to their completed or 
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withdrawn status are outlined in Table 4.  The Mann-Whitney U test and Pearson’s 
Chi-Square test of contingencies indicated that completers were more likely to speak more 
than one language at home, be less physically active and less likely to use supplements than 
those who withdrew.  
Table 4. Demographic and lifestyle characteristics of recruited subjects (n=71) according 
to completed or withdrew status 
Variablesa Number  (%) of 
Subjects who 
completed (n=59) 
Number (%) of 
Subjects who 
withdrew (n=12) 
p-value 
Gender    
 Male 19 (32) 4 (33)  
 Female  40 (68) 8 (67) 0.593 
Education level achieved    
 University postgraduate 24 (40.7) 5 (41.7)  
 University undergraduate 22 (37.3) 5 (41.7)  
 Certificate/diploma 11 (18.6) 0 (0)  
 Secondary school 2(3.4)  2(16.7) 0.290 
Occupation     
 Family duties 3(5.1) 1(8.3)  
 Students 34(57.6) 5(41.7)  
 Clerical and administrative workers 2(3.4) 2(16.7)  
 Community and personal service workers 5(8.5) 0(0)  
 Technician and trade workers 1(1.7) 0(0)  
 Managers and Professionals (in 
Education, Health, Legal and social 
welfare, and Information and 
organisation) 
14(23.7) 4(33.3) 0.691 
Ancestry    
 Caucasian 38(64.4) 9(75)  
 South East Asian 6(10.2) 0(0)  
 South Asian 3(5.1) 0(0)  
 North East Asian 5(8.5) 0(0)  
 Middle Eastern, North Africa, Somalia 
Peninsular 
2(3.4) 0(0)  
 Central/South America 2(3.4) 1(8.3)  
 Other and Mixed ancestry (Caucasian & 
Central and West Africa; Caucasian & 
Indigenous Australian; Caucasian & 
Central/South American; Caucasian & 
Asian) 
3(5.1) 2(16.7) 0.435 
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Variablesa Number  (%) of 
Subjects who 
completed (n=59) 
Number (%) of 
Subjects who 
withdrew (n=12) 
p-value 
Language spoken at home    
 English 38(64.4) 12(100)  
 Other languages (Cantonese, Arabic, 
Mandarin, Spanish, German, Hindi, 
Malay, Persian, Urdu, Afrikaans, 
Macedonian, Bahasa Indonesian) 
21(35.6) 0(0) 0.014 
Region of Country of birth    
 Oceania and Antarctica 29(49.2) 7(58.3)  
 Europe (North-West Europe, Southern 
and Eastern Europe) 
10(16.9) 4(33.3)  
 North Africa and the Middle East 2(3.4) 0(0)  
 Asia (South-East Asia, North-East Asia, 
Southern and Central Asia) 
14 (23.7) 0(0)  
 Americans 2(3.4) 1(8.3)  
 Sub-Saharan Africa 2(3.4) 0(0) 0.330 
Physical Activity Level (PAL)    
 Sedentary 6(10) 1(8.3)  
 Light 18(30) 1(8.3)  
 Moderate 21(35) 3(25)  
 High 15(25) 7(58.3) 0.047 
Smoking status    
 Never smoked 38(64.4) 7(58.3)  
 Past smoker 14(23.7) 3(25)  
 Current smoker 7(11.9) 2(16.7) 0.884 
Bowel frequency    
 1-3/week 3(5.1) 1(8.3)  
 4-7/week 21(35.6) 5(41.7)  
 >7/week 35(59.3) 6(50) 0.526 
Bowel movement    
 Mushy and watery/liquidy 2(3.4) 0(0)  
 Smooth and easy to pass 53(89.8) 10(83.3)  
 Lumpy, Hard to pass 4(6.8) 2(16.7) 0.448 
Commercial supplement use    
 No 32(54.2) 2(16.7)  
 Yes 27(45.8) 10(83.3) 0.018 
a Chi-square test of contingencies was used for Gender, Ancestry, Language spoken at home, Region of country of birth, 
Smoking status, Bowel movement and Commercial supplement use. Mann-Whitney U test was used for Education level 
achieved, Occupation, Physical activity level and Bowel frequency. 
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4.2 Intake and excretion of phytoestrogens 
4.2.1 Intake and excretion of lignans and enterolignans 
Median, range of intakes of lignans and enterolignans measured by the pre- and post-FFQ and 
WFR, and excretion of corresponding urinary metabolites (biomarkers) are shown in Table 5.  
Urinary PINO and LARI were not detected, as the mass spectrometer used was unable to 
ionise the analytes. 
There were wide inter-individual ranges of intake observed for lignans from all dietary 
assessment methods, with smallest variation (20-fold) in LARI from the pre- and post-FFQs 
and highest variation (500-fold) in PINO from the WFR. Similar wide inter-individual 
variation was observed in urinary excretion of metabolites, with smallest variation (40-fold) 
in SECO and highest variation (500-fold) in ENL. All data were markedly skewed towards 
higher values.  
 
The majority of total lignan intake was contributed by SECO, from 45% to 71% across 
dietary assessment methods; followed by PINO (14% to 30%), LARI (10% to 20%), and 
MAT (4% from all methods). SECO contributed to the majority of lignan excretion (53.5%) 
followed by MAT (46.5%). 
ENL consistently contributed more than 99% to total enterolignan intake with less than 1% 
from END. The proportion of END increased to 15% in urinary excretion (Table 5). 
 
4.2.2 Comparison of intake and excretion of lignans and enterolignans 
Due to the non-normal distribution of these variables, non-parametric measures, the Wilcoxon 
signed rank test to compare median intakes, and Spearman’s Rho correlations were used for 
all comparisons. 
 
The reliability of the FFQ for lignans and enterolignans was examined by comparing intakes 
from the pre and post FFQ (Table 5).  Median intakes were significantly different for 
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individual lignans (p<0.05 to 0.002), total lignans (p<0.001) and combined total lignans and 
enterolignans (p<0.05); but not for ENL and END. There were highly significant associations 
between individual lignans and enterolignans and combined total lignans and enterolignans (rs 
=0.71 to 0.86, p<0.001 for all).  
 
The convergent validity of the FFQ for lignans and enterolignans was examined by 
comparing intakes from the pre FFQ and WFR (Table 5). The median intakes of individual 
lignans and enterolignans and combined total lignan and enterolignan by pre FFQ and WFR 
were not significantly different (p>0.05), except for LARI (p=0.03). Moderately significant 
associations were observed between individual lignans and enterolignans, and total lignans 
and enterolignans (rs =0.32-0.62, p<0.05), except for END.   
 
The criterion validity of the FFQ was examined by comparing lignan and enterolignan intakes 
from the pre-FFQ with urinary excretion of corresponding biomarkers; intake from the WFR 
was also compared with biomarker excretion. Because of the known interconversions of 
metabolites after ingestion in the diet, comparisons of intake and excretion were based on the 
combined value for all lignans plus enterolignans; individual associations were not examined 
(Table 5). There were no significant differences between median combined intake of total 
lignans and enterolignans from the pre-FFQ or WFR and median biomarker excretion; there 
were no significant associations between intake and excretion.
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Table 5. Median daily intake and excretion of lignans and enterolignans - comparisons between pre-FFQ, post-FFQ, 3-day WFR (n=59) and 
urinary biomarkers (BM) (n=53) 
      Tools            
 (µg/day) 
Pre FFQ Post FFQ WFR BM† Reliability 
(pre-post FFQ) 
Validity  
(pre FFQ-WFR) 
Validity  
(pre FFQ-BM‡ 
Validity 
(WFR-BM)‡ 
Median (Q1-Q3)     Wilcoxon signed ranked test, Z statistics, (p-value) for median  
 SECO 2625 (1166, 4806) 2204 (958,4157) 1813 (837,  
3903) 
809 (419, 991) -2.57 (p=0.010) -1.62 (p=0.105) - - 
 MAT 163 (84, 252) 125 (75, 229) 183 (77, 381) 336 (211, 540) -3.09 (p=0.002) 1.37 (p=0.169) - - 
 PINO 431 (266, 929) 391 (214, 638) 562 (211, 1546) - -2.40 (p=0.017) 0.99 (p=0.324) - - 
 LARI 518 (320, 685) 466 (226, 658) 636 (283, 1234) - -1.98 (p=0.048) 2.21 (p=0.027) - - 
 Total lignans 3914 (1965, 7317) 3839 (1795, 5845) 4302 (1920, 6354) 1118 (776, 1530) -3.53 (p<0.001) 0.09 (p=0.929) 5.17 (p<0.001) (a) 5.66 (p<0.001) (a) 
 ENL 54 (22, 104) 52 (21, 101) 64 (34, 82) 1583 (589, 3151) -1.62 (p=0.106) -0.24 (p=0.813) - - 
 END 0.31 (0.14, 0.60) 0.35 (0.18, 0.68) 0.32 (0.05, 0.83) 175 (81, 344) 1.36 (p=0.176) 0.75 (p=0.453) - - 
 Total enterolignans 54 (23, 104) 53 (22, 102) 65 (35, 83) 1837 (740, 3856) -1.41 (p=0.158) -0.24 (p=0.807) -6.33 (p<0.001) -6.33 (p<0.001) 
Total lignans and 
enterolignans± 
4051 (1995, 7945) 3930 (1851, 6058) 4446 (1877, 6959) 3104 (1685, 5725) -3.65 (p<0.001) 0.32 (p=0.751) 1.24 (p=0.217) 1.16 (p=0.244) 
Min, Max     Spearman’s Rho correlation, (95% CI)  
 SECO 161, 43455 78, 15391 328, 14673 74, 3220 0.81** (0.69, 0.88) 0.45** (0.22, 0.64) - - 
 MAT 21, 1765 18, 1713 23, 1682 19, 5269 0.82** (0.71,0.89) 0.45** (0.21,0.63) - - 
 PINO 59, 6612 27, 3203 41, 22560 - 0.71** (0.56,0.82) 0.32* (0.07, 0.53) - - 
 LARI 96, 2248 72, 1688 112, 9014 - 0.79** (0.66,0.87) 0.39** (0.15,0.59) - - 
 Total lignans 377, 46919 195, 18426 587, 47213 93, 6884 0.85** (0.76,0.91) 0.42** (0.18,0.61) 0.15 (-0.13, 0.40)(a) 0.24 (-0.03, 0.48)(a) 
 ENL 0, 416 0, 237 0, 257 54, 25657 0.86** (0.79, 0.90) 0.63**(0.44,0.76) - - 
 END 0, 2.34 0, 3.73 0, 4.16 16, 6491 0.75** (0.62,0.85) 0.15 (-0.11,0.39) - - 
Total lignans and 
enterolignans± 
389, 46963 203, 21618 670, 536273 480, 35549 0.86** (0.77, 0.91) 0.44** (0.21, 0.63) 0.16 (-0.12, 0.41) 0.14 (-0.14, 0.40) 
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Table 5. continued    
Median daily intake and excretion of lignans and enterolignans 
 
Tools 
(µg/day) 
Pre FFQ Post FFQ WFR BM† 
Percentage (%) 
contribution 
    
 SECO 71.15% (1st) 69.92% (1st) 45.33% (1st) 53.5% 
 MAT 3.73% (4th) 4.29% (4th) 4.46% (4th) 46.5% 
 PINO 14.70% (2nd) 13.78% (2nd) 30.35% (2nd) - 
 LARI 10.42% (3rd) 12.01% (3rd) 19.86% (3rd) - 
 ENL 99.42% 99.22% 99.10% 84.6% 
 END 0.58% 0.78% 0.90% 15.4% 
         
**p<0.001*p=0.02   (a) comparison between intake of SECO, MAT, PINO, LARI and excretion of SECO, MAT   
† the dash line’-‘ for the BM column indicated that PINO and LARI were not detected in the LC-MS and subsequent analysis was not applicable   
‡ the dash line ‘-‘  indicated that the comparison was not reported for between individual lignan intake and excretion due to inter-conversion from individual to enterolignan   
± combined total intake of lignans (SECO, MAT, PINO, LARI) and enterolignans (ENL, END)
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4.2.3 Intake and excretion of isoflavonoids 
Median (IQR) and range of intakes of isoflavonoids measured by pre FFQ, post FFQ and 
WFR, and excretion of corresponding urinary metabolites (biomarkers) are shown in Table 6. 
Urinary biochanin A was not detected, as the mass spectrometer was unable to ionise the 
analyte. 
Inter-individual variation in isoflavonoid intakes were overall greater than those for lignans 
and enterolignans, with 300- to 6,000-fold variation observed for major isoflavonoids, 
daidzein and genistein, and up to 8,000-fold for glycitein, formononetin and biochanin A, 
where intake from individual subjects was very low, less than 1 µg/d. Data were notably 
skewed towards higher values. 
The majority of total isoflavonoid intake was contributed by daidzein (37% across all dietary 
intake methods) and genistein (3% to 47%), with smaller contributions from glycitein (5% to 
9%), formononetin (0.3% to 3%) and biochanin A (1% to 7%). Daidzein contributed to the 
majority of isoflavonoid excretion (61%), followed by genistein (33%). 
 
4.2.4 Comparison of intake and excretion of isoflavonoids 
Due to the non-normal distribution of these variables, non-parametric measures, the Wilcoxon 
signed rank test to compare medians, and Spearman’s Rho correlations, were used for all 
comparisons.   
The reliability of the FFQ for isoflavonoids was examined by comparing intakes from the pre 
and post FFQs. Median intakes were not significantly different for individual or total 
isoflavonoids (Table 6). There were highly significant associations between individual 
isoflavonoids and total isoflavonoids (rs =0.76 to0.87, p<0.001 for all). 
The convergent validity of the FFQ for isoflavonoids was examined by comparing intakes 
from the pre FFQ and WFR reference method (Table 6). The median intakes of individual and 
total isoflavonoids were not significantly different.  Moderately significant associations were 
observed between individual or total isoflavonoids (rs =0.36 to 0.46, p<0.001 for all, except 
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formononetin rs =0.26, p<0.05). 
The criterion validity of the FFQ was examined by comparing isoflavonoid intakes from the 
pre-FFQ with urinary excretion of corresponding biomarkers; intake from the WFR was also 
compared with biomarker excretion (Table 6).  Median intakes for individual and total 
isoflavonoids from the FFQ and WFR were significantly different to median biomarker 
excretion (p<0.001 for all). There were significant associations between intake from the WRF 
and biomarker excretion for daidzein (rs =0.46, p<0.001), glycitein (rs =0.30, p<0.05) and 
total isoflavonoids (rs =0.28, p<0.05) but not for genistein or formononetin; there were no 
significant associations between intake from the FFQ and biomarker excretion.  
 
4.2.5 Intake and excretion of total phytoestrogens 
Total phytoestrogen intake varied from 150-fold in the post-FFQ to 400-fold in the WFR. 
Total isoflavones contributed 45% to 69% of total phytoestrogen intake obtained from the 
three dietary tools and to 80% of urinary biomarker excretion (Table 7).  
 
4.2.6 Comparison of intake and excretion of total phytoestrogens 
There were significant associations between phytoestrogen intakes from the pre- and post 
FFQs (rs =0.78, p<0.001) and pre-FFQ and WFR (rs =0.33, p<0.05), but not between the FFQ 
or WFR and urinary biomarker excretion. (Table 7) 
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Table 6. Median daily intake and excretion of isoflavonoids (µg/day) -comparisons between pre-FFQ, post-FFQ, 3-day WFR, (n=59) and urinary 
biomarkers (n=53) (BM) 
      Tools            
 (µg/day) 
Pre FFQ Post FFQ WFR BM† Reliability 
(pre-post FFQ) 
Validity  
(pre FFQ-WFR) 
Validity   
(pre FFQ-BM)† 
Validity (WFR-BM)† 
Median (Q1-Q3)     Wilcoxon signed ranked test, Z statistics, (p-value) for median 
Daidzein 1213 (269,4673) 608 (200,5294) 695 (203,3558) 161 (40, 569) -1.28 (p=0.199) -0.16 (p=0.874) 4.81 (p<0.001) 4.37 (p<0.001) 
Genistein  1321 (243,5245) 1006 (218,5429) 721(280,4424) 91 (35, 489) -1.01 (p=0.312) -0.41 (p=0.684) 5.62 (p<0.001) 5.39 (p<0.001) 
Glycitein 198 (36,1046) 145 (31,1328) 87 (26,1060) 18 (5, 55) -1.19 (p=0.233) -0.15 (p=0.880) 5.38 (p<0.001) 5.23 (p<0.001) 
Formononetin 108 (26,367) 67 (21,372) 55 (21,378) 1.9 (1.4, 2.5) -1.18 (p=0.239) -0.52 (p=0.602) 6.03 (p<0.001) 6.08 (p<0.001) 
Biochanin A 97 (29,252) 103 (24,256) 57 (22,175) - -0.94 (p=0.345) -0.78 (p=0.437) - - 
Total 
isoflavonoids 
3851 (920,11857) 2667 (795,12823) 2287 (847,11129) 268 (96, 1388) -0.69 (p=0.487) 0.42 (p=0.673) 5.75 (p<0.001)(b) 5.63 (p<0.001) (b) 
Min, Max     Spearman’s Rho correlation, (95% CI) 
Daidzein 41, 124990 36, 22508 40, 89183 8, 7780 0.77***(0.63,0.85) 0.46***(0.23,0.64) 0.18 (-0.10, 0.43) 0.46*** (0.22, 0.65) 
Genistein  52,164962 41, 30551 60, 121264 10, 3554 0.76***(0.63,0.85) 0.44***(0.21,0.63) 0.03 (-0.24, 0.30) 0.23 (-0.04, 0.47) 
Glycitein 9, 36727 6, 8669 2, 15807 0.9, 692.2 0.80***(0.69,0.88) 0.45***(0.22,0.63) 0.22 (-0.05, 0.46) 0.30* (0.03, 0.53) 
Formononetin 5, 1994 1, 2661 2, 1981 0.5, 68.2 0.83***(0.73,0.90) 0.26*(0.01,0.49) 0.14 (-0.14, 0.40) 0.02 (-0.25, 0.29) 
Biochanin A 6, 1098 1, 1200 2, 15918 - 0.87***(0.79,0.92) 0.38***(0.14,0.58) - - 
Total 
isoflavonoids 
 
 
 
 
 
202, 326708 122, 57996 208, 226389 20, 10293 0.78***(0.66,0.86) 0.36***(0.12,0.57) 0.10 (-0.18, 0.36)(b) 0.28** (0.01, 0.51)(b) 
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Table 6. continued 
Median daily intake and excretion of isoflavonoids 
 
  
      Tools            
 (µg/day) 
Pre FFQ Post FFQ WFR BM† Reliability 
(pre-post FFQ) 
Validity  
(pre FFQ-WFR) 
Validity   
(pre FFQ-BM)† 
Validity (WFR-BM)† 
Percentage (%) 
contribution (a) 
        
Daidzein 37.87% (2nd) 37.94% (2nd) 37.24% (2nd) 61.4% (1st)     
Genistein  48.74% (1st) 47.16% (1st) 44.47% (1st) 33.3% (2nd)     
Glycitein 9.85% (3rd) 9.33% (3rd) 8.77% (3rd) 5.0% (3rd)     
Formononetin 2.09% (4th) 3.22% (4th) 2.37% (5th) 0.3% (4th)     
Biochanin A 1.46% (5th) 2.35% (5th) 7.15% (4th) -     ***p<0.001 **p=0.044 *p=0.03  
(a) total isoflavone biomarker = daidzein, genistein, glycitein and formononetin 
(b) comparison between intake of daidzein, genistein, glycitein, formononetin and biochanin A and excretion (excluding biochanin A, not detected) 
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Table 7. Median daily intake and excretion of total phytoestrogens (µg/day) - comparisons between the pre-FFQ, post-FFQ, 3-day WFR (n=59), 
and urinary biomarker (n=53) (BM) 
      Tools            
 (µg/day) 
Pre FFQ Post FFQ WFR BM Reliability 
(pre-post FFQ) 
Validity  
(pre FFQ-WFR) 
Validity  
(pre FFQ-BM 
Validity 
(WFR-BM) 
Median (Q1-Q3)     Wilcoxon signed ranked test, Z statistics, (p-value) for median 
Total 
phytoestrogens  
9633 (4663, 21329) 8592 (3863, 19259) 7775 (4774, 28596) 3924 (2205, 7575) -2.05 (p=0.041) 1.05 (p=0.294) 4.27 (p<0.001) 4.40 (p<0.001) 
Min, Max     Spearman’s Rho Correlation, (95% CI) 
Total 
phytoestrogens  
1331, 333011 440, 65893 1233, 543004 522, 38567 0.78** (0.66, 0.87) 0.33* (0.08, 0.54) 0.12 (-0.16, 0.38) 0.002 (-0.27, 0.27) 
Percentage (%) 
contribution (a) 
        
Total isoflavones 68.9% 65.6% 44.9% 20.8%     
Total lignans and 
enterolignans 
31.1% 34.4% 55.1% 79.2%     
**p<0.001 *0.011    
(a) contribution to total phytoestrogen
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4.3 Cross classification of phytoestrogen intake 
Dietary intake and urinary excretion data for individual phytoestrogens were categorised into 
quartiles and a comparison of ranks was conducted between tools to further evaluate the 
validity and reliability of the modified FFQ (Table 8).  
 
The reliability of the FFQ was examined by comparing intakes from the pre- and post- FFQ; 
64% to 73% of total lignans, enterolignans or isoflavones were correctly classified into the 
same quartiles, with 23.7% to 32.2%, correctly classified into adjacent quartiles. 
 
The convergent validity was examined by comparing intakes from the pre-FFQ and WFR; 
32% to 47% of total lignans, enterolignans or isoflavones were correctly classified into the 
same quartile, with 45.8% to 52.5%, correctly classified into adjacent quartiles. 
 
The criterion validity was examined by comparing intakes from the pre-FFQ with biomarker 
excretion; 24.5% to 26.4% of total lignans, enterolignans or isoflavones were correctly 
classified into the same quartile, with 47.2% to 54.7% correctly classified into adjacent 
quartiles; cross classification of ranks between the WFR and biomarker excretion was 
comparable. 
 
More than 90% were ranked in either the same or adjacent quartile when comparing the 
pre-FFQ and post-FFQ, indicating the FFQ was a highly reliable tool for ranking intake in the 
same, ±1 or ±2 quartiles. More than 80% were ranked in either the same or adjacent quartile 
when comparing the FFQ with WFR indicating that the FFQ was a highly valid tool for 
ranking intake. More than 70% were ranked in either the same or adjacent quartile when 
comparing the FFQ with the urinary biomarker indicating moderate criterion validity 
(Fernandez et al., 2013).
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Table 8. Cross classification comparison between quartiles of phytoestrogen intake and excretion for pre FFQ, post FFQ, WFR (n=59) and 
urinary biomarkers (n=46) 
 Pre FFQ and Post FFQ Pre FFQ and WFR Pre FFQ and Biomarker† WFR and Biomarker† 
Phytoestrogens Same 
quartiles 
Adjacent 
quartiles 
Opposite 
quartiles 
Same 
quartiles 
Adjacent 
quartiles 
Opposite 
quartiles 
Same 
quartiles 
Adjacent 
quartiles 
Opposite 
quartiles 
Same 
quartiles 
Adjacent 
quartiles 
Opposite 
quartiles 
SECO 62.7% 33.9% 3.4% 32.2% 52.5% 15.3% 28.3% 54.7% 17.0% 26.4% 58.5% 15.1% 
MAT 64.4% 28.8% 6.8% 33.9% 52.5% 13.6% 24.5% 54.7% 20.8% 24.5% 52.8% 22.6% 
PINO 57.6% 39.0% 3.4% 23.7% 55.9% 20.3% - - - - - - 
LARI 59.3% 37.3% 3.4% 35.6% 50.8% 13.6% - - - - - - 
Total lignan 71.2% 23.7% 5.1& 32.2% 52.5% 15.3% 26.4% 54.7% 18.9% 30.2% 58.5% 11.3% 
ENL 71.2% 27.1% 1.7% 50.8% 40.7% 8.5% 28.3% 47.2% 24.5% 26.4% 49.1% 24.5% 
END 66.1% 30.5% 3.4% 25.4% 54.2% 20.3% 26.4% 43.4% 30.2% 22.6% 49.1% 28.3% 
Total enterolignan 72.9% 25.4% 1.7% 47.5% 45.8% 6.8% 24.5% 47.2% 28.3% 28.3% 47.2% 24.5% 
Daidzein 64.4% 32.2% 3.4% 39.0% 49.2% 11.9% 26.4% 52.8% 20.8% 41.5% 47.2% 11.3% 
Genistein 66.1% 28.8% 5.1% 45.8% 42.4% 11.9% 22.6% 54.8% 22.6% 24.5% 58.5% 17.0% 
Glycitein 72.9% 22.0% 5.1% 33.9% 54.2% 11.9% 43.4% 35.8% 20.8% 33.9% 47.2% 18.9% 
Formononetin 64.4% 33.9% 1.7% 30.5% 55.9% 13.6% 35.8% 43.4% 20.8% 24.5% 49.1% 26.4% 
Biochanin A 67.8% 28.8% 3.4% 39.0% 45.8% 15.3% - - - - - - 
Total isoflavone 64.4% 32.2% 3.4% 37.3% 45.8% 16.9% 26.4% 52.8% 20.8% 37.7% 45.3% 17% 
Total Lignan and Total 
Enterolignan 
71.2% 23.7% 5.1% 33.9% 50.8% 15.3% 28.3% 49.1% 22.6% 24.5% 60.4% 15.1% 
Total Phytoestrogens‡  71.2% 25.4% 3.4% 35.6% 49.2% 15.3% 26.4% 54.7% 18.9% 26.4% 47.2% 26.4% 
†the dash line ‘-‘indicated that the PINO, LARI and biochanin A were not detected in the LC-MS and the analysis cannot be conducted    
‡ total phytoestrogens = total lignans + total enterolignans + total isoflavonoids
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4.4 Bland Altman plots of assessing the validity of food frequency questionnaire with 
weighed food record 
Bland Altman plots for comparing consistency of individual and total phytoestrogen intakes 
estimated by pre FFQ and WFR are shown in Figures 11-14.  
 
The mean bias between intakes, and limits of agreement for phytoestrogen intakes measured 
from the pre-FFQ and WFR are shown in Table 9. The mean bias for individual 
phytoestrogens measured by the two tools, ranged from 1256 µg/day for SECO to –1075 
µg/day for PINO; the FFQ overestimated intake compared to the WFR for all individual 
phytoestrogens except SECO, ENL, daidzein and genistein. 
 
The Bland Altman plots showed a similar trend towards greater bias at higher mean 
phytoestrogen intakes (Figure 11-14), suggesting poorer consistency of intake between the 
FFQ and reference method for those subjects reporting higher phytoestrogen intakes. 
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Table 9. Bias and 95% limits of agreement for measures of phytoestrogen by pre FFQ 
compared with the WFR 
Phytoestrogens n Mean 
difference/Bias
* 
95% CI Limits of agreement† 
Lignans     
SECO 58 1256 -383, 2895 -11212, 13724 
MAT 58 -67  -161, 27 -784, 650 
PINO 58 -1075  -2249, 98 -10001, 7850 
LARI 58 -658  -1125, -190 -4217, 2902 
Total lignan 58 -544  -3248, 2160 -21109, 20021 
Enterolignans     
ENL 59 4  -11, 19 -115, 123 
END 59 -0.2  -0.4, 0 -2.1, 1.7 
Total enterolignan 59 3.8  -11, 19 -115, 123 
Isoflavones     
Daidzein 59 522  -4505, 5550 -38061, 39105 
Genistein 59 1106  -5498, 7710 -49578, 51790 
Glycitein 59 -251  -1108, 1610 -10180, 10682 
Formononetin 59 -10  -157, 137 -1142, 1122 
Biochanin A 59 -697  -1396, 1.2 -6059, 4664 
Total isoflavone 59 1172  -11811, 14154 -98460, 100803 
     
Total lignan and 
enterolignan 
59 -9217  -26794, 8360 -178626, 125680 
Total phytoestrogens 59 -8045  -30272, 14181 -178626, 162535 
*Bias is the difference (pre FFQ -WFR) between the raw values of intake phytoestrogens estimated from the pre FFQ and 
WFR. This is the absolute difference between the raw mean intakes estimated from the pre FFQ and WFR.  
† 95% Limits of agreement (mean difference±2SD) 
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Figure 11. Bland Altman plots of estimated intake of (a) SECO, (b) MAT, (c) PINO, (d) LARI, (e) total lignan 
by pre FFQ and average of 3-day WFR.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD of the mean difference) 
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Figure 12. Bland Altman plots of estimated intake of (a) ENL, (b) END, (c) total enterolignan by pre FFQ and 
average of 3-day WFR.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD of the mean difference) 
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Figure 13. Bland Altman plots of estimated intake of (a) daidzein, (b) genistein, (c) glycitein, (d)formononetin, 
(e) biochanin A, (f) total isoflavone by pre FFQ and average of 3-day WFR.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD of the mean difference) 
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Figure 14. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and 
enterolignan (END, ENL) (b) Total phytoestrogen (total lignan, total enterolignan and total isoflavone) by pre 
FFQ and average of 3-day WFR.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD of the mean difference) 
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4.5 Bland Altman plots of assessing the validity of food frequency questionnaire with 
biomarkers 
Bland Altman plots for comparing consistency of intake and excretion of total lignans, 
enterolignans and isoflavonoids estimated by pre FFQ, and urinary biomarker excretion are 
shown in Figures 15-18.  The comparisons of individual phytoestrogens are not shown.   
 
The mean bias between intake from the pre-FFQ and biomarker excretion, and limits of 
agreement are shown in Table 10. The mean bias ranged from -3119 µg/day for total 
enterolignans to 13179 µg/day for total isoflavonoids; the FFQ overestimated compared to 
urinary excretion for all phytoestrogen classes except total enterolignans. 
 
Bland Altman plots (Figures 15 to 18) demonstrated a trend towards larger bias at higher 
mean estimates of intake and excretion of the phytoestrogen classes. This trend is similar to 
those observed for individual phytoestrogens in Figures 11 to 14, indicating poorer 
consistency of measurement between intake and excretion at higher intakes. 
 
Table 10. Bias and 95% limits of agreement for measures of phytoestrogen by pre FFQ 
compared with the Biomarker (BM) 
Phytoestrogens n Mean 
difference/Bias 
* 
95% CI Limits of 
agreement† 
Total lignan 53 4188  2128, 6249 -10762, 19139 
Total enterolignan 53 -3119  -4517, -1722 -13259, 7020 
Total isoflavone 53 13179  761, 25598 -76926, 103285 
Total lignan and 
enterolignan 
53 1069  -1421, 3559 -16999, 19136 
Total phytoestrogens 53 14248  1513, 26983 -78156, 106652 
*Bias is the difference (pre FFQ -BM) between the raw values of intake phytoestrogens estimated from the pre FFQ and 
excretion estimated from BM. This is the absolute difference between the raw mean intakes estimated from the pre FFQ and 
excretion from BM.  
† 95% Limits of agreement (mean difference±2SD) 
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Figure 15. Bland Altman plots of estimated intake of (a) total lignans by pre FFQ (SECO, MAT, PINO, LARI) 
and average of urinary biomarkers (SECO, MAT).  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD ± mean difference) 
 
 
 
   
 
 
 
 
 
 
 
 
   
Figure 16. Bland Altman plots of estimated intake of (a) total enterolignan (END, ENL) by pre FFQ and average 
of urinary biomarkers.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD ± mean difference) 
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Figure 17. Bland Altman plots of intake of (a) total isoflavone intake by pre FFQ (daidzein, genistein, glycitein, 
formononetin, biochanin A) and average of urinary biomarkers (daidzein, genistein, glycitein, formononetin).  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD ± mean difference) 
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Figure 18. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and 
enterolignan (END, ENL) (b) total phytoestrogen (lignan, enterolignans and isoflavones) by pre FFQ and 
average of urinary biomarkers.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD of the mean difference). 
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4.6 Bland Altman plots of assessing the reliability of FFQ 
Bland Altman plots for comparing consistency of phytoestrogen intakes estimated by the pre 
FFQ and post FFQ are shown in Figures 19 to 22. The mean bias between the intakes and 
limits of agreement for phytoestrogen intake measured by the FFQ administered 1 to 2 weeks 
apart are shown in Table 11. The mean bias for individual phytoestrogens ranged from -9.2 
µg/day for biochanin A to 2496 µg/day for genistein.  The pre-FFQ overestimated intake 
compared to the post-FFQ for all individual phytoestrogens except END and biochanin A. 
The Bland Altman plots show a trend towards greater bias at higher mean phytoestrogen 
intakes suggesting poorer consistency of intake between repeat FFQs for those subjects with 
higher phytoestrogen intakes (Figures 19-22).  
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Table 11. Bias and 95% limits of agreement for measures of phytoestrogen by pre 
FFQ compared with the post FFQ 
Phytoestrogens n Mean 
difference/Bias* 
95% CI Limits of 
agreement† 
Lignans     
SECO 58 1119  -294, 2552 -9693, 11951 
MAT 58 32  12, 52 -123, 187 
PINO 58 262  -34, 557 -1985, 2508 
LARI 58 89  -8, 186 -650, 828 
Total lignan 58 1512  112, 2911 -9136, 12159 
Enterolignans     
ENL 59 8.9  -3.2, 21.1 -85, 103 
END 59 -0.1  -0.19, 0.04 -0.97, 0.81 
Total enterolignan 59 8.9  -3.3, 21.1 -85, 103 
Isoflavones     
Daidzein 59 1823  -2212, 5858 -29142, 32789 
Genistein 59 2496  -2788, 7780 -38057, 43048 
Glycitein 59 522  -663, 1707 -8573, 9617 
Formononetin 59 1.2  -98, 100 -757, 759 
Biochanin A 59 -9.2  -51, 33 -330, 311 
Total isoflavone 59 4833  -5670, 15336 -75774, 85439 
     
Total lignan and 
enterolignan 
59 1529  155, 2903 -9015, 12074 
Total phytoestrogens 59 6362  -4371, 17095 -76008, 88732 
*Bias is the difference (pre FFQ-post FFQ) between the raw values of intake phytoestrogens estimated from the pre 
FFQ and post FFQ. This is the absolute difference between the raw mean intakes estimated from the pre FFQ and post 
FFQ.  † 95% Limits of agreement (mean difference±2SD) 
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Figure 19. Bland Altman plots of estimated intake of (a) SECO, (b) MAT, (c) PINO, (d) LARI, (e) total lignan 
by pre FFQ and post FFQ.  The central dashed line represents the mean difference (bias). The upper and lower 
dashed lines represent the 95% limits of agreement (2SD of the mean difference) 
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Figure 20. Bland Altman plots of estimated intake of (a) ENL, (b) END, (c) total enterolignan by pre FFQ and 
post FFQ.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD of the mean difference) 
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Figure 21.Bland Altman plots of estimated intake of (a)daidzein (b)genistein (c)glycitein (d)formononetin 
(e)biochanin A (f)total isoflavone by pre FFQ and post FFQ.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD ±the mean difference)
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Figure 22. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and 
enterolignan (END, ENL) (b) total phytoestrogen (total lignan, total enterolignan and total isoflavone) by pre 
FFQ and post FFQ.  The central dashed line represents the mean difference (bias). The upper and lower dashed 
lines represent the 95% limits of agreement (2SD of the mean difference) 
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4.7 Bland Altman plots for weighed-food record and urinary biomarkers 
Bland Altman plots for comparing consistency of total phytoestrogen intake and excretion for 
total lignans, enterolignans and isoflavonoids, estimated by the WFR and urinary biomarkers 
are shown in Figures 23-26. The mean bias between the intakes and excretion of 
phytoestrogen classes ranged from -3120 µg/day, for total enterolignans, to 14230 µg/day for 
total lignans (Table 12); dietary intake estimated by the WFR was greater than urinary 
biomarker excretion for total lignans and isoflavonoids, but urinary excretion of total 
enterolignans exceeded enterolignan intake.  The Bland Altman plots showed the bias of the 
estimates between WFR and biomarkers, (Figure 23-26), was larger when the mean estimates 
of intake and excretion were higher. This trend is similar to what was observed between FFQ 
and biomarker in Figures 15-18 and between estimates of intake between FFQ and WFR in 
Figures 11-14.  
 
 
Table 12. Bias and 95% limits of agreement for measures of phytoestrogen by WFR 
compared with the Biomarker 
Phytoestrogens n Mean 
difference/Bias* 
95% CI Limits of 
agreement† 
Total lignans 53 14230  -5928, 34388 -132037, 160497 
Total enterolignans 53 -3120  -4515, -1726 -13239, 6999 
Total isoflavones 53 11703  2922, 20485 -52016, 75423 
Total lignans and 
enterolignans 
53 11110  -9021, 31240 -134958, 157177 
Total phytoestrogens 53 22813  1303, 44323 -133264, 178890 
* Bias is the difference (WFR-BM) between the raw values of intake phytoestrogens estimated from the WFR and excretion 
from BM. This is the absolute difference between the raw mean intakes estimated from the WFR and excretion from BM.  
† 95% Limits of agreement (mean difference±2SD 
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Figure 23. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) by average of 
3-day WFR and average of urinary biomarker (SECO, MAT).  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD ± mean difference) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 24. Bland Altman plots of estimated intake of (a) total enterolignan (END, ENL) by average of 3-day 
WFR and average of urinary biomarker (END, ENL).  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD ± mean difference) 
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Figure 25. Bland Altman plots of estimated intake of (a) total isoflavone (daidzein, genistein, glycitein, 
formononetin, biochanin A) by average of 3-day WFR and average of urinary biomarker (daidzein, genistein, 
glycitein, formononetin).  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD ±the mean difference)
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Figure 26. Bland Altman plots of estimated intake of (a) total lignan (SECO, MAT, PINO, LARI) and 
enterolignan (END, ENL) (b) total phytoestrogens (total lignans, total enterolignans and total isoflavones) by 
average of 3-day WFR and average of urinary biomarkers.  
The central dashed line represents the mean difference (bias). The upper and lower dashed lines represent the 
95% limits of agreement (2SD of the mean difference) 
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4.8 Intake and excretion of phytoestrogens and demographic and lifestyle characteristics 
The associations between demographic and lifestyle characteristics and median intakes of 
total lignans, enterolignans and isoflavones from the FFQ and WFR are shown in Tables 13 
and 14, respectively. Associations with median biomarker excretion are shown in Table 15. 
The Mann-Whitney U test and Kruskal-Wallis one-way ANOVA were used to compare the 
median intakes across categories of these demographic and lifestyle factors. A Bonferroni 
adjustment was made for multiple comparisons, with a probability of P<0.0125 taken as 
statistically significant.  
  
Based on the FFQ, total lignan intake was higher in subjects with Caucasian ancestry, who 
spoke English at home and who used commercial supplements (all p=0.01); there was a trend 
towards higher intakes in females compared to males (p=0.03) and those born in Oceania, 
North Africa or Middle East (p=0.02). Total enterolignan intake was higher in subjects who 
used commercial supplements (p=0.01); there was a trend to higher intakes in subjects with 
university education (p=0.02) (Table 13).  Based on the WFR, there were trends towards 
higher total lignan intake in subjects who spoke English at home and higher total enterolignan 
intake in those who used commercial supplements (both p=0.03). Phytoestrogen intake was 
significantly in subjects who were either sedentary or had high physical activity (both p=0.01) 
(Table 14).   
 
Based on the urinary biomarkers, there were no significant associations for total lignan or 
total isoflavone intakes. There were trends towards higher enterolignan excretion in females 
compared to males, in subjects with education to secondary school, certificate or diploma 
(both p=0.03), and in subjects from Oceania (p=0.04) (Table 15). Commercial supplements 
consumed by subjects included multivitamins, calcium, iron, fish oil, protein powder. 
Isoflavonoid or lignan dietary supplements such as LSA (linseed, soy, almond) were coded as 
food items. 
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Table 13. Average intake of lignans, enterolignans, isoflavones (µg/day) from pre-food 
frequency questionnaire (FFQ pre) according to subjects’ characteristics (n=59) 
Subject characteristics Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Gender     
  Male (n=19) 2356±2663 54±83 2453±8806 6678±10786 
  Female (n=40) 4660±6735 54±81 4684±12260 10828±17064 
 p-value† 0.03 0.75 0.48 0.12 
     
BMI(kg/M2)     
  <20.00 (n=5) 2942±4310 61±211 832±10582 6064±11713 
  20.00-25.00 (n=28) 3895±3762 48±81 2216±9109 8398±13686 
  25.01-30.01 (n=15) 4148±8576 44±110 7102±14858 12905±27614 
  >30.01 (n=11) 4108±11931 59±64 6202±11771 12299±23708 
 p-value‡ 0.74 0.66 0.45 0.49 
 
Age (y) 
    
 18-28 (n=26) 3102±4820 53±67 1971±7937 7325±13826 
 29-39 (n=16) 3895±4066 44±83 6257±5873 9842±7164 
 40-50 (n=9) 3984±4983 66±93 11857±27316 19921±28639 
 >50 (n=8) 9809±9733 57±124 9540±27171 18596±33138 
 p-value‡  0.08 0.94  0.34  0.19  
     
Occupation     
 Family duties (n=3) and  
 Students (n=34) 
3894±6853 52±75 2453±10407 9553±14836 
 Clerical and administrative 
 workers (n=12) 
4894±5444 76±107 6656±10421 11845±14362 
 Community and personal  
 service (n=2) & Technician 
 and trade workers (n=2) 
3941±2557 56±35 11602±20726 16165±22081 
 Professionals (n=5) &  
 Managers (n=1) 
3143±13101 63±202 4273±15787 8914±40140 
 p-value‡ 0.94 0.85  0.80  0.98 
     
Education level achieved     
Below university (Other (n=1), 
    Secondary school (n=1),  
 Certificate/diploma (n=11) 
5254±9271 15±57 7102±25839 18365±36049 
University (undergraduate (n=22, 
    postgraduate (n=24)  
3757±5195 59±82 2518±9002 9452±12740 
p-value† 0.53 0.02 0.49 0.42 
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Table 13 continued 
Subject characteristic 
Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Ancestry     
Caucasian (n=38) 5264±8158 55±83 2352±12354 10757±21450 
Other ethnic groups (n=21)1  2356±2608 37±91 5732±9600 7303±11404 
p-value† 0.01 0.73 0.67 0.23 
     
Language spoken at home     
 English (n=38) 4156±8156 57±84 3217±12354 11811±21009 
 Other languages (n=21)2 2345±3707 37±91 3853±9974 7303±13608 
p-value† 0.01 0.54 0.94 0.16 
     
Region of country of birth     
Oceania and Antarctica 
(n=29) 
5640±8544 59±97 1992±10462 11322±19906 
North-West (n=9) & 
Southern and Eastern Europe 
(n=1) 
3939±6117 57±50 2299±16692 7936±27408 
North Africa and the Middle 
East (n=2), Americans (n=2), 
Sub-Saharan Africa (n=2) 
5596±4623 69±160 7598±9613 11840±10843 
Asia (n=14)3  2182±2229 29±49 5967±12533 7300±14059 
p-value‡ 0.02  0.44  0.74 0.91  
     
Physical activity level 
(PAL) 
    
 Sedentary (n=5) 4108±9009 13±22 16263±17243 26918±16872 
 Light (n=18） 3884±5731 61±106 5624±6875 10477±11824 
 Moderate (n=21) 3897±3639 54±75 1950±8595 6678±11279 
 High (n=15) 4164±9030 55±70 3853±10474 12368±31924 
 p-value‡  0.64 0.13 0.06  0.053  
     
Smoking status     
 Never smoked (n=38) 3491±3736 52±78 4684±9940 8560±13680 
 Past smoker (n=14) 7098±14890 49±108 8924±31712 22765±47001 
 Current smoker (n=7) 4148±8705 71±102 1544±3358 9028±10146 
  p-value‡ 0.08 0.54 0.17 0.08 
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Table 13 continued 
Subject characteristic 
Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Bowel frequency     
1-7/week (n=24) 3152±3762 36±61 4792±11015 7387±14220 
>7/week (n=35) 4108±6889 55±92 2584±10937 12299±20687 
p-value† 0.06 0.15 0.88 0.17 
     
Bowel movement     
 Mushy and watery (n=2) & 
Smooth and soft to pass 
(n=53) 
3897±5865 54±82 2584±11610 9633±18639 
 Hard to pass (n=4) 4652±8033 54±117 4683±4872 10175±11717 
P-value† 0.55 0.74 0.94 0.85 
     
Commercial supplements 
use 
    
 No (n=32) 2644±3434 36±51 2382±14764 7278±17800 
 Yes (n=27) 5640±8595 71±120 5732±9229 12299±15973 
P-value† 0.01 0.01 0.52 0.10 
*Mann-Whitney U test 
 ** Kruskal-Wallis One-Way ANOVA    
1 South East Asian (n=6), South Asian (n=3), North East Asian (n=5), Middle Eastern, North Africa, Somalia 
Peninsular (n=2), Central/South America (n=2), Other (n=1) & Mixed ancestry (n=2)  
2 Cantonese, Arabic, Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonian, Bahasa 
Indonesian)  3(South-East (n=6), North-East (n=5), Southern and Central (n=3)
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Table 14. Average intake of lignans, enterolignans, isoflavones from 3-day weighed food 
record (WFR) according to subjects’ characteristics (n=59) 
Subject characteristics Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Gender     
 Male (n=19) 4460±4547 65±43 3171±8770 7775±24986 
 Female (n=40) 4302±6228 62±59 2069±12438 8137±23522 
p-value† 0.81 0.74 0.91 0.99 
     
BMI(kg/M2)     
 <20.00 (n=5) 4160±17955 79±139 931±4248 4630±21840 
 20.00-25.00 (n=28) 4284±7337 69±50 2809±12172 9009±31556 
 25.01-30.01 (n=15) 4543±4185 65±93 5277±27635 9860±24552 
 >30.01 (n=11) 3104±3555 53±40 1251±7804 6341±8049 
p-value‡ 0.99 0.65 0.14 0.30 
 
Age (y) 
    
18-28 (n=26) 3791±7231 62±51 2809±12524 8506±25734 
29-39 (n=16) 4548±8956 66±69 2063±4836 8117±28086 
40-50 (n=9) 3104±3674 78±61 1748±17001 8781±18157 
>50 (n=8) 5555±7353 55±81 1596±11030 7000±18830 
p-value‡ 0.49 0.92 0.44 0.97 
     
Occupation     
Family duties (n=3) and 
Students (n=34) 
4543±8953 53±50 2448±9476 8781±21185 
Clerical & administrative 
workers (n=12) 
2292±4074 60±96 1102±7507 4799±11979 
Community and personal 
service (n=2) &Technician 
and trade workers (n=2) 
3829±7729 79±30 15195±34408 23134±38137 
Professionals (n=5) & 
Managers (n=1) 
4831±4133 73±105 12966±30147 19242±28317 
P-value‡ 0.55 0.25 0.16 0.18 
     
Education level achieved     
Below university (Other 
(n=1), Secondary school (n=1), 
Certificate/diploma (n=11) 
4554±8497 40±68 11129±34173 17647±36894 
University (undergraduate 
(n=22, postgraduate (n=24) 
4134±4411 66±58 2284±8575 7603±16531 
p-value† 0.77 0.25 0.24 0.25 
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Table 14 continued 
Subject characteristics 
Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Ancestry     
Caucasian (n=38) 4499±6149 69±57 3426±14968 11030±24919 
Other ethnic groups 
(n=21)1  
3473±4587 58±55 2010±3963 7714±13114 
p-value† 0.25 0.37 0.18 0.13 
     
Language spoken at 
home 
    
 English (n=38) 4972±5878 53±63 3426±14971 8506±25475 
 Other languages (n=21)2 2485±4003 39±61 1565±7322 5985±13203 
 p-value† 0.03 0.15 0.23 0.08 
     
Region of country of 
birth 
    
Oceania and Antarctica 
(n=29) 
4612±6262 58±71 2280±16827 7492±25384 
North-West (n=9) & 
Southern and Eastern 
Europe (n=1) 
4276±6285 73±45 4340±12950 14577±27402 
North Africa and the 
Middle East (n=2), 
Americans (n=2), 
Sub-Saharan Africa (n=2) 
2292±9863 74±38 1705±19509 8826±36564 
Asia (n=14)3 4008±5365 39±60 1775±6225 8278±10988 
p-value‡  0.46 0.37 0.72 0.71 
     
Physical activity level 
(PAL) 
    
 Sedentary (n=5) 5510±10868 8±103 13670±31778 17647±31510 
 Light (n=18） 2898±3869 39±83 1221±1874 5971±4262 
 Moderate (n=21) 4160±5929 65±37 4236±11878 12822±23798 
 High (n=15) 5502±15512 79±55 3596±23915 19278±37868 
 p-value‡ 0.36 0.09 0.08 0.01 
     
Smoking status     
 Never smoked (n=38) 4501±5019 65±44 2809±8851 9009±12930 
 Past smoker (n=14) 4951±5314 53±75 1630±27454 6249±42342 
 Current smoker (n=7) 1766±11815 82±69 14572±28859 27240±32199 
 p-value‡ 0.36 0.47 0.85 0.99  
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Table 14 continued 
Subject characteristics 
Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Bowel frequency     
1-7/week (n=24) 2875±4280 42±52 1934±11002 7874±12781 
>7/week (n=35) 4554±9262 78±62 3171±10259 7775±23802 
p-value† 0.06 0.07 0.64 0.17 
     
Bowel movement     
 Mushy and watery (n=2) 
& Smooth and soft to pass 
(n=53) 
4160±4053 58±48 2010±9283 7492±14648 
 Hard to pass (n=4) 13679±24396 111±52 15940±25020 33881±7626 
p-value† 0.10 0.07 0.09 0.03 
     
Commercial supplements 
use 
    
 No (n=32) 4493±6687 58±60 1976±12172 9009±23244 
 Yes (n=27) 4160±3877 76±87 3171±10313 7492±26296 
p-value† 0.91 0.03 0.69 0.98 
†Mann-Whitney U test  
‡ Kruskal-Wallis One-Way ANOVA  
1 South East Asian (n=6), South Asian (n=3), North East Asian (n=5), Middle Eastern, North Africa, Somalia 
Peninsular (n=2), Central/South America (n=2), Other (n=1) & Mixed ancestry (n=2)   
2 Cantonese, Arabic, Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonian, Bahasa 
Indonesian)  3(South-East (n=6), North-East (n=5), Southern and Central (n=3) 
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Table 15. Average excretion of lignans, enterolignans and isoflavones from urinary 
biomarkers according to subjects’ characteristics (n=53) 
Subject characteristic Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Gender     
 Male (n=18) 1253±684 1178±1903 274±582 3554±5091 
 Female (n=35) 932±794 1952±3991 259±1569 4190±6828 
p-value† 0.14 0.03 0.56 0.24 
     
BMI(kg/M2)     
 <20.00 (n=5) 895±581 1930±1752 252±561 2531±2221 
 20.00-25.00 (n=25) 1228±1332 2734±3668 573±2007 6363±5555 
 25.01-30.01 (n=14) 976±734 642±1822 152±517 2567±4497 
 >30.01 (n=9) 1318±586 1837±1872 208±391 3449±4099 
p-value‡ 0.42 0.054 0.12 0.07 
 
Age (y) 
    
18-28 (n=23) 1052±887 1942±3083 392±2001 4606±4523 
29-39 (n=15) 1228±621 1887±3489 259±1139 3540±5333 
40-50 (n=8) 1313±1668 1052±2722 454±4104 5320±8237 
>50 (n=7) 1019±674 1934±3706 81±161 3449±6325 
p-value‡ 0.93 0.49  0.11 0.75 
     
Occupation     
 Family duties (n=3) and 
Students (n=29) 
1028±767 1579±2556 226±313 3178±4698 
 Clerical and administrative 
workers (n=11) 
1341±954 3279±3425 1203±1138 4606±4282 
 Community and personal 
service & (n=2), Technician 
and trade workers (n=2) 
1461±4130 2219±10674 3722±4730 8427±15661 
 Professionals (n=5) & 
Managers (n=1) 
676±900 1002±2880 309±2968 3063±6264 
p-value‡ 0.09 0.47 0.06 0.12  
     
Education level achieved     
Below university (Other (n=1), 
Secondary school (n=1), 
Certificate/diploma (n=10) 
1036±902 3322±5824 416±2315 5710±8151 
University (undergraduate 
(n=19, postgraduate (n=22) 
1170±738 1445±2361 259±1292 3782±4520 
p-value† 0.72 0.03 0.64 0.17 
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Table 15 continued 
Subject characteristics 
Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Ancestry     
Caucasian (n=33) 1118±698 1934±3116 273±1503 3897±5425 
Other ethnic groups (n=20)1  1122±973 1411±2419 256±954 4123±5449 
p-value† 0.66 0.19 0.78 0.49 
     
Language spoken at home     
 English (n=34) 1146±830 1985±3341 321±1491 4237±5539 
 Other languages (n=19)2 1036±696 1378±1191 248±1107 3782±4546 
p-value† 0.53 0.34 0.74 0.45 
     
Region of country of birth     
 Oceania and Antarctica 
(n=26) 
1146±762 2966±2812 390±1506 4445±4520 
 North-West (n=7) & 
Southern and Eastern 
Europe (n=1) 
1258±913 769±1952 266±3841 3220±8067 
 North Africa and the 
Middle East (n=2), 
Americans (n=1), 
Sub-Saharan Africa (n=2) 
1118±1186 927±2330 268±1136 2181±4289 
Asia (n=14)3 1045±752 1201±1528 213±1751 3227±6394 
p-value‡ 0.96 0.04 0.98 0.58 
     
Physical activity level 
(PAL) 
    
 Sedentary (n=4) 1417±4968 3274±5356 5691±6628 11406±8578 
 Light (n=17） 932±587 1887±2952 199±354 3449±3006 
 Moderate (n=19) 1118±665 1332±2305 273±1574 3540±6019 
 High (n=13) 1464±1711 1952±3355 413±1785 6314±5285 
p-value‡ 0.42 0.71 0.09 0.07 
     
Smoking status     
 Never smoked (n=35) 1118±857 1942±3047 274±1462 4285±5088 
 Past smoker (n=12) 1220±889 1828±3474 146±470 3317±7574 
 Current smoker (n=6) 850±1901 1631±13333 918±1593 3490±16318 
p-value‡ 0.71 0.85 0.15 0.96 
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Table 15 continued 
Subject characteristics 
Total lignans 
Median±IQR 
Total 
enterolignans 
Median±IQR 
Total 
isoflavones 
Median±IQR 
Total 
phytoestrogens 
Median+IQR 
Bowel frequency     
1-7/week (n=21) 903±914 1445±3576 413±1338 4284±4554 
>7/week (n=32) 1199±730 1862±2914 260±1298 3910±5555 
p-value† 0.29 0.86 0.65 0.72 
     
Bowel movement     
 Mushy and watery (n=2) & 
Smooth and soft to pass 
(n=47) 
1123±753 1837±2820 261±1292 3924±4783 
 Hard to pass (n=4) 913±4472 4289±12713 450±1722 5453±18415 
p-value† 0.81 0.71 0.86 0.83 
     
Commercial supplements 
use 
    
 No (n=30) 1087±924 1824±3040 265±2035 4445±5529 
 Yes (n=23) 1118±794 1837±3340 274±749 3540±4637 
p-value† 0.57 0.86 0.47 0.46 
†Mann-Whitney U test   
‡Kruskal-Wallis One-Way ANOVA    
1 South East Asian (n=6), South Asian (n=3), North East Asian (n=5), Middle Eastern, North Africa, Somalia 
Peninsular (n=2), Central/South America (n=1), Other (n=1) & Mixed ancestry (n=2)     
2 Cantonese, Arabic, Mandarin, Spanish, German, Hindi, Malay, Persian, Urdu, Afrikaans, Macedonian, Bahasa 
Indonesian)  3(South-East (n=6), North-East (n=5), Southern and Central (n=3)
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4.9 Food sources contributing to lignans, enterolignans and isoflavones 
The contributing food sources to dietary total lignans, enterolignans and isoflavones, are 
shown in Figure 27 to 29.  They were based on usual dietary patterns over the previous 
month as recorded in the pre FFQ.  
 
The top three contributing food sources of lignans were from the nuts and seeds group (30%), 
such as linseed and cashews; nonalcoholic beverages such as coffee, tea and plant-based 
milk-like beverages (19%); and breads and cereals including multigrain bread (19%). The 
least important contributing food group was meat, poultry, seafood and eggs (Figure 27).   
 
The majority of dietary enterolignans (86%) were from dairy products, namely milk, yoghurt 
and cheese from animal origin, followed by nonalcoholic beverages (11%). Dairy products, 
e.g. milk, were used in coffee and tea, and specialty coffees, such as like latte and cappuccino, 
were commonly consumed in this research population. Plant-based food groups, including 
nuts and seeds, breads and cereals, vegetables, fruits, legumes, and alcoholic beverages do not 
contain enterolignans and therefore contributed none to dietary intake (Figure 28).  
 
Legumes, including soy and related food products and beans and related food products were 
the major contributors (78%) to total isoflavones; breads and cereal products was the second 
highest contributor (17%) (Figure 29). 
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Figure 27. Contributing food sources to dietary lignans estimated in usual diet over 1 month from food frequency questionnaire (n=59)
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Figure 28. Contributing food sources to dietary enterolignans estimated in usual diet over 1 month from food frequency questionnaire 
(n=59) 
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Figure 29. Contributing food sources to dietary isoflavones estimated in usual diet over 1 month from food frequency questionnaire 
(n=59)
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4.10 Triangular comparison of FFQ, WFR and biomarker 
The triangular comparison between three measurement methods, namely the FFQ, WFR and 
biomarkers for each phytoestrogen was conducted with the Method of Triads (Figure 9).  
The validity coefficients (VC) between FFQ (Q) and true intake (T), between WFR (R) and 
(T), and between the biomarker (M) and (T) are reported in Table 16.  Spearman 
correlations were selected due to the non-parametric nature of the data.    
 
All VCs were estimated based on intake and excretion of each measurement with adjustment 
for demographic and lifestyle variables. These variables were selected based on results in 
Section 4.8. Variables were included in the MOT model if the median measurements were 
found to be significantly different across levels or categories of that variable for at least two 
methods, for example, the intake classified by gender was found to be significantly different 
in both FFQ and WFR. Comparison between enterolignan intake and excretion was not 
conducted due to inter-conversion from dietary intake of lignans to excretion in the form of 
enterolignans. 
The correlations between FFQ and WFR (rQR) were moderate but between biomarker and 
WFR (rRM) or FFQ (rQM) were low. Heywood cases, that is the value exceeding 1, appeared 
on most VCs for (R) and (T) on each comparison except for that of total lignans and 
enterolignans (VC=0.78) and total phytoestrogen (VC=0.33) (Table 16). VCs for (Q) and (T) 
ranged between 0.10 and 0.79, and for (M) and (T) ranged between 0.13 and 0.56, except for 
the two Heywood cases for MAT and total phytoestrogen. Total lignans and enterolignans had 
the highest VC in the WFR (0.78) and FFQ (0.79), and daidzein in the biomarkers (0.56).  
The VCs for formononetin and total phytoestrogen were based on Spearman’s correlations 
unadjusted for demographic and lifestyle variables, since the VCs when adjusted could not be 
calculated due to an odd number of negative correlations, i.e. one or all three negative 
correlation coefficients.  
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Table 16. Validity coefficients for triangular comparison between FFQ, WFR and biomarker adjusted for demographic and lifestyle 
characteristics 
 Correlation coefficients† Validity Coefficients (VC)‡ (95% CI) 
 rQR± rRM± rQM± WFR (R) &True intake (T)± FFQ (Q) & (T)± Biomarker (M) & (T)± 
SECO 0.44 0.21 0.05 2.07 (0.44, 12.80) 0.38 (0.13, 2.41) 0.13 (0.02, 0.55) 
MAT 0.44 0.10 0.16 13.68 (0.41, 16.53) 0.10 (0.14, 4.54) 1.65 (0.02, 1.29) 
Total Lignan 0.41 0.24 0.16 1.26 (0.51, 10.02) 0.57 (0.09, 2.03) 0.28 (0.05, 1.33) 
Daidzein 0.52 0.45 0.24 2.50 (1.28, 19.09) 0.43 (0.08, 1.71) 0.56 (0.10, 2.37) 
Genistein 0.51 0.22 0.07 3.34 (0.58, 21.39) 0.33 (0.07, 2.36) 0.23 (0.03, 1.61) 
Glycitein 0.51 0.26 0.27 1.37 (0.63, 9.02) 0.58 (0.14, 2.58) 0.48 (0.07, 1.67) 
Formononetin^ 0.18 -0.11 -0.13 1.45 (0.16, 15.88) 0.33 (0.06, 4.03) 0.44 (0.02, 2.47) 
Total Isoflavone 0.42 0.26 0.15 2.16 (0.65, 14.57) 0.42 (0.09, 2.18) 0.37 (0.05, 1.84) 
Total Lignan and 
Enterolignan 
0.41 0.10 0.13 0.78 (0.21, 4.07) 0.79 (0.15, 2.71) 0.16 (0.02, 0.58) 
Total Phytoestrogen* 0.08 0.25 0.07 0.33 (0.03, 4.09) 0.26 (0.03, 2.97) 1.68 (0.23, 12.86) 
†Spearman correlation coefficients 
‡VCs were based on Spearman correlation adjusted for demographic and lifestyle variables. Lignans, SECO, MAT, total lignan, and total lignan and enterolignan were adjusted for age, BMI and 
language spoken at home (English or non-English), isoflavones, daidzein, genistein, glycitein, formononetin, total isoflavone were adjusted for age and BMI. Total phytoestrogens were adjusted 
for physical activity level (sedentary, light, moderate, high) and bowel movement (mushy/watery and smooth to pass or hard to pass) 
± Q=food frequency questionnaire (FFQ), R=weighed food record (WFR), M=biomarker, T=true intake 
^ VCs were based on Spearman correlation unadjusted for demographic and lifestyle variables due to validity coefficients not calculated or adjusted for Spearman correlation when there is a 
negative correlation between the two measures
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CHAPTER FIVE: DISCUSSION 
5.1 Research findings 
The current research focused on evaluation of the validity and reliability of a modified 
FFQ specially designed to measure intake of phytoestrogens in a group of 59 men and 
women living in Perth, Western Australia. Three classes of phytoestrogens were measured: 
lignans, enterolignans and isoflavonoids. 
An original 112-item FFQ was customised by expanding the food list to include 277 
items, to align with food groups and items provided in the most recent Australian Dietary 
Guidelines (NHMRC, 2013a); selected ethnic items commonly-available in the Australian 
market, were also included. Estimation of the lignan content of foods from the FFQ was 
also modified. There is currently no available comprehensive database for estimating 
dietary lignans and in the original 112-item FFQ, lignan content was based on an indirect 
in-vitro colonic fermentation method providing estimated availability from foods of two 
plant lignans (Thompson, Robb, Serraino, & Cheung, 1991). For the current FFQ, 
estimates were based on more recent data for direct measurement of four lignans in 
plant-based foods, previously compiled by our research group from a range of 
international published values. The FFQ was also expanded to include food sources of 
enterolignans, which are obtained exclusively from animal products such as dairy foods; 
these are derived from consumption of plant lignans by the animal and interconversion to 
enterolignans that then are absorbed and secreted into milk. The purpose of modifying the 
FFQ was an attempt to improve performance as a potential tool for measuring 
phytoestrogen intake, especially lignans, which had been a limitation with the original 
questionnaire. The modified FFQ was designed to capture phytoestrogen intake over the 
previous month.  
The validation involved the use of a reference dietary assessment tool, namely WFR, and 
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urinary biomarkers of phytoestrogen excretion. The measurement derived from the FFQ 
was compared with the WFR and biomarkers. The reliability of the FFQ was tested by 
comparing the intake of pre FFQ with that of the post FFQ, administered one week apart. 
 
5.1.1 Evaluation of the FFQ 
Convergent validity and reliability 
Convergent validity was evaluated by comparing usual daily intake of phytoestrogens 
from the FFQ with usual intake from a 3-day WFR reference method collected over 
consecutive days to include two weekdays and one weekend day. In support of our first 
and third hypotheses, the FFQ had acceptable convergent validity for intake of total 
lignans and enterolignans when compared to a WFR, in terms of median intakes (lignans: 
3.91 versus 4.30 mg/day, p=0.09; and enterolignans: 0.054 versus 0.065 mg/day, p=0.81, 
respectively); and associations between the two methods (lignans ρ=0.42, p<0.001; and 
enterolignans ρ=0.62, p<0.001) (Table 5). Median intakes of total isoflavonoids from the 
FFQ and WFR were also comparable (3.85 versus 2.29 mg/day, p=0.67) with a significant 
association between the two tools (ρ=0.36, p<0.001), although weaker than for total 
lignans (Table 6). In addition to validation as a continuous measure, the FFQ was 
examined by cross-classifications to determine whether it could accurately rank subjects 
into quartiles of intake assessed by the WFR. With a total of 7% to 17% of subjects 
misclassified into opposite quartiles for different phytoestrogen classes, the results further 
indicate that the FFQ does accurately classify subjects assessed by the WFR (Table 8).  
In support of our second hypothesis, the FFQ also had acceptable reliability when 
compared to a repeat FFQ, for all classes of phytoestrogens, with strong correlations 
between intakes (ρ=0.78 to ρ=0.85, p<0.001 for all) (Tables 5, 6) and minor 
misclassifications into opposite quartiles, between 2% to 5% (Table 8). 
Contrary to our fourth hypothesis, when the FFQ was assessed for agreement between 
individual values in the WFR, the mean bias was moderately high for all phytoestrogen 
classes (-0.54 mg/day for total lignans, +0.004 mg/day for enterolignans and +1.17 
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mg/day for isoflavonoids); and visual inspection of the Bland Altman graphs showed 
trends towards greater inconsistency at higher median intakes (Figures 11e, 12c, 13f). 
 
Criterion validity 
Criterion validity was evaluated by comparing usual intake of four lignans and five 
isoflavonoids from the FFQ with usual excretion of their biomarkers in three 24-hour 
urine samples. Extensive interconversions of dietary lignans occur in the colon, with the 
majority of dietary lignans converted to enterolignans prior to absorption and excretion 
(Figure 3). For example in the current study, intake of enterolignans was low at 0.054 
mg/day while urinary excretion was 30-fold higher at 1.84 mg/day. For this reason the 
assessment of criterion validity was conducted using one combined value for lignans plus 
enterolignans. Although median intake and excretion were not significantly different 
(4.05 versus 3.10 mg/day, p=0.22, respectively), there was no significant correlation 
between intake and excretion (ρ=0.16, NS) (Table 5). For total isoflavonoids, excretion 
was 10-fold lower than intake from the FFQ (0.27 versus 3.85 mg/day, respectively 
p<0.001) and there was no significant correlation between the two tools (ρ=0.10, NS). 
Misclassification into the opposite quartile was also relatively high for both 
phytoestrogen classes (21% to 23%) (Table 8). When usual intake from the 3-day WFR 
was compared with 3-day urinary excretion collected over the same time period, the 
associations became stronger and significant for isoflavonoids (ρ=0.28, p<0.05) but not 
for lignans and enterolignans (ρ=0.14, NS). Despite previous studies reporting significant 
dose-dependent relationships between intake and excretion of phytoestrogens and their 
respective metabolites (French et al., 2007; Hanna et al., 2005; Huang et al., 2000; 
Yamamoto et al., 2001), there were no significant associations in the current data, 
indicating poor validity for the modified FFQ in relation to biomarkers of phytoestrogen 
excretion.    
 
Based on these findings, we conclude that the modified phytoestrogen FFQ is highly 
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reliable. It would be a useful assessment tool for example to rank usual intake of 
phytoestrogen classes for individuals within a group, or quantify mean intakes between 
different population groups. It is not acceptably valid or accurate for estimation of 
individual phytoestrogen status, for example for use in experimental studies or to 
investigate associations with chronic diseases. 
 
Reliability and validity data for individual phytoestrogens showed similar trends to data 
for phytoestrogen classes with highly significant positive associations between intakes 
from the repeat FFQs, moderately significant associations between intakes from the FFQ 
and WFR, but weak and non-significant associations between intake from the FFQ and 
excretion of respective urinary biomarkers.  
 
Comparison of results with previous studies 
Previous reliability studies using repeat FFQs administered from 1 month to 10 months 
apart, have found moderate to strong associations between intake of isoflavones (r=0.60 
to r=0.77) and lignans (r=0.36 to r=0.80) (French et al., 2007; Hanna et al., 2005; 
Horn-Ross et al., 2006). Our associations of between ρ= 0.69 to 0.85 are comparable or 
higher, possibly due to the shorter time frame of 1 week between repeat questionnaires, 
which would have avoided possible seasonal changes that could contribute to variability 
in previous studies with longer time intervals. 
 
Contrary to the current findings of weak non-significant associations between intake from 
the FFQ and excretion of urinary isoflavonoids (ρ=0.10) or lignans (ρ=0.16), previous 
studies have reported significant moderate associations for isoflavonoids (r=0.21 to 0.54) 
but smaller or non-significant associations for lignans (r=0.14 to 0.40) (French et al., 
2007; Hanna et al., 2005; Horn-Ross et al., 2006). Reasons for the discrepancy in our 
study could be the lack of excretion data for PINO and LARI, due to failure of ionisation 
of metabolites during the LC-MS analysis procedure (Grace et al., 2007; Valentin-Blasini 
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et al., 2000), which would have resulted in underestimation of total lignan excretion, and 
potential recall bias when subjects were recalling frequency and portion size in 
completing the FFQ.  Previous studies did not attempt to measure intake or excretion of 
these two lignans yet they were significant dietary contributors in our study, providing 
about 25% of total lignan intake. Other factors that could affect bioavailability and hence 
excretion of the phytoestrogens, include variations in individual gastrointestinal transit 
time, efficiency of conversion of metabolites in the colon, and the degree of enterohepatic 
recycling (Clavel et al., 2005; Lampe, 2003; Lampe et al., 2006; Landete, 2012). 
Collection of faecal samples and measurement of faecal losses in future studies could 
help identify these sources of variability.  
 
Cross classification analyses 
In the current study, cross classification analyses using quartiles of intake, indicated that 
58-73% between the two repeat FFQs, 24-51% of intakes between the FFQ and WFR, 
and 25-43% between the FFQ and urinary biomarkers, were classified into the same 
quartiles.   
Ideally a large proportion of subjects classified in the same quartile affirms the tool’s 
accuracy to rank individuals according to their phytoestrogen intake, but the proportion 
classified in the adjacent quartiles also suggests that the tool is effective in ranking 
intakes. Bhakta et al. (2005) conducted a validation study with 58 English women and 
compared dietary intake obtained by a FFQ with intake from twelve 24h dietary recalls 
collected over a year as the reference standard.  Their results showed that 53% of 
subjects were classified into adjacent quartiles for total lignans and isoflavones, which is 
comparable to the 51% and 46% for total lignans and isoflavones, respectively, reported 
in our validation study. This proportion of cases should be included in considering the 
effectiveness of the tool in ranking intake. Eighty percent of cases or more in the same 
and adjacent quartiles is considered an excellent tool, and between 60-70% is a good tool 
(Fernandez et al., 2013). Using these criteria, the current FFQ is regarded as an excellent 
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tool in ranking intake against the reference method; and a good tool for ranking intake 
against biomarkers, with above 70% classified in the same or adjacent quartiles.  
 
Individual agreement from Bland Altman plots 
The Bland Altman plot is a method to assess the degree of agreement between two tools. 
The plots provide a graphical means to observe for systematic differences, including 
mean difference, limits of agreement and proportional bias between the two methods.  
The mean difference between the measurements of the FFQ and WFR represents the 
systematic error or bias of the tools, the limits of agreement show how far apart the 
measurements are by the two tools, and the proportional bias at low and high intake levels 
informs the trends in variation of phytoestrogen intake within the sample. 
In the current study, the limits of agreement were relatively wide in all classes of 
phytoestrogens for evaluation of both reliability and validity of the FFQ, and proportional 
bias existed with greater inconsistency at higher than lower mean phytoestrogen intakes.  
Bland Altman analyses conducted by previous studies that examined intake of isoflavones 
have shown similar results, with the bias increasing with increasing intake between a FFQ 
and 24h dietary recalls (Chan et al., 2008) and between repeat measures of a FFQ 
administered 1 week apart (Frankenfeld et al., 2003).  
 
In order to evaluate the clinical relevance of this variation, it is important to identify what 
this difference and variation represent with regard to dietary intake. The mean bias 
between the FFQ and WFR was 0.54 mg/day for total lignans, 0.004 mg/day for total 
enterolignans and 1.17 mg/day for total isoflavones, and is equivalent to consuming 0.16g 
of flaxseed, 17g or 1 tablespoon of milk and 4g or a teaspoon of tofu per day, respectively. 
The median intakes of 4.23 mg/day for total lignans, 0.062 mg/day for total enterolignans 
and 4.36 mg/day for total isoflavones that differentiates low intakes from high intakes, are 
equivalent to having 1.2 g or ¼ of teaspoon of flaxseed, 1 cup of milk, and 15 g or 1 
tablespoon of tofu per day, respectively.  Phytoestrogens, especially lignans, are present 
136  
in a wide range of foods but are concentrated in only limited food groups, namely nuts 
and seeds (especially flaxseeds) for lignans, dairy products of animal origin for 
enterolignans, and soy and related products for isoflavones. These food groups aligned to 
the top contributing food sources of the sample in the current study (Figure 27-29). The 
consumption or non-consumption of foods from these food groups, both between subjects 
or day-to day within subjects, would result in sporadic intakes of the phytoestrogen 
classes and contribute to the observed high variation in the current study. 
 
Triangular comparison with Method of Triads 
The current research is only the second study to conduct a triangular comparison of three 
methods, the FFQ, WFR reference method, and biomarkers using the Method of Triads 
(MOT) to evaluate the performance of each method for determining phytoestrogen status 
(Bhakta et al., 2005). The validity coefficient (VC) indicates the correlation of the intake 
by one method with the true but unknown intake, and therefore is an indication of the 
degree of agreement between the methods in assessing phytoestrogen status in the 
research population. 
 
Since the introduction of MOT by Kaaks (1997), validation studies have widely adopted 
this method when assessing three or more methods for nutrient status. To date, only 
Bhakta et al. (2005) has utilised the MOT for phytoestrogen status in a study comparing 
an FFQ, 24h recalls and plasma biomarkers in South Asian women in the UK. They 
reported the highest VC for 24h recalls in measuring genistein (0.95) and daidzein (0.83), 
the highest VC for the FFQ in measuring total lignans (0.91), and the poorest VC 
(0.11-0.45) for biomarkers in measuring genistein, daidzein and total lignans. This 
supports the current research in which higher VCs were observed for the FFQ in 
measuring total lignans (VC=0.57) or the FFQ and WFR for measuring combined lignans 
plus enterolignans (VC=0.79, 0.78, respectively) (Table 16). In addition, the VCs for the 
current research were adjusted for demographic and lifestyle variables and the VCs 
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improved slightly (data not shown). 
The results for individual phytoestrogens were complicated by Heywood cases, defined 
as VCs or CIs exceeding 1. For example, VCs and CIs exceeded 1 for all variables 
measured by the WFR except combined total lignans and enterolignans (Table 16). VCs 
are mathematically based on the correlation coefficients (Figure 9 in Methods). To have a 
high VC, that is within the acceptable range of 0 to 1, values of all correlation coefficients 
between the methods are required to be at a relatively equal level. In Table 16, 
coefficients were moderate for FFQ and WFR, but low for the urinary biomarkers. This 
suggests that the biomarker is not a good indicator of the true intake. The appearance of 
Heywood cases could be the result of random sampling variation or may result from the 
violation of the assumption of MOT, that the errors of the three methods are uncorrelated 
and that a linear relationship of measurements exists between the methods. In this regard, 
the WFR was chosen because it shared uncorrelated sources of error with FFQ (Table 1). 
For the WFR, consumption was recorded for two weekdays and one weekend day using 
precise kitchen scales and measuring cups and spoons to assist in portion size estimation; 
the FFQ required a recall of past consumption on a regular frequency basis over the 
previous month. As the FFQ and WFR are two distinct tools requiring responses in 
different ways, the errors from each tool are likely to be unrelated.  
 
Yokota et al. (2010) suggested that a larger sample size could reduce the chances of 
Heywood cases for the VCs. They also highlighted recent guidelines for consideration of 
sample sizes with at least 50 subjects for studies with a biomarker as a reference methods. 
There were 53 subjects with complete data for the FFQ, WFR and biomarkers. Therefore 
a further increase in the sample size could potentially improve the VCs.  
 
5.1.2 Phytoestrogen intake and excretion 
In comparison to previous studies conducted in Western countries, median intake of 
lignans in the current study (3.91mg/day) was three times higher than that by Lahmann et 
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al. (2012) in Australia, but similar to that found by Hedelin, Klint, Chang, Bellocco, 
Johansson, Andersson, Heinonen, Adlercreutz, Adami, Gronberg, et al. (2006) in Sweden 
(3.05mg/day), and considerably lower than that consumed in Eastern countries by 
Bangladeshi women (7.32 mg/day) (Saleh et al., 2011). Enterolignan intakes in the 
current study (0.056 mg/day) were also three fold higher than intakes reported by 
Lahmann et al. (2012) (0.022 mg/day). Isoflavones in the current study (3.85 mg/day) 
were considerably lower than amounts consumed in a Chinese population (11.5 mg/day) 
(Wong, Lau, Leung, Leung, & Woo, 2007). 
 
Median urinary excretion in the current study of lignans (-0.12mg/day), enterolignans 
(1.84mg/day), and isoflavones (0.27mg/day) was consistently higher than the median 
excretion in an Australian group  (lignans 0.01mg/day, enterolignans 0.22mg/day, 
isoflavones 0.07mg/day) (Hanna et al., 2005) and in Canada (enterolignans 837µg/day, 
isoflavones 759µg/day) (French et al., 2007).  
 
Differences may be explained by the design of the FFQ, for example, the number of items 
included in the food list was longer in the current study than previous study by Hanna et 
al. (2005); use of different sources of published phytoestrogen databases for measuring 
intake; as well as different dietary preferences, for example high isoflavone intake related 
to high consumption of soy products as staple items in the Chinese population (Table 3). 
 
5.1.3 Contributing food sources to phytoestrogen intake 
The major contributing food sources to lignans in the current research were similar to 
other previous studies conducted in Western countries, with flaxseed, breads and cereals, 
beverages such as tea and coffee, vegetables, and fruits being the most common sources 
in the current research (Figure 27). Other ethnic groups such as Chinese populations, 
consumed more legumes and beans, vegetables, and tea, than bread and cereals (Hu et al., 
2014).  
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Enterolignan intake is more likely to be measured in Western countries because of 
frequent consumption of dairy products and other foods of animal origin. Foods of dairy 
origin, as expected, contributed to 80-90% of enterolignan intake in both the current 
research (Figure 28) and previous research (Zamora-Ros, Knaze, et al., 2012). Specialty 
milk beverages such as latte and cappuccino were included in the current FFQ, and 
subjects consumed these non-alcoholic beverages on a frequent basis.   
Food sources contributing to isoflavone intake were soybeans, legumes and soy products 
including soymilk and tofu.  Bread and cereals was the second highest contributor to 
isoflavones in the current research since manufacturers in Australia use soy flour as an 
ingredient in bread making (Lahmann et al., 2012). Popular items advertised for health, 
such as soy and linseed bread, are available in the consumer market and were consumed 
by subjects in the current research (Figure 29). In other ethnic groups, isoflavone intake 
was derived from less refined sources, legumes and beans, vegetables such as soybean 
sprouts and cabbage, and fruits (Bhakta et al., 2006; Huang et al., 2012; Saleh et al., 
2011).  
 
5.1.4 Intake of phytoestrogen and demographic and lifestyle characteristics 
In the current study, an attempt was made to recruit subjects from diverse backgrounds to 
capture cultural diversity in an Australian group. While 64% of subjects were of 
Caucasian ancestry and spoke English at home, 36% spoke another language at home, 
including subjects from South East, South and North Asia, North Africa and South 
America; 68% of subjects were females and 32% were males. The majority was recruited 
from around the university and were university educated (78%); and 46% used 
commercial dietary supplements.  
 
Female subjects who were Caucasian, were at, or had achieved university education level 
and took regular commercial dietary supplements, were more likely to have a higher 
lignan and enterolignan intake than subjects with different characteristics (Table 13). This 
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was also reflected in the urinary excretion of enterolignan metabolites in those subjects 
with the same characteristics (Table 15). The food choices were plausibly the reason for 
the higher intakes of lignans and enterolignans in these groups.  For example, subjects 
who were of other ethnic background, spoke languages other than English at home and 
were born outside of Australia had varying intake level and variety of food choices from 
vegetables, fruit and cereal products, such as white rice and noodles, which contain low to 
moderate lignan content (Section 2.9). Use of commercial supplements could be an 
attribute of those subjects who were health conscious, and hence more inclined to select 
foods that were nutrient dense such as wholegrain cereals and specialty seed breads, 
promoted for health benefits and also rich in lignans. Subjects did not consume 
isoflavonoid and lignan dietary supplements. Our findings support those in a previous 
study conducted by Hanna et al. (2010), who investigated the intake of phytoesetrogens 
and associated lifestyle factors in Australian older women (aged 40-80 years), and 
reported higher education level and supplement use in the group of soy and linseed 
consumers with at least one serve of soy and/or linseed item. 
 
5.2 Limitations 
One limitation of the current research is that urinary biomarker excretion was not 
corrected for creatinine concentration, to indicate possible incompleteness of the 24-h 
urine collections. Although creatinine concentrations were analysed, the correction of 
phytoestrogen concentration was not conducted due to time constraints of thesis 
submission. In the current research, subjects were encouraged to state the completeness of 
the collection in a designated area on each urine bottle for any collection they had missed. 
Twenty-three out of the 59 subjects stated that they had incomplete urine samples at some 
time during their 3-day 24-hour collections. This could have added to the variability in 
the urinary biomarker data and indicates the need for a follow up analysis of data, after 
assessing samples for completeness and excluding any samples with implausibly low 
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creatinine concentrations.  
 
Another limitation is related to the intrinsic properties of phytoestrogens. Phytoestrogen 
content naturally varies in foods as a result of genetic factors and the growing 
environment, and effects of harvesting and processing (Kuhnle, Dell'Aquila, Runswick, et 
al., 2009). Therefore the estimated intake may not be reflected in what was actually 
present in the food consumed. Possible hidden sources of soy isoflavones in the food 
supply, especially in processed foods, and foods with no database content of lignan, 
would result in underestimation of the intake of lignans and isoflavones. This would 
impact on the assessment of the FFQ validity with respect to the urinary biomarkers. For 
the current research, phytoestrogen contents reported across multiple databases for the 
same food item were averaged to minimise the effect of the natural variability of 
phytoestrogens. Food items with missing lignan content were substituted with the content 
of an appropriate food item in the phytoestrogen intake calculation. Other limitations that 
could impact on the assessment of FFQ validity, include subjects’ day-to-day variation in 
intake, particularly when subjects had sporadic intake of phytoestrogen rich food on one 
day but not on the other day (See Bland Altman plots 4.4 and 4.7). Potential recall or 
social desirability bias when subjects were completing the FFQ, inaccuracies in 
estimation of frequency of intake or portion sizes and inter-individual variation in 
phytoestrogen absorption, metabolism and excretion could also have contributed to the 
variation in intake and excretion, and hence the evaluation of the FFQ.  
 
While the current research included males and females from a range of cultural 
backgrounds, it is not widely representative as subjects were recruited from a university 
community rather than the general population. The anticipated number of subjects in the 
current study was not achieved, due to time constraints of subject recruitment, which 
could have reduced the likelihood of observing significant associations within the dataset.  
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5.3 Recommendations and conclusions 
The evaluation of the phytoestrogen food frequency questionnaire assisted in establishing 
a valid and reliable dietary tool in measuring phytoestrogen status. The database used for 
the current study to estimate intake was updated with content for lignans and 
enterolignans from international published data. Even with actual estimates of 
phytoestrogen content in food from the database and a FFQ well designed for capturing 
the dietary intake, the bioavailability would be affected by natural variability of 
phytoestrogens in foods. Therefore analyses are required for the phytoestrogen content of 
foods grown and consumed in Australia, collated to develop a database culturally specific 
to the Australian context.  
 
The purpose of the FFQ in the current research was to quantify intake at the individual 
and population level. While the FFQ was acceptably valid for measuring intake at the 
group or population level, Bland Altman plots indicated wide individual variability and 
greater variation of individual measurements between two methods at higher median 
intakes. One reason for the variability is the sporadic nature of phytoestrogens, which are 
concentrated in a few very rich food sources.  Consuming as little as 1.2g of flaxseed, 1 
cup of milk or 15g of tofu a day would significantly increase the variation in the intake. 
Using this as a reference, future researchers could screen consumers and non-consumers 
of phytoestrogen rich foods with preliminary questions about regular consumption of 
these typical foods before completing the dietary assessment tool.  
 
The 3-day WFR was chosen as a reference method to evaluate convergent validity of the 
FFQ. However, the WFR only represented a snapshot of dietary consumption over 3 days 
and the observed sporadic nature of phytoestrogen intake over this relatively short time 
period, both between and within subjects, impacted considerably on the estimate of 
average daily intake. The FFQ was designed to survey usual diet over the past month and 
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hence average daily intake would be less impacted by these sporadic intakes. Therefore 
based on the study design and the interpretation of the results for the current research, it is 
more appropriate to use the FFQ for status of usual phytoestrogen intake. 
 
Food metabolomics is a branch of the nutrition research that focuses on the digestion and 
biotransformation of foods and constituents and the identification of associated 
metabolites. These metabolites include biomarkers that measure dietary exposure. The 
current research involved the use of biomarkers to exemplify the exposure and 
bioavailability of phytoestrogens. The excretion of metabolites and the population intake 
level are of particular importance as these could relate food consumption over time with 
development of diseases. An optimal intake level and metabolomics profile could be 
derived from epidemiological studies of phytoestrogen status in relation to the status of 
disease or health and wellbeing.   
 
Metabolites acquire a range of routes for their excretion, and after absorption, they can 
circulate in the plasma, and be secreted into bodily fluids, such as breast milk, and finally 
excreted in urine and faeces. Urinary biomarkers were adopted in the current research and 
although dose-dependent relationships have been observed between intake and excretion 
in previous studies after phytoestrogen supplementation (Hutchins et al., 2000; Morimoto, 
Beckford, et al., 2014), our cross-sectional data do not support a strong association. The 
complexity of metabolic pathways is an obstacle in nutrition research involving the use of 
biomarkers. A recommendation for future research is that the urinary biomarkers alone 
are not sufficient to indicate phytoestrogen status, and additional use of faecal and plasma 
collections would provide a more complete profile of phytoestrogen status. The effect of 
lifestyle factors and dietary components on the gastrointestinal environment should also 
be explored to address the inter- and intra-individual variation in biomarker excretion. 
 
In conclusion, the results of the current research suggest that the modified phytoestrogen 
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FFQ is valid with respect to WFR and reliable for the majority of the phytoestrogens.  
The lack of associations between measurement of the FFQ and biomarkers, suggest that 
urinary biomarkers alone are not sufficient for estimation of phytoestrogen status.  
Addition of other biomarkers utilising faecal and plasma samples should be considered 
for a more complete assessment of phytoestrogen status. 
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Appendix B. Pilot study questions 
                                                                                   Name:_________________________ 
 
Face validity and pilot test questions for the food frequency questionnaire  Please spend some time to answer the following questions and express your opinion about the food frequency questionnaire after you have completed it. Your response and opinion will be considered to make the food frequency questionnaire a better tool for everyone else to complete within a reasonable time.  
1. How long did it take you to complete this questionnaire?    
2. Do you find the format of the questionnaire easy to understand, i.e. portion size estimation, frequency of consumption? If not, please be specific of how it can be improved.    
3. Do you require visual aids for any Standard serve size to assist your portion size estimation? i.e. a photo of how a medium apple looks like, a photo of a tablespoon.    
4. Are there any food items that you normally consume but were not included in the questionnaire? Please name them to be considered in the questionnaire.      
5. Are there any comments in regards to improving the questionnaire?    
6. Would you prefer to do the questionnaire online? i.e. Qualtrics, PDF version with fillable space or Microsoft Word version ? 
 
Thank you so much for your time to test this questionnaire and your comments! 
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Appendix C. Demographic and lifestyle questionnaire 
 
Demographic and lifestyle 
questionnaire 
          Date:(DD/MM/YY)_____________________________  Subject ID # _____________________________________ Contact details:__________________________________  Date of birth:(DD/MM/YYYY)__________________  
1. Gender 
 Male         Female 
 
2. What is your age: __________________ 
 
3. Weight:_________________________    Height:_______________________    
BMI:________________________ 
 
4. What is your occupation, please specify: 
__________________________________________ 
 
5. What is your highest achieved or current level of education or qualification 
 University postgraduate (Master degree, PhD) 
 University undergraduate (Bachelor degree) 
 Certificate/Diploma (TAFE/technical college/business college) 
 Secondary school, Year 12 
 Secondary school, Year 10 
 Other, please specify: _____________________________________ 
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6. Ancestry/ethnicity  
Please describe which group(s) best defines the ancestry/ethnicity (based on a 
mixture of culture, religion, skin colour and language) of you and your biological 
parents. You may choose more than one group for each person. 
 
A. Caucasian – Australian/NZ (Anglo European), Europe (includes Russia Central and West Asia) & North Mediterranean, America, Canada, South Africa & Zimbabwe 
B. Indigenous Australian – Aboriginal, Torres Strait Islands 
C. Pacific Islander – New Zealand Maori or Pacific Islands, Hawaii, New Guinea 
D. South-East Asia – Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar/Burma, Philippines, Singapore, Thailand, Vietnam 
E. South Asian – Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka 
F. North East Asia – China, Hong Kong, Japan, Korea, Macau, Taiwan 
G. North Asia – Mongolia, Siberia 
H. Middle Eastern, North Africa, Somalia Peninsular – Algeria, Bahrain, Djibouti, Eritrea, Ethiopia, Egypt, Israel, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Oman, Palestinian Territories turkey, Turkish Cypriots, Qatar Saudi Arabia, Somalia, Syria, Tunisia, United Arab Emirates, Yemen 
I. Sub-Saharan Africa – indigenous African, African American 
J. Central/South America – Central/South America 
K. Other 
L. Don’t know 
 
 Your biological 
father 
 
Your biological 
mother 
You 
A. Caucasian    B. Indigenous Australian    C. Pacific Islander    D. South-East Asian    E. South Asian    F. North East Asian    G. North Asian    H. Middle Eastern, North Africa, Somali Peninsular    I. Sub-Saharan African    J. Central/South American    K. Other (please specify below)    L.  Don’t know    
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If Other, please specify for each: 
 
Your Biological father: 
______________________________________________________________________________ 
 
Your Biological mother: 
____________________________________________________________________________ 
 
You: _______________________________________________________________________ 
 7. Which language do you mainly speak at home (if more than one language, indicate 
the one that is spoken most often) 
 English 
 Italian 
 Greek 
 Cantonese 
 Arabic 
 Mandarin 
 Vietnamese 
 Spanish 
 German 
 Hindi 
 Other, please specify: _________________________________ 
 
8. What is your country of birth, please specify: 
____________________________________________________ 
If you were not born in Australia, please specify your date of arrival to Australia: 
____________________________________________DD/MM/YYYY  
 
9. What is your physical activity level 
 Sedentary, move only for necessary chores/walking/other activities 
1-2/week 
 Light, walking/other activities >3/week 
 Moderate, exercise to perspire 1-2 times/week, or moderate labour or 
physically demanding work 
 High, heavy exercise or sport several times/week, heavy labour or 
physically demanding work 
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10. Your smoking status: 
 Never smoked 
 Current smoker, daily, please specify how many times you smoke daily: ___ 
 Current smoker, weekly, please specify how many times you smoke weekly:  
 Current smoker, other, please specify the frequency you smoke: _______ 
 Past smoker 
 
11. Your bowel habits: 
11.1How often do you have bowel movement? 
     >7/week 
     4-7/week 
     1-3/week 
     <1/week 
 
11.2 What is the best way to describe your bowel movement? 
     Hard to pass  
     Smooth and soft to pass 
     Mushy and watery 
 
12. Supplemental use 
12.1 Do you take any commercial supplement? 
 Yes           No 
 
12.2 How many regular supplements do you take? E.g. vitamins, fish oil, flaxseed 
etc. 
     None 
  1  
  2 
  ≥3 
 
Regular: supplements taken consistently in the past month, e.g. 1 times per week, 
daily 
 
12. 3 Please specify the type, brand name, dosage and frequency of each 
supplement you take: (For the Frequency, please respond on either ‘times per 
week ‘ or ‘times per day’) 
(TURN to the back page) 
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Type of 
supplement 
Frequency (how often) Description (e.g. brand 
name) 
Dose (e.g. 500mg, 2 
capsules or 2 
teaspoons) 
Times per 
week 
Times per 
day 
Example:  Fish oil 3 times  Blackmores Omega Daily concentrated fish oil, double strength 
1034mg omega -3 triglycerides-fish 1 capsule 
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Appendix D. Three-day weighed food record  
3-Day Weighed Food Record 
          Subject ID # _____________________________________________________   Contact details: _________________________________________________    
          PLEASE write food record on two weekdays and one weekend 
 
Instruction to Complete the Food Record Food records allow detailed description of all food and beverages consumed over a period of multiple days. The food records provide a way to validate the data supplied from the Food Frequency Questionnaire. Data from the food records will be analysed statistically. It is very important that as much detail regarding the food and drinks you consumed, including the meal you consumed for, the amount you consumed, the place of consumption and preparation is written down.  
• Please eat as you usually eat  
• Record everything you eat and drink, including snacks 
• Complete the Meal, time, and place prepared and consumed columns for each meal or snack. Please write in name of restaurant if you know it. 
• Start each new day on a new page 
• You do not have to use the whole booklet; just record what you eat and drink on the day of recording. 
• Please write clearly         
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How to Record Each Food 
• Describe each food and beverages in detail, as best you can. See example below  
INCLUDE FOR EXAMPLE 
How prepared Fried, grilled, stir fried, roast, barbeque, pam fry 
Added fat Cook with oil, butter 
Brand name and 
type 
Wheatbelt Bakehouse Magnificent Multigrain with added Chia and quinoa 
Portion size 1/2 cup, 2 slices, 1tbsp  
• Describe each ingredient in a mixed dish in the food record, or use Recipes section on page 34. See example below  
Spaghetti Bolognese 11/2 cups cooked spaghetti, 125g lean beef mince, 1/4 large onion, sliced, 1 clove garlic, 100g crushed tomato, sliced mushrooms, 2tbsp salt reduced tomato paste  
Pizza 3/4 cup flour, 1tbsp vegetable oil, 40g cheese, 38g tomato, 20g mushroom, capsicum and onion, 75g pineapple, 40g chicken  
• Ideally weigh the amount of food before eating and record any leftovers with the provided kitchen scale. Estimate the amount of each ingredient with measuring tools. Demonstration on how to weigh food and drinks with the scale will be provided. Weights of food can be calculated by weighing total and subtracting utensil weight 
Accuracy and detail is essential. This includes obtaining information such as: 
• Dairy foods – varying fat contents, calcium enriched 
• Bread – type, e.g. white, multigrain, wholemeal, fruit/raisin, sour dough 
• Method of preparing food = e.g. boiled, baked, pan fried, stir fried, steamed, roast 
• Amount and type of fat used in cooking – olive, canola, sesame, butter  
• Use of fortified foods – e.g. calcium enriched, fortified cereals wit nuts and seeds 
• Brand names whatever possible – for bread, cereals 
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An Example: 
  
Food Record: 
Day: _________1________    Date: __21 (DD)_ /__8 (MM)__ / _2013_(YYYY)_ 
Scale and measuring tools used?     Yes       No  
Meal B=Breakfast L=Lunch D=Dinner S=Snacks 
Time Place 
prepared 
and 
consumed H=Home R=Restaurant O=Other, please specify 
Food and Beverages (Please describe Brand name, cooking method used, type i.e. low fat, and any additional information) 
Amount and unit 
of consumption, (e.g. Tbsp, Tsp, Oz., Pieces, Slice, Cup, gram, handful, glass, etc.) 
B 8am H Homemade breakfast cereal: 1 bowl      Milk, reduced fat, Harvey Fresh 200ml      Corn flakes, Freedom Foods 1/4 cup      Wheat germ powder 2 tsp      Almonds 6 nuts      Pistachio 4 nuts      Dried cranberry 5 berries      White chocolate chips 8 chips      Oat, minute, McKenzie’s 3/4 cup    All microwaved    
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Food Record: 
Day: _______________________________             Date: _____ /_____ / ______ 
Scale and measuring tools used?     Yes       No  
Meal B=Breakfast L=Lunch D=Dinner S=Snacks 
Time Place prepared 
and consumed H=Home R=Restaurant O=Other, please specify 
Food and Beverages (Please describe Brand name, cooking method used, type i.e. low fat, and any additional information) 
Amount and 
unit of 
consumption, (e.g. Tbsp, Tsp, Oz., Pieces, Slice, Cup, gram, handful, glass, etc.)                                                                                  
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Appendix E. Urine collection protocol 
 
Urine collection protocol for subjects - It is important that you drink normally during the day. This means do not drink more or less fluids than you usually would during a normal day. - For accurate evaluation of tests of how much metabolites are excreted on your 24-hour urine samples, it is important that you make the effort to collect every 
drop of urine during each 24-hour period.  - It is important that you will need to produce at least 100ml of urine per 24 hour 
 
You will need: 
• 3x3-litre urine collection bottles, with vitamin C added as preservative (supplied in 1st session) 
• A pen, pencil or marker 
• Funnel and Collection ‘hat’ (supplied in 1st session) 
• Cooler bag, ice pack (supplied in 1st session) 
• Watch/clock 
 1. You will be given equipment, 3x3-litre urine collection bottles, funnel, collection container/hat, cooler bag and ice pack for urine collection in the 1st session. Discuss with Winnie if you think you will need more collection bottles.   2. RECORD information, such as the start and complete date and time of urine collection, and sample complete or incomplete on the label of the bottles. If any sample is missed, record the time of the missed sample on the calendar provided.   3. BEGIN the urine collection, after you have DISCARDED the first urine sample you made in the morning or day after you wake up for the day ONE only. Record the time on the front of your bottle. You will collect all samples for the day TWO and day 
THREE.  4. COLLECT all urine for the remainder of the day, finishing with the last sample before rest. Write the finished time on the bottle.  5. Use the collection hat to assist the collection. Place the clean collection hat between the toilets bowl top and lid to hold it in place. Make sure the curved part of the hat is lined up with the front edge of the toilet bowl. You should urinate in the collection hat. If it is convenient, you can instead urinate directly into the bottles with the funnel.    
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6. Remove the red cap off the bottle; insert the funnel into the bottle. Transfer the urine to the bottle through the funnel without splashing or spilling. The collection ‘hat’ has a pour spout which makes it easy to pour the urine into the collection bottles. Close the cap when you finish transferring the urine sample into the bottle.  
Note: It is best to do the transferring immediately after urinating. If you get up during the night but do not pour the urine into the bottle immediately, please do so as soon as possible the next morning.  7. Please store the bottles in a cool place. If it is okay for you, you may store in the fridge. If not, for example, in bathroom or air conditioned environment, during the day of collection or in the cooler bag provided with ice pack. Remember to cap the bottle and close it tightly.  8. When you finish all 3x24-hour urine samples, put them all in the cooler bag with ice pack, along with other given equipment and ready to return them to Winnie.  If you know you will be on ECU Joondalup campus after you have finished one 24-hour urine collection, you may bring the completed 24-hour urine bottle from the previous day to Winnie at the time of your convenience. Please contact Winnie to do so.  Alternatively, you may choose to bring all the bottles along with other equipment and paperwork, i.e. Food record, calendar, food frequency questionnaire, to the 2nd session.   
Note:  If you need to have a bowel movement, any urine passed with the bowel movement should be collected. Try not to include faeces with the urine collection. If faeces does get mixed in, do not try to remove the faeces from the urine collection bottle.   For female subject, please do not collect samples during menstrual cycle.   The vitamin C powder inside the bottles is added as preservative. You will not be in direct contact with the powder. Please leave them as it is and the powder is not harmful. 
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Appendix F. Laboratory protocol for measuring weight and volume of urine 
 
Protocol for measuring total weight and volume of urine samples 
 
You will need: 
-24 hour urine sample 
-top pan balance 
-graduated cylinder, beaker 
 
 Record subject name and subject ID in the 24-hour urine sample page of the Lignan 
project laboratory manual 
 To obtain the weight of the 24-hour urine sample, weigh the urine bottle and the urine 
sample with the top pan balance, record the total weight (g) of bottle and urine in the 
laboratory manual 
 Decant the urine into the graduated cylinder to measure the total volume (L) for each day 
sample and record its volume in the laboratory manual  
 Weigh the empty bottle and subtract its weight from the total weight of the bottle and 
urine to obtain the weight of the urine 
 Record the weight (g) and volume (L) of each sample in the 24-hour urine samples page 
of the manual (Day 1, 2 or 3), indicate the completeness of each sample, the date of 
sample return and the date of sodium azide added 
 Rinse out the graduated cylinder after measurement of each day sample to minimise cross 
contamination 
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Appendix G. Laboratory protocol for urine sample aliquoting 
 
Protocol for sample aliquoting and aliquot storage 
 
You will need: 
-24 hour urine samples 
-sodium azide solution 
-pipette that measure 10ml, 10µL and pipette tip 
-dropper 
-10ml centrifuge tubes, 2ml eppendorf 
-beaker 
-label, pen and plastic bag 
 
 Create new entries of the urine aliquots in the Aliquot page of the Lignan project 
laboratory manual. Assign a subject ID to new subject. Assign a sample ID to each 
aliquot, record the content of each aliquot and create comment and note columns about 
what these samples, how they will be used for and how they will be treated  
 Rinse all glassware with water and urine sample before use 
 After measuring the total volume for each 24-hour urine sample with the graduated 
cylinder, decant urine into a 100ml beaker 
 Adjust the pipette to measure 10ml. Insert the appropriate pipette tip that can transfer the 
volume of 10ml. Use this 10ml pipette to measure one 10ml aliquot from each day 
sample and transfer into 10ml polypropylene centrifuge tubes. Label them with their 
subject and sample IDs (refer to Lignan project laboratory manual). These aliquots are 
sent to PathWest for creatinine analysis 
 Use a dropper or the pipette to measure two approximately 2ml urine into 2ml centrifuge 
tube from each day sample, you will have a total of six 2ml centrifuge tubes per subject. 
Close the lid. Label them with their unique sample IDs. These centrifuge tubes are 
reserved for Dr. Mary Boyce to develop urinary creatinine analysis method using 
capillary electrophoresis.  
 Top up the beaker with urine if necessary 
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 Prepare a sodium azide solution as per the Protocol for preparing the sodium azide 
solution.  
 Use the 10ml pipette to measure three 10ml aliquots from each day sample into 10ml 
polypropylene centrifuge tubes. You will have a total of twelve aliquots per subject, plus 
the first one prepared without sodium azide added for each day sample. Each tube is to 
be labeled with the type of sample (i.e. 24-hour urine), subject and sample ID, initial of 
person and the date of aliquoting  
 Adjust a different pipette that can measure 10µL and insert a pipette tip that can transfer 
this volume. Use this pipette to measure 10µL sodium azide solution and add to the other 
three 10ml aliquots (Except for the ones that will be sent to PathWest for creatinine 
analysis). 
 Mix the sodium azide by slowly inverting each tube 4 to 5 times.  
 Pour the unused volume of urine from the cylinder to the sink or decant back to the urine 
bottles (if needed), rinse the sink with shower, and clean the cylinder after aliquoting 
each day sample. Dispose the pipette tip and dropper after aliquoting each day sample 
and change to a new one before pipetting new day sample 
 You will have a total of twelve 10ml aliquots (four per each of three days sample) and six 
2ml centrifuge tubes (two per each of three days sample) per subject. Ensure the lids are 
closed firmly 
 Place the tubes for each subject in the rack. Put the rack with sample tubes in the plastic 
bag, with a paper label in the bag. The label should contain information of the name of 
the study (LIGNAN study), name of supervisor (Dr. Mary Boyce), date to discard (2018) 
 Store the plastic bag with rack of sample tubes in the -80°C freezer (19.206) 
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Appendix H. Screening questions  
Screening questions  These questions will be asked to screen potential participants. All answer must be No in order for a participant to be eligible to participate   1. Are you currently taking any antibiotics? Yes, exclude the subject.     No, ask Question 2  2. Have you taken any antibiotics for the past 6 to 12 months? Yes, exclude the subject     No, ask Question 3  3. Did you make substantial changes to your usual diet for the past 3 months? Yes, exclude the subject       No, ask Question 4  4. Do you have any currently diagnosed gastrointestinal problems, such as ulcerative colitis, or Crohn’s disease? Yes, exclude the subject       No, ask Question 5  5. Have you had gastric surgery that remove all or part of your large intestine? Yes, exclude the subject       No, ask Question 6  6. Do you have chronic renal or liver diseases? Or have had acute renal or liver diseases in the previous 6 to 12 months? Yes, exclude the subject.       No, subject is eligible to participate 
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Appendix I. Study flyer 
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Appendix J. Study calendar  
